0001654954-23-002031.txt : 20230224 0001654954-23-002031.hdr.sgml : 20230224 20230224080106 ACCESSION NUMBER: 0001654954-23-002031 CONFORMED SUBMISSION TYPE: 10-Q/A PUBLIC DOCUMENT COUNT: 55 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20230224 DATE AS OF CHANGE: 20230224 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tego Cyber, Inc. CENTRAL INDEX KEY: 0001815632 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 842678167 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-56370 FILM NUMBER: 23662396 BUSINESS ADDRESS: STREET 1: 8565 S. EASTERN AVENUE SUITE 150 CITY: LAS VEGAS STATE: NV ZIP: 89123 BUSINESS PHONE: 855-939-0100 MAIL ADDRESS: STREET 1: 8565 S. EASTERN AVENUE SUITE 150 CITY: LAS VEGAS STATE: NV ZIP: 89123 10-Q/A 1 tgcb_10qa.htm FORM 10-Q/A tgcb_10qa.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q/A

Amendment No. 1

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2022

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Transition Period from ____________ to . ____________

 

Commission File Number 000-56370

 

TEGO CYBER INC.

(Exact name of registrant as specified in its charter)

 

Nevada

 

84-2678167

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification Number)

 

8565 South Eastern Avenue, Suite 150

Las Vegas, Nevada, 89123

(Address of Principal Executive Offices) (Zip Code)

 

(855) 939-0100

(Registrant’s Telephone Number, Including Area Code)

 

Not applicable

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Title of each class

Trading Symbol(s)

Name of the principal U.S. market

 

 

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐     No ☒.

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒     No ☐ 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes      No ☒.

 

As of February 24, 2023, there were 34,681,377 shares of common stock issued and outstanding, par value $0.001 per share.

 

 

 

 

EXPLANATORY NOTE

 

Tego Cyber Inc. is filing this Amendment No. 1 on Form 10-Q/A for the period ended September 30, 2022, as filed with the Securities and Exchange Commission (the “SEC”) on November 21, 2022 (the “Original Filing”).

 

This Amendment No. 1 on Form 10-Q/A is to amend the accounting treatment of the issuance of three promissory notes issued by the Company during the fiscal quarter ended September 30, 2022. In the original Form 10-Q filing, the promissory notes were reported as convertible which is incorrect.

 

For convenience and ease of reference, the Company is filing this Form 10-Q/A in its entirety with all applicable changes and unless otherwise stated, all information contained in this amendment is as of November 21, 2022, the filing date of the Original Filing. Except as stated herein, this Form 10-Q/A does not reflect events or transactions occurring after such filing date or modify or update those disclosures in the original Form 10-Q that may have been affected by events or transactions occurring subsequent to such filing date.

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

Certain information included in this Quarterly Report on Form 10-Q and other filings of the Registrant under the Securities Act of 1933, as amended (the “Securities Act”), and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as well as information communicated orally or in writing between the dates of such filings, contains or may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements in this Quarterly Report on Form 10-Q, including without limitation, statements related to our plans, strategies, objectives, expectations, intentions and adequacy of resources, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, trends and uncertainties that could cause actual results to differ materially from expected results. Among these risks, trends and uncertainties are the availability of working capital to fund our operations, the competitive market in which we operate, the efficient and uninterrupted operation of our computer and communications systems, our ability to generate a profit and execute our business plan, the retention of key personnel, our ability to protect and defend our intellectual property, the effects of governmental regulation, and other risks identified in the Registrant’s filings with the Securities and Exchange Commission from time to time.

 

In some cases, forward-looking statements can be identified by terminology such as “may,” “will,” “should,” “could,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of such terms or other comparable terminology. Although the Registrant believes that the expectations reflected in the forward-looking statements contained herein are reasonable, the Registrant cannot guarantee future results, levels of activity, performance or achievements. Moreover, neither the Registrant, nor any other person, assumes responsibility for the accuracy and completeness of such statements. The Registrant is under no duty to update any of the forward-looking statements contained herein after the date of this Quarterly Report on Form 10-Q.

 

 

 

 

TEGO CYBER INC.

FORM 10-Q/A

SEPTEMBER 30, 2022

 

INDEX

 

 

 

 

Page

 

Part I – Financial Information

 

 

 

Item 1.

Financial Statements (Unaudited)

 

F-1

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operation

 

3

 

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

 

7

 

Item 4.

Controls and Procedures

 

7

 

 

 

 

 

 

Part II – Other Information

 

 

 

Item 1.

Legal Proceedings

 

9

 

Item 1A.

Risk Factors

 

9

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

 

9

 

Item 3.

Defaults Upon Senior Securities

 

9

 

Item 4.

Mine Safety Disclosures

 

11

 

Item 5.

Other Information

 

11

 

Item 6.

Exhibits

 

12

 

 

 

 

 

 

Signatures

 

13

 

 

 

 

 

Certifications

 

 

 

 

2

Table of Contents

 

PART I – FINANCIAL INFORMATION

    

Item 1. Financial Information

 

 

 

 

 

 

 

Condensed Consolidated Balance Sheets as of September 30, 2022 and June 30, 2022 (Unaudited)

 

F-2

 

 

 

 

 

Condensed Consolidated Statements of Operations for the Three Months Ended September 30, 2022 and the Three Months Ended September 30, 2021 (Unaudited)

 

F-3

 

 

 

 

 

Condensed Consolidated  Statements of Changes in Shareholders’ Equity for the Three Months Ended September 30, 2022 and the Three Month Ended September 30, 2021 (Unaudited)

 

F-4

 

 

 

 

 

Condensed Consolidated Statements of Cash Flows for the Three Months Ended September 30, 2022 and September 30, 2021 (Unaudited)

 

F-5

 

 

 

 

 

Notes to the Condensed Consolidated  Financial Statements for the Three Months Ended September 30, 2022 (Unaudited)

 

F-6

 

 

 
F-1

Table of Contents

 

TEGO CYBER INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(Expressed in US Dollars)

 

 

 

September 30, 2022

 

 

June 30, 2022

 

ASSETS

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Cash

 

$37,459

 

 

$47,742

 

Accounts receivable

 

 

-

 

 

 

1,150

 

Prepaid expenses (Note 5)

 

 

111,978

 

 

 

66,119

 

Total current assets

 

 

149,437

 

 

 

115,011

 

 

 

 

 

 

 

 

 

 

Computer equipment, net

 

 

1,398

 

 

 

3,207

 

Software (Note 6)

 

 

507,185

 

 

 

411,122

 

TOTAL ASSETS

 

$658,020

 

 

$529,340

 

 

 

 

 

 

 

 

 

 

LIABILITIES & SHAREHOLDERS’ DEFICIT

 

 

 

 

 

 

 

 

Accounts payable & accrued liabilities  (Note 7)

 

$67,677

 

 

$66,066

 

Notes payable, net (Note 9)

 

 

342,702

 

 

 

-

 

TOTAL LIABILITIES

 

 

410,379

 

 

 

66,066

 

 

 

 

 

 

 

 

 

 

SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Common shares 50,000,000 shares authorized $0.001 par value 26,483,044 shares issued and outstanding at September 30, 2022 and 25,508,044 shares at June 30, 2022

 

 

26,483

 

 

 

25,508

 

Additional paid in capital

 

 

5,687,572

 

 

 

4,586,049

 

Accumulated deficit

 

 

(5,466,414 )

 

 

(4,148,283 )

 

 

 

 

 

 

 

 

 

TOTAL SHAREHOLDERS’ EQUITY

 

 

247,641

 

 

 

463,274

 

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES & SHAREHOLDERS’ EQUITY

 

$658,020

 

 

$529,340

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

 

 
F-2

Table of Contents

 

TEGO CYBER INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(Expressed in US Dollars)

 

 

 

Three Months Ended

September 30, 2022

 

 

Three Months Ended

September 30, 2021

 

OPERATING EXPENSES

 

 

 

 

 

 

General & administration

 

$880,512

 

 

$260,341

 

Professional fees

 

 

64,962

 

 

 

117,274

 

Sales & marketing

 

 

180,324

 

 

 

65,382

 

 

 

 

 

 

 

 

 

 

TOTAL OPERATING EXPENSES

 

 

1,125,798

 

 

 

442,997

 

 

 

 

 

 

 

 

 

 

NET OPERATING LOSS

 

 

(1,125,798 )

 

 

(442,997 )

 

 

 

 

 

 

 

 

 

OTHER EXPENSE

 

 

 

 

 

 

 

 

  Accretion expense

 

 

(192,332)

 

 

(29,215 )

 

 

 

 

 

 

 

 

 

TOTAL OTHER EXPENSE

 

 

(192,332 )

 

 

(29,215 )

 

 

 

 

 

 

 

 

 

NET LOSS

 

$(1,318,130 )

 

$(472,212 )

 

 

 

 

 

 

 

 

 

BASIC AND DILUTED LOSS PER COMMON SHARE

 

$(0.05 )

 

$(0.02 )

 

 

 

 

 

 

 

 

 

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING

 

 

26,305,571

 

 

 

19,335,634

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

 

 
F-3

Table of Contents

 

TEGO CYBER INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2022 AND SEPTEMBER 30, 2021

(Unaudited)

(Expressed in US Dollars)

 

 

 

Number

of

Shares

 

 

Common

Stock

 

 

Additional

Paid-In

Capital

 

 

Subscriptions

Receivable

 

 

Accumulated

Deficit

 

 

Total

Shareholder

Equity

 

Balances, June 30, 2021

 

 

18,296,511

 

 

$18,297

 

 

$1,720,631

 

 

$(10,500 )

 

$(1,000,382 )

 

$728,046

 

Shares issued for cash

 

 

5,458,810

 

 

 

5,459

 

 

 

1,359,243

 

 

 

(9,500 )

 

 

-

 

 

 

1,355,202

 

Net loss for the period ended September 30, 2021

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(472,212 )

 

 

(472,212 )

Balances, September 30, 2021

 

 

23,755,321

 

 

$23,756

 

 

$3,079,874

 

 

$(20,000 )

 

$(1,472,594 )

 

$1,611,036

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances, June 30, 2022

 

 

25,508,044

 

 

$25,508

 

 

$4,586,049

 

 

$-

 

 

$(4,148,284)

 

$463,274

 

Shares issued as transaction costs for notes payable

 

 

700,000

 

 

 

700

 

 

 

151,442

 

 

 

-

 

 

 

-

 

 

 

152,142

 

Shares issued for services

 

 

275,000

 

 

 

275

 

 

 

137,225

 

 

 

-

 

 

 

-

 

 

 

137,500

 

Share-based compensation

 

 

-

 

 

 

-

 

 

 

625,367

 

 

 

-

 

 

 

-

 

 

 

625,367

 

Shares issued with notes payable

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Warrants issued with promissory notes

 

 

-

 

 

 

-

 

 

 

187,489

 

 

 

-

 

 

 

-

 

 

 

187,489

 

Net loss for the period ended September 30, 2022

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(1,318,130 )

 

 

(1,318,130 )

Balances, September 30, 2022

 

 

26,483,044

 

 

$26,483

 

 

$5,687,572

 

 

$-

 

 

$(5,466,414 )

 

$247,641

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

 

 
F-4

Table of Contents

 

TEGO CYBER INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE THREE MONTHS

ENDED SEPTEMBER 30, 2022 AND SEPTEMBER 30, 2021

 

(Unaudited)

(Expressed in US Dollars)

 

 

 

Three Months  Ended

September 30, 2022

 

 

Three Months Ended September 30, 2021

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

Net loss for the period

 

$(1,318,130 )

 

$(472,212 )

 

 

 

 

 

 

 

 

 

Adjustments to reconcile net loss to net cash used in operating activities

 

 

 

 

 

 

 

 

Shares issued for services

 

 

137,500

 

 

 

-

 

Interest on short term debt

 

 

-

 

 

 

1,816

 

Amortization

 

 

1,809

 

 

 

-

 

Accretion expense

 

 

-

 

 

 

29,215

 

Amortization of discount of debt issuance

 

 

192,332

 

 

 

-

 

Share-based compensation

 

 

625,367

 

 

 

-

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

1,150

 

 

 

300

 

Prepaid expenses

 

 

(45,859 )

 

 

9,273

 

Accounts payable and accrued liabilities

 

 

1,611

 

 

 

14,928

 

NET CASH USED IN OPERATING ACTIVITIES

 

 

(404,220 )

 

 

(416,680 )

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

 

 

 

 

 

Capitalized software development costs

 

 

(96,063 )

 

 

(36,950 )

NET CASH USED IN INVESTING ACTIVITIES

 

 

(96,063 )

 

 

(36,950 )

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

 

 

Proceeds from shares issued

 

 

-

 

 

 

1,355,202

 

Cash received from issuance of notes payable

 

 

540,000

 

 

 

-

 

Cash Costs for promissory notes

 

 

(50,000)

 

 

-

 

NET CASH PROVIDED BY FINANCING ACTIVITIES

 

 

490,000

 

 

 

1,355,202

 

 

 

 

 

 

 

 

 

 

NET INCREASE (DECREASE) IN CASH

 

 

(10,283 )

 

 

901,572

 

CASH AT BEGINNING OF THE PERIOD

 

 

47,742

 

 

 

583,015

 

CASH AT END OF THE PERIOD

 

$37,459

 

 

$1,484,587

 

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION

 

 

 

 

 

 

 

 

Cash paid for interest

 

$12,666

 

 

$-

 

Cash paid for taxes

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

NON-CASH TRANSACTIONS

 

 

 

 

 

 

 

 

Shares issued as transaction costs for notes payable

 

$152,142

 

 

 

-

 

Shares issued for services

 

$137,500

 

 

 

-

 

Warrants issued with notes payable

 

$187,489

 

 

 

-

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated audited financial statements

 

 
F-5

Table of Contents

 

  TEGO CYBER INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in US Dollars)

 

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS

 

Tego Cyber Inc. (the “Company”) was incorporated in the State of Nevada on September 6, 2019. It was created to capitalize on the emerging cyber threat intelligence market and has developed a state-of-the-art cyber threat intelligence application that enriches threat data to help enterprises identify cyber threats within their environments. Tego Guardian is a proactive intelligent cyberthreat hunting tool that gives enterprises the ability to quickly track threats throughout their networks, mapping out exposures and expediting remediation. Tego Guardian integrates with the widely used Splunk Security Information and Event Management (SIEM) platform. Tego Guardian is a Splunk approved app and available for download through Splunk’s marketplace. The Company plans on developing future versions of Tego Guardian for integration with other established SIEM systems and platforms including: Elastic, IBM QRadar, AT&T AlienVault, Exabeam, and Google Chronical.

 

The Company’s head office is at 8565 S. Eastern Ave. #150, Las Vegas, Nevada, 89123.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Preparation

The Company prepares its financial statements in accordance with rules and regulations of the Securities and Exchange Commission (“SEC”) and GAAP in the United States of America. The accompanying interim financial statements have been prepared in accordance with GAAP for interim financial information in accordance with Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the Company’s opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2022, are not necessarily indicative of the results for the full year. While management of the Company believes that the disclosures presented herein are adequate and not misleading, these interim financial statements should be read in conjunction with the audited financial statements and the footnotes thereto for the year ended June 30, 2022.

Going Concern

 

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of the business. The Company has incurred material losses from operations and has an accumulated deficit. At September 30, 2022, the Company had a negative working capital of $260,942. For the three months ended September 30, 2022, the Company sustained net losses and generated negative cash flows from operations. In March 2020, the World Health Organization recognized the outbreak of COVID-19 as a global pandemic. The COVID-19 pandemic and government actions implemented to contain the further spread of COVID-19 have severely restricted economic activity around the world. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that may be necessary should the Company be unable to continue as a going concern. These adjustments could be material. The Company’s continuation as a going concern is contingent upon its ability to earn adequate revenues from operations and to obtain additional financing. There is no assurance that the Company will be able to obtain such financings or obtain them on favorable terms.

 

 
F-6

Table of Contents

 

Use of Estimates

 

In preparing financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements, as well as the reported amounts of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. However, actual results could differ materially from those estimates.

 

Concentrations of Credit Risk

 

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and accounts receivable. As at September 30, 2022, substantially all of the Company’s cash was held by major financial institutions located in the United States, which management believes are of high credit quality. With respect to accounts receivable, the Company extended credit based on an evaluation of the customer’s financial condition. The Company generally did not require collateral for accounts receivable and maintained an allowance for doubtful accounts of accounts receivable if necessary.

 

Cash

 

Cash consists of cash held at major financial institutions and is subject to insignificant risk of changes in value.

 

Receivables and Allowance for Doubtful Accounts

 

Trade accounts receivable are recorded at net realizable value and do not bear interest. No allowance for doubtful accounts was made during the three-month period ended September 30, 2022 and the year ended June 30, 2022, based on management’s best estimate of the amount of probable credit losses in accounts receivable. The Company evaluates its allowance for doubtful accounts based upon knowledge of its customers and their compliance with credit terms. The evaluation process includes a review of customers’ accounts on a regular basis. The review process evaluates all account balances with amounts outstanding for more than 60 days and other specific amounts for which information obtained indicates that the balance may be uncollectible. As of September 30, 2022 and June 30, 2022, there was no allowance for doubtful accounts and the Company does not have any off-balance-sheet credit exposure related to its customers.

 

Software

 

Software is stated at cost less accumulated amortization and is amortized using the straight-line method over the estimated useful life of the asset. The estimated useful life of the asset is 5 years and is not amortized until it is available for use by the Company.

 

Leases

 

The Company determines if an arrangement is a lease at inception. Operating and financing right-of-use assets and lease liabilities are included on the balance sheet. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company uses its incremental borrowing rate, based on the information available at the commencement date, in determining the present value of future lease payments. Right-of-use assets include any prepaid lease payments and exclude any lease incentives and initial direct costs incurred. Operating lease expenses are recognized on a straight-line basis over the term of the lease, consisting of interest accrued on the lease liability and amortization of the right-of-use asset. The lease terms may include options to extend or terminate the lease is it is reasonably certain the Company will exercise that option. The Company leases its corporate office located at 8565 S. Eastern Ave. #150, Las Vegas, Nevada. The initial lease term is for 12 months commencing on September 8, 2019 after which the term is on a month-to-month basis. After the initial term, the Company may cancel the lease agreement at any time by providing 30 days written notice. The Company has elected the short-term lease practical expedient of 12 months and has not recorded a lease.

 

 
F-7

Table of Contents

 

Fair Value of Financial Instruments

 

Accounting Standards Codification (“ASC”) 820 “Fair Value Measurements and Disclosures”, adopted January 1, 2008, defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The Company’s financial instruments include cash, current receivables and payables. These financial instruments are measured at their respective fair values. The three levels are defined as follows:

 

Level 1 - inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.

 

Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.

 

Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value.

 

For cash, accounts receivable, accounts payable and accrued liabilities and due to related parties, it is management’s opinion that the carrying values are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and if applicable, their stated interest rate approximates current rates available.

 

For convertible debts, the carrying values, excluding any unamortized discounts, approximate the respective fair value. The convertible debts have been discounted to reflect their net present value as at September 30, 2022. The carrying values of embedded conversion features not considered to be derivative instruments were determined by allocating the remaining carrying value of the convertible debt after deducting the estimated carrying value of the liability portion.

 

Estimating fair value for warrants require determining the most appropriate valuation model which is dependent on the terms and conditions of the grant. This estimate requires determining the most appropriate inputs to the valuation model including the expected life of the warrant, volatility, dividend yield, and rate of forfeitures and making assumptions about them.

 

Revenue Recognition

 

Revenue is recognized under ASC 606, “Revenue from Contracts with Customers” using the modified retrospective method. Under this method, the Company follows the five-step model provided by ASC Topic 606 in order to recognize revenue in the following manner: 1) identify the contract; 2) identify the performance obligations of the contract; 3) determine the transaction price of the contract; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue. The Company recognizes revenue for the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services.

 

The Company currently has not generated any revenue from its threat intelligence software.

 

Income Taxes

 

The Company uses the asset and liability method of accounting for income taxes pursuant to ASC 740 “Income Taxes”. ASC 740 requires an asset and liability approach for financial accounting and reporting for income taxes and allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Valuation allowances are provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The provision for income taxes represents current taxes payable net of the change during the period in deferred tax assets and liabilities.

 

 
F-8

Table of Contents

 

Earnings (Loss) per Share

 

Basic earnings (loss) per share is computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. If applicable, diluted earnings (loss) per share assume the conversion, exercise or issuance of all common stock instruments unless the effect is to reduce a loss or increase earnings (loss) per share.

 

Recently Issued Accounting Pronouncements

 

In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes which amends ASC 740 Income Taxes (ASC 740). This update is intended to simplify accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and amending existing guidance to improve consistent application of ASC 740. This update is effective for fiscal years beginning after December 15, 2021. The guidance in this update has various elements, some of which are applied on a prospective basis and others on a retrospective basis with earlier application permitted. The Company’s management is currently evaluating the effect of this ASU on the Company’s financial statements and related disclosures.

 

In June 2020, the FASB issued ASU 2020-05 in response to the ongoing impacts to U.S. businesses in response to the COVID-19 pandemic. ASU 2020-05, Revenue from Contracts with Customers (Topic 606) and Leases (Topic 842) Effective Dates for Certain Entities provide a limited deferral of the effective dates for implementing previously issued ASU 606 and ASU 842 to give some relief to businesses considering the difficulties they are facing during the pandemic. These entities may defer application to fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. As the Company has already adopted ASU 606 and ASU 842, the Company does not anticipate any effect on its financial statements.

 

In August 2020, the FASB issued ASU 2020-06Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. ASU 2020-06 reduces the number of accounting models for convertible debt instruments and convertible preferred stock. For convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital, the embedded conversion features no longer are separated from the host contract. ASU 2020-06 also removes certain conditions that should be considered in the derivatives scope exception evaluation under Subtopic 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity, and clarify the scope and certain requirements under Subtopic 815-40. In addition, ASU 2020-06 improves the guidance related to the disclosures and earnings-per-share (EPS) for convertible instruments and contract in entity’s own equity. ASU 2020-06 is effective for public business entities that meet the definition of a SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Board specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Company’s management is currently evaluating the impact this ASU will have on its financial statements.

 

Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying consolidated financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

 

NOTE 5 – PREPAID EXPENSES

 

Prepaid expense balance as of September 30, 2022 and June 30, 2022 consisted of the following:

 

 

 

September 30, 2022

 

 

June 30, 2022

 

Advertising & promotion

 

$10,109

 

 

$5,500

 

Consultants & contractors

 

 

10,055

 

 

 

5,301

 

Platform costs

 

 

21,814

 

 

 

30,318

 

Software development

 

 

70,000

 

 

 

25,000

 

Total

 

$111,978

 

 

$66,119

 

 

 
F-9

Table of Contents

 

NOTE 6 – SOFTWARE

 

The Company has developed an automated threat intelligence defense platform, marketed as Tego Guardian. Tego Guardian is a threat correlation and threat hunting application that integrates directly into existing Security Information and Event Management (SIEM) platforms to provide threat tracking, mapping of exposures, and assist with expediting remediation. With performance capable of querying over 1 million records in just 4 seconds, Tego Guardian saves security operations teams time and money in an environment where timing is everything as efforts are made to lower mean-time-to-detection (MTTD) and mean-time-to-response (MTTR). What makes Tego Guardian different from other cyber threat correlation applications, is that it is the first commercially available solution that was specifically developed for the customer’s existing SIEM platform. It operates within the platform environment, so security operations teams do not have to use multiple tools and views to complete a specific task or research a threat. Tego Guardian cross-correlates threats in real time and not only looks forward but also backwards in order to see if the organization’s network has been previously exposed (active foresight and hindsight). The first version of Tego Guardian integrates with the industry leading Splunk® SIEM platform. Tego Guardian is now available for download through Splunk’s app store and is compatible with Splunk Cloud and Splunk Enterprise versions: 9.0, 8.2, 8.1, and 8.0.

 

Balance, June 30, 2021

 

$75,750

 

Additions

 

 

335,372

 

Amortization

 

 

-

 

Balance, June 30, 2022

 

$411,122

 

Additions

 

 

96,063

 

Amortization

 

 

-

 

Balance, September 30, 2022

 

$507,185

 

 

As at September 30, 2022, the software was not generating revenue and no amortization has been recorded for the periods then ended. It is expected the software will begin to generate revenue in the quarter ending December 31, 2022.

 

NOTE 7 – ACCOUNTS PAYABLE & ACCRUED LIABILITIES

 

Accounts payable & accrued liabilities balance as of September 30, 2022 and June 30, 2022 consisted of the following:

 

 

 

September 30, 2022

 

 

June 30, 2022

 

Exchange & listing fees

 

 

710

 

 

 

-

 

Legal & accounting

 

 

13,213

 

 

 

23,247

 

Platform costs

 

 

2,856

 

 

 

-

 

Software development

 

 

50,898

 

 

 

42,819

 

Total

 

$67,677

 

 

$66,066

 

 

NOTE 8 – RELATED PARTY TRANSACTIONS

 

Related party transactions are measured at the exchange amount, which is the amount of consideration established and agreed to by the related parties. Related parties are natural persons or other entities that have the ability, directly, or indirectly, to control another party or exercise significant influence over the party in making financial and operating decisions. Related parties include other parties that are subject to common control or that are subject to common significant influences.

 

 
F-10

Table of Contents

 

During the three-month period ended September 30, 2022, there were transactions incurred between the Company and Shannon Wilkinson, Director, CEO, President, Secretary and Treasurer of the Company for management fees of $Nil (September 30, 2021 - $45,000) and gross wages of $30,000 (September 30, 2021 - $8,692).

 

During the three-month period ended September 30, 2022, there were transactions incurred between the Company and Earl Johnson, Chief Financial Officer of the Company for gross wages of $9,000 (September 30, 2021 - $Nil).

 

During the three-month period ended September 30, 2022, there were transactions incurred between the Company and Chris White, Director and Chief Information Security Officer of the Company for management fees of $Nil (September 30, 2021 - $12,500) and gross wages of $12,500 (September 30, 2021 - $6,519).

 

During the three-month period ended September 30, 2022, there were transactions incurred between the Company and Troy Wilkinson, Director of the Company for management fees of $10,000 (September 30, 2021 - $20,000).

 

NOTE 9 – NOTES PAYABLE (convertible only at default)

 

(a)

On July 12, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $300,000 at $270,000 with a $30,000 original issue discount. In connection with this note, the Company paid an additional $27,500 in cash transaction costs, issued 350,000 common shares valued at $175,000 in transaction costs, and issued 500,000 warrants exercisable at $0.25 per share, expiring on July 12, 2027. The warrants were calculated to have a fair value of $215,638 as at September 30, 2022. This note payable is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly.

 

 

 

The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.

 

 

 

The proceeds were allocated between the note payable, warrants and shares issued on a relative fair value basis. The fair value of the note payable was calculated using the present value of the debt and related interest at 12% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 10) and the shares issued were allocated proportionately for issuance cost for liability and equity portions under ASC 470-20 Debt with Conversion and Other Options. The shares are valued based on a relative fair market value of the shares on the issuance date.

 

 

 

In connection with the notes, the Company issued warrants indexed to an aggregate 500,000 shares of common stock. The warrants have a term of five years and an exercise price of $0.25. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair value of $93,740.

 

 

 

The Company also agreed to pay a commitment fee of $175,000 by issuing that number of shares of the Company’s common stock equal to such amount, aggregating to a total of 350,000 common shares of the Company. Under ASC 1.2.2 Debt Issuance Costs, the Company recognized the commitment fee as incremental costs specifically attributable to issuing the promissory note, while the commitment fee share were recorded in additional paid-in capital under their aggregate relative fair value of $76,074.

 

 

 

As at September 30, 2022, the carrying value of this note payable was $171,518 (September 30, 2021 - $Nil) net of $128,482 unamortized discounts.

 

 
F-11

Table of Contents

 

(b)

On July 15, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $150,000 at $135,000 with $15,000 original issue discount. In connection with this note, the Company paid an additional $11,250 in cash transaction costs, issued 175,000 common shares valued at $87,500 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on July 15, 2027. This promissory note is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly.

 

 

 

The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.

 

 

 

The proceeds were allocated between the note payable, warrants and shares issued on a relative fair value basis. The fair value of the note payable was calculated using the present value of the debt and related interest at 12% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 10) and the shares issued were allocated proportionately for issuance cost for liability and equity portions under ASC 470-20 Debt with Conversion and Other Options. The shares are valued based on a fair market value of the shares on the issuance date.

 

 

 

In connection with the notes, the Company issued warrants indexed to an aggregate 250,000 shares of common stock. The warrants have a term of five years and an exercise price of $0.25. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair value of $46,878.

 

 

 

The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.

 

 

 

The Company also agreed to pay a commitment fee of $87,500 by issuing that number of shares of the Company’s common stock equal to such amount, aggregating to a total of 175,000 common shares of the Company. Under ASC 1.2.2 Debt Issuance Costs, the Company recognized the commitment fee as incremental costs specifically attributable to issuing the promissory note, while the commitment fee share were recorded in additional paid-in capital under their aggregate relative fair value of $38,033.

 

 

 

As at September 30, 2022, the carrying value of this note payable was $86,129 (September 30, 2021 - $Nil) net of $63,871 unamortized discounts.

 

 

(c)

On July 18, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable e in the principal amount of $150,000 at $135,000 with $15,000 original issue discount. In connection with this note, the Company paid an additional $11,250 in cash transaction costs, issued 175,000 common shares valued at $87,500 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on July 18, 2027. This note payable is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly.

 

 
F-12

Table of Contents

 

 

The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.

 

 

 

The proceeds were allocated between the note payable, warrants and shares issued on a relative fair value basis. The fair value of the note payable was calculated using the present value of the debt and related interest at 12% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 10) and the shares issued were allocated proportionately for issuance cost for liability and equity portions under ASC 470-20 Debt with Conversion and Other Options. The shares are valued based on a fair market value of the shares on the issuance date.

 

 

 

In connection with the notes, the Company issued warrants indexed to an aggregate 250,000 shares of common stock. The warrants have a term of five years and an exercise price of $0.25. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair value of $46,871.

 

 

 

The Company also agreed to pay a commitment fee of $87,500 by issuing that number of shares of the Company’s common stock equal to such amount, aggregating to a total of 175,000 common shares of the Company. Under ASC 1.2.2 Debt Issuance Costs, the Company recognized the commitment fee as incremental costs specifically attributable to issuing the promissory note, while the commitment fee share were recorded in additional paid-in capital under their aggregate relative fair value of $38,034.

 

 

 

As at September 30, 2022, the carrying value of this note payable was $85,055 (September 30, 2021 - $Nil) net of $64,945 unamortized discounts.

 

NOTE 10 – COMMON SHARES

 

Common Stock

 

At September 30, 2022, the Company’s authorized capital consisted of 50,000,000 of common shares with a par value of $0.001

 

During the three-month period ended September 30, 2022, the Company incurred the following transactions:

 

On July 12, 2022, the Company issued 350,000 common shares at a relative fair value of $0.22 per share for transaction costs associated with the issuance of a note payable.

 

On July 15, 2022, the Company issued 175,000 common shares at a relative fair value of $0.22 per share for transaction costs associated with the issuance of a note payable.

 

On July 18, 2022, the Company issued 175,000 common shares at a relative fair value of $0.22 per share for transaction costs associated with the issuance of a note payable.

 

On July 26, 2022, the Company issued 275,000 common shares at a price of $0.50 per share for marketing and branding services valued at $137,500.

 

 
F-13

Table of Contents

 

During the year ended June 30, 2022, the Company incurred the following transactions:

 

During the period July 1, 2021 to October 28, 2021, the Company completed various private placements whereby a total of 5,558,810 common shares were issued for a total proceeds of $1,425,202.

 

On October 15, 2021, the Company issued 125,000 common shares at a price of $0.80 per share for marketing services valued at $100,000.

 

On October 28, 2021, the Company issued 28,572 common shares at a price of $0.70 per share for legal services valued at $20,000.

 

On December 8, 2021, the Company issued 50,000 common shares at a price of $0.71 per share for consulting services valued at $35,250.

 

On December 31, 2021, the Company issued 583,936 common shares for the conversion of debt at a conversion price of $0.10 per share for a total value of $58,394.

 

On December 31, 2021, the Company issued 353,215 common shares for the conversion of debt at a conversion price of $0.10 per share for a total value of $35,321. See Note 10 (b).

 

On January 1, 2022, the Company issued 100,000 common shares at a price of $0.65 per share for consulting services valued at $65,000.

 

On March 25, 2022, the Company issued 12,000 shares to a non-related party at a price of $0.60 per share for a total value of $7,200 in exchange for services.

 

On May 19, 2022, the Company issued 400,000 shares to a non-related party at a price of $0.577 per share for investor relations services valued at $230,800.

 

Warrants

 

On December 28, 2020, the Company granted 1,100,000 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction. The warrants were valued at $146,942 using the Black Scholes Option Pricing Model.

 

On March 25, 2021, the Company granted 1,100,000 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction. The warrants were valued at $148,438 using the Black Scholes Option Pricing Model.

 

On April 22, 2021, the Company granted 506,838 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction. The warrants were valued at $399,087 using the Black Scholes Option Pricing Model.

 

On April 28, 2021, the Company granted 307,408 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction. The warrants were valued at $196,399 using the Black Scholes Option Pricing Model.

 

On July 12, 2022, the Company granted 500,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $215,638 using the Black Scholes Option Pricing Model and they were recorded at $93,740 in additional paid-in capital under using the relative fair value method.

 

On July 15, 2022, the Company granted 250,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a   note payable financing transaction (Note 9). The warrants were valued at $107,848 using the Black Scholes Option Pricing Model and they were recorded at $46,878 in additional paid-in capital under using the relative fair value method.

 

On July 18, 2022, the Company granted 250,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $107,831 using the Black Scholes Option Pricing Model and they were recorded at $46,871 in additional paid-in capital under the using relative fair value method.

 

 
F-14

Table of Contents

 

The Black Scholes Option Pricing Model assumptions used in the valuation of the warrants are outlined below. The stock price was based on recent issuances. Expected life was based on the expiry date of the warrants as the Company did not have historical exercise data of such warrants.

 

 

 

September 30, 2022

 

 

Stock price

 

$0.50 - $0.51

 

 

Risk-free interest rate

 

3.19%-3.22

 

Expected life

 

5 Years

 

 

Expected dividend rate

 

0

 

 

Expected volatility

 

103.20% - 103.28

%

 

 

Continuity of the Company’s common stock purchase warrants issued and outstanding is as follows:

 

 

 

Number

of

Warrants

 

 

Weighted

Average

Exercise

Price

 

Outstanding, June 30, 2022

 

 

3,014,246

 

 

$0.25

 

Granted

 

 

1,000,000

 

 

 

0.25

 

Exercised

 

 

-

 

 

 

-

 

Expired

 

 

-

 

 

 

-

 

Outstanding, September 30, 2022

 

 

4,014,246

 

 

$0.25

 

 

As at September 30, 2022, the weighted average remaining contractual life of warrants outstanding was 4.80 years with an intrinsic value of $0.25.

 

Stock Options

 

On December 8, 2021, the Board of Directors of the Company approved the adoption of the 2021 Equity Compensation Plan (the “Equity Compensation Plan”) to provide employees, certain consultants and advisors who perform services for the Company, and non-employee members of the Board of Directors of the Company with the opportunity to receive grants of incentive stock options, nonqualified stock options, stock appreciation rights, stock awards, stock units and other stock-based awards.

 

The following is a continuity schedule for the Company’s outstanding non-qualified stock options:

 

 

 

Number of

options

 

 

Weighted

Average

Exercise Price

 

Outstanding, June 30, 2022

 

 

6,000,000

 

 

$0.65

 

Granted

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

Cancelled

 

 

-

 

 

 

-

 

Outstanding, September 30, 2022

 

 

6,000,000

 

 

$0.65

 

 

 
F-15

Table of Contents

 

At September 30, 2022, the Company had the following stock options outstanding:

 

Grant

Date

 

Number

Outstanding

 

 

Number

Exercisable

 

 

Exercise

Price

 

 

Weighted

Average Life

(Years)

 

 

Expiry Date

 

January 3, 2022

 

 

125,000

 

 

 

125,000

 

 

$0.65

 

 

 

9.27

 

 

January 3, 2032

 

January 4, 2022

 

 

5,875,000

 

 

 

5,875,000

 

 

 

0.65

 

 

 

9.27

 

 

January 4, 2032

 

Total

 

 

6,000,000

 

 

 

6,000,000

 

 

$0.65

 

 

 

9.27

 

 

 

 

 

During the three-month period ended September 30, 2022, the Company recorded $382,577 as share-based compensation relating to the issuance of the non-qualified stock options.

 

The fair value of the options granted during the year ended September 30, 2022 was estimated on the date of the grant date using the Black-Scholes option pricing model with the following weighted average assumptions:

 

Expected volatility

 

 

91.03%

Expected option life (years)

 

6 years

 

Risk-free interest rate (10-year U.S. treasury yield)

 

1.55 - 1.66

%

Expected dividend yield

 

 

0%

 

Performance Stock Units

 

On December 8, 2021, the Board of Directors of the Company approved the adoption of the 2021 Equity Compensation Plan (the “Equity Compensation Plan”) to provide employees, certain consultants and advisors who perform services for the Company, and non-employee members of the Board of Directors of the Company with the opportunity to receive grants of incentive stock options, nonqualified stock options, stock appreciation rights, stock awards, stock units and other stock-based awards.

 

The following is a continuity schedule for the Company’s outstanding performance stock units:

 

 

 

Number of

Performance

Units

 

 

Weighted

Average Exercise

Price

 

Outstanding, June 30, 2022

 

 

4,000,000

 

 

$-

 

Granted

 

 

-

 

 

 

-

 

Released

 

 

-

 

 

 

-

 

Forfeited or cancelled

 

 

-

 

 

 

-

 

Outstanding, September 30, 2022

 

 

4,000,000

 

 

$-

 

 

At September 30, 2022, the Company had the following performance units outstanding:

 

Grant

Date

 

Number

Outstanding

 

 

Number

Exercisable

 

 

Exercise

Price

 

Weighted Average Life (Years)

 

 

Expiry Date

 

March 8, 2022

 

 

4,000,000

 

 

 

4,000,000

 

 

USD $0.00

 

 

4.25

 

 

December 31, 2026

 

Total

 

 

4,000,000

 

 

 

4,000,000

 

 

USD $0.00

 

 

4.25

 

 

 

 

 

During the three-month period ended September 30, 2022, the Company recorded $242,790 as share-based compensation relating to the issuance of the performance units.

 

The fair value of the performance units granted during the year ended September 30, 2022 was estimated on the date of the grant date using N(d2) output from a Black-Sholes model to calculate the value of the award multiplying N(d2) by the current stock price as of the valuation date with the following weighted average assumptions:

 

Expected volatility

 

 

85.0%

Requisite period

 

4.25 years

 

Risk-free interest rate (US Treasury Bond rate as of the grant date)

 

 

1.80%

Expected dividend yield

 

 

0%

 

 
F-16

Table of Contents

 

NOTE 11 – INCOME TAXES

 

As of September 30, 2022, the Company was in a loss position; therefore, no deferred tax liability was recognized related to the undistributed earnings subject to withholding tax.

 

Net operating loss carry forward of the Company, amounted to $3,406,686 (June 30, 2022 - $2,909,935) for the three-month period ended September 30, 2022. The net operating loss carry forwards are available to be utilized against future taxable income for years through calendar year 2042. In assessing the reliability of deferred income tax assets, management considers whether it is more likely than not that some portion or all of the deferred income tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled projected future taxable income, and tax planning strategies in making this assessment.

 

NOTE 12 – RECLASSIFICATION OF PRIOR YEAR PRESENTATION

 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications are limited to the Statement of Operations and have no effect on the reported results of operations.

 

NOTE 13 – SUBSEQUENT EVENTS

 

On October 13, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $150,000 at $135,000 with $15,000 original issue discount. In connection with this note, the Company paid an additional $23,750 in cash transaction costs, issued 416,667 common shares valued at $50,000 in transaction costs, and issued 500,000 warrants exercisable at $0.25 per share, expiring on October 13, 2027. This note payable is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly, and matures on April 13, 2023 (the “Maturity Date”). The Maturity Date may be extended by up to 6 months following the date of the original Maturity Date. In the event that the Maturity Date is extended, the interest rate shall increase to 18% per annum for any period following the original Maturity Date, payable monthly.

 

On October 13, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $75,000 at $135,000 with $7,500 original issue discount. In connection with this note, the Company paid an additional $5,625 in cash transaction costs, issued 208,300 common shares valued at $25,000 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on October July 13, 2027. This note payable is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly, , and matures on April 13, 2023 (the “Maturity Date”). The Maturity Date may be extended by up to 6 months following the date of the original Maturity Date. In the event that the Maturity Date is extended, the interest rate shall increase to 18% per annum for any period following the original Maturity Date, payable monthly.

 

On October 13, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $75,000 at $135,000 with $7,500 original issue discount. In connection with this note, the Company paid an additional $5,625 in cash transaction costs, issued 208,300 common shares valued at $25,000 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on October July 13, 2027. This note payable is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly,  and matures on April 13, 2023 (the “Maturity Date”). The Maturity Date may be extended by up to 6 months following the date of the original Maturity Date. In the event that the Maturity Date is extended, the interest rate shall increase to 18% per annum for any period following the original Maturity Date, payable monthly.

 

On November 29, 2022, the Company completed a private placement whereby a total of 100,000 common shares were issued for cash at a price of $0.10 per share for a total value of $10,000.

 

On December 5, 2022, the Company completed a private placement whereby a total of 400,000 common shares were issued for cash at a price of $0.10 per share for a total value of $40,000.

 

On January 6, 2023, the Company completed a private placement whereby a total of 100,000 common shares were sold for cash at a price of $0.10 per share for a total value of $10,000. Shares have yet to be issued.

 

 
F-17

Table of Contents

 

On January 9, 2023, the Company issued 500,000 shares with a fair value of $100,000 to a non-related party in exchange for services.

 

On January 9, 2023, the Company issued 45,000 shares with a fair value of $9,000 to a non-related party in exchange for settlement of a debt.

 

On January 11, 2023, the Company completed a private placement whereby a total of 300,000 common shares were sold for cash at a price of $0.10 per share for a total value of $30,000.

 

On January 15, 2023, the Company completed a private placement whereby a total of 600,000 common shares were sold for cash at a price of $0.10 per share for a total value of $60,000.

 

On January 16, 2023, the Company completed a private placement whereby a total of 150,000 common shares were sold for cash at a price of $0.10 per share for a total value of $15,000.

 

On January 17, 2023, the Company completed various a private placement whereby a total of 70,000 common shares were sold for cash at a price of $0.10 per share for a total value of $7,000.

 

On January 21, 2023, the Company completed various private placements whereby a total of 1,115,000 common shares were issued for cash at a price of $0.10 per share for a total value of $111,500.

 

On January 22, 2023, the Company completed a private placement whereby a total of 15,000 common shares were sold for cash at a price of $0.10 per share for a total value of $1,500.

 

On January 23, 2023, the Company completed various private placements whereby a total of 430,000 common shares were sold for cash at a price of $0.10 per share for a total value of $43,000.

 

On January 24, 2023, the Company completed a private placement whereby a total of 1,000,000 common shares were sold for cash at a price of $0.10 per share for a total value of $100,000.

 

On January 25, 2023, the Company completed a private placement whereby a total of 100,000 common shares were sold for cash at a price of $0.10 per share for a total value of $10,000.

 

On January 28, 2023, the Company completed a private placement whereby a total of 150,000 common shares were sold for cash at a price of $0.10 per share for a total value of $15,000.

 

On January 30, 2023, the Company completed various private placement whereby a total of 850,000 common shares were sold for cash at a price of $0.10 per share for a total value of $85,000.

 

On February 6, 2023, the Company completed a private placement whereby a total of 225,000 common shares were sold for cash at a price of $0.10 per share for a total value of $22,500. Shares have yet to be issued.

 

On February 6, 2023, the Company issued 1,000,000 shares with a fair value of $200,000 to a non-related party in exchange for services.

 

On February 7, 2023, the Company completed a private placement whereby a total of 215,000 common shares were sold for cash at a price of $0.10 per share for a total value of $21,500.

 

On February 14, 2023, the Company completed a private placement whereby a total of 1,000,000 common shares were sold for cash at a price of $0.10 per share for a total value of $100,000. Shares have yet to be issued.

 

 
F-18

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

You should read the following discussion and analysis of our financial condition and results of operations together with our condensed financial statements and related notes appearing in this Quarterly Report on Form 10-Q. This discussion and other parts of this Quarterly Report contain forward-looking statements that involve risks and uncertainties, such as statements of our plans, objectives, expectations and intentions. As a result of many factors, including those factors set forth in the “Risk Factors” section of this Quarterly Report, our actual results could differ materially from the results described in, or implied by, the forward-looking statements contained in the following discussion and analysis.

 

Overview

 

We were incorporated in the State of Nevada on September 6, 2019. We have developed a cyber threat intelligence application that integrates with top end security platforms to gather, analyze, then proactively identify threats to an enterprise network. The Tego Guardian app takes in vetted and curated threat data and through a proprietary process compiles, analyzes, and delivers that data to an enterprise network in a format that is timely, informative and relevant. The first version of the Tego Guardian app integrates with the Splunk SIEM (Security Information and Event Management) platform. Splunk is a recognized industry leader in data analytics and has an established user base of over 22,000 enterprise clients including 90 of the Fortune 100 companies. The Tego Guardian app will be marketed as a value-add enhancement to an existing Splunk SIEM environment. Tego Guardian adds value by providing data enrichment: a detailed ‘who, what, when and where’ of any potential cyberthreat within an enterprise network environment. Other similar applications identify that something is ‘bad’ but do not provide any additional context, so it is up to the enterprise’s cybersecurity team to analyze the threat data to establish which threats need to be acted upon. It is then up to the enterprise’s cybersecurity team to analyze the threat data to establish which threats need to be acted upon. Tego Guardian automates this process thereby saving the enterprise time and money. The Tego Guardian app is now available to Splunk SIEM platform users via direct download through Splunk’s app store: Splunkbase. Tego Cyber plans to develop future versions of the Tego Guardian app for integration with other leading SIEM platforms including Elastic, Devo, IBM QRadar, AT&T Cybersecurity, Exabeam and Google Chronical. The goal is to have a version of the Tego Guardian available for integration with these SIEM platforms within the next two years. For more information, please visit www.tegocyber.com.

 

Results of operations for the three months ended September 30, 2022 compared to the three months ended September 30, 2021

 

Revenues

 

We are in development stage and generated $Nil revenue for the three months ended September 30, 2022 compared to $Nil for the three months ended September 30, 2021.

 

Operating Expenses

 

We incurred total operating expenses of $1,125,798 for the three months ended September 30, 2022, compared to $442,997 for the three months ended September 30, 2021. These amounts consisted of the following:

 

 

 

2022

 

 

2021

 

General & administration

 

$880,512

 

 

$260,341

 

Professional fees

 

 

64,962

 

 

 

117,274

 

Sales & marketing

 

 

180,324

 

 

 

65,382

 

Total operating expenses

 

$1,125,798

 

 

$442,997

 

 

General & administration increased by $620,171 to $880,512 for the three months ended September 30, 2022, as compared to $260,341 for the three months ended September 30, 2021, due to share-based compensation of $625,367  relating to the  issuance of  non-qualified stock options and performance stock units.  Professional fees decreased by $52,312 to $64,962 for the three months ended September 30, 2022, as compared to $117,274 for the three months ended September 30, 2021, as we had completed our initial public listing on the OTCQB.

 

 
3

Table of Contents

 

Sales & marketing increased $114,942 to $180,324 for the three months ended September 30, 2022, as compared to $65,382 for the three months ended September 30, 2021, due to the commercialization of the first version of our application. 

 

Net Loss

 

We incurred a net loss of $1,318,130 for the three months ended September 30, 2022 compared to a net loss of $472,212 for the three months ended September 30, 2021.

 

Liquidity and Capital Resources

 

As at September 30, 2022, we have a working capital deficit of $260,942, a net loss of $1,318,130 and have earned no revenue to cover our operating costs. We have $37,459 cash on hand and our burn rate is approximately $150,000 per month. We intend to fund future operations through debt or equity financing arrangements. Our ability to realize our business plan is dependent upon, among other things, obtaining additional financing to continue operations, and development of our business plan. In response to these problems, management intends to raise additional funds through debt, public or private placement offerings. These factors, among others, raise substantial doubt about our ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Cash Flow from Operating Activities

 

For the three months ended September 30, 2022, the cash flows used in our operating activities was $404,220 compared to $416,680 for the three months ended September 30, 2021. This amount was primarily related to a net loss of $1,318,130 and share based compensation of $625,367.

 

Cash Flow from Investing Activities

 

For the three months ended September 30, 2022, the net cash used in investing activities by the Company was $96,063 compared to $36,950 for the three months ended September 30, 2021. The amount was related to the capitalization of software development costs.

 

Cash Flow from Financing Activities

 

For the three months ended September 30, 2022, the net cash provided by financing activities by the Company was $490,000 compared to $1,355,202 for the three months ended September 30, 2021. The cash provided by financing activities is related to the proceeds received from the issuance of notes payable debt and sales of our common stock.

 

Contractual Obligations

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

Future Financings 

 

We will continue to rely on equity sales of our common shares and debt proceeds in order to continue to fund our business operations. Issuances of additional shares will result in dilution to existing stockholders. There is no assurance that we will achieve any additional sales of the equity securities or arrange for debt or other financing to fund our operations and other activities.

 

Expected Purchase or Sale of Significant Equipment

 

We do not anticipate the purchase or sale of any significant equipment, as such items are not required by us at this time or in the next twelve months.

 

 
4

Table of Contents

 

Off-Balance Sheet Arrangements

 

We have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to stockholders.

 

Critical Accounting Policies

 

This summary of significant accounting policies is presented to assist in understanding the financial statements. The financial statements and notes are representations of the Company’s management, who are responsible for their integrity and objectivity. These accounting policies conform to US GAAP and have been consistently applied in the preparation of the financial statements.

 

Basis of Preparation

 

The accompanying financial statements have been prepared to present the balance sheets, the statements of operations, statements of changes in shareholders’ equity and cash flows of the Company for the three months ended September 30, 2022, and the three months ended September 30, 2021 and have been prepared in accordance with US GAAP.

 

Use of Estimates

 

In preparing financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements, as well as the reported amounts of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. However, actual results could differ materially from those estimates.

 

Concentrations of Credit Risk

 

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and accounts receivable. During the fiscal periods ended September 30, 2022 and June 30, 2022, substantially all of the Company’s cash was held by major financial institutions located in the United States, which management believes are of high credit quality. With respect to accounts receivable, the Company extended credit based on an evaluation of the customer’s financial condition. The Company generally did not require collateral for accounts receivable and maintained an allowance for doubtful accounts of accounts receivable if necessary.

 

Cash

 

Cash consists of cash held at major financial institutions and is subject to insignificant risk of changes in value.

 

Receivables and Allowance for Doubtful Accounts

 

Trade accounts receivable are recorded at net realizable value and do not bear interest. No allowance for doubtful accounts was made during the three-month period ended September 30, 2022, based on management’s best estimate of the amount of probable credit losses in accounts receivable. The Company evaluates its allowance for doubtful accounts based upon knowledge of its customers and their compliance with credit terms. The evaluation process includes a review of customers’ accounts on a regular basis. The review process evaluates all account balances with amounts outstanding for more than 60 days and other specific amounts for which information obtained indicates that the balance may be uncollectible. As of September 30, 2022, there was no allowance for doubtful accounts and the Company does not have any off-balance-sheet credit exposure related to its customers.

 

 
5

Table of Contents

 

Fair Value of Financial Instruments

 

Accounting Standards Codification (“ASC”) 820 “Fair Value Measurements and Disclosures”, adopted January 1, 2008, defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The Company’s financial instruments include cash, current receivables and payables. These financial instruments are measured at their respective fair values. The three levels are defined as follows:

 

Level 1 - inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.

 

Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.

 

Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value.

 

For cash, accounts receivables, subscription receivables, and accounts payable and accrued liabilities, it is management’s opinion that the carrying values are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and if applicable, their stated interest rate approximates current rates available.

 

Management believes it is not practical to estimate the fair value of related party receivables and payables because the transactions cannot be assumed to have been consummated at arm’s length, the terms are not deemed to be market terms, there are no quoted values available for these instruments, and an independent valuation would not be practical due to the lack of data regarding similar instruments, if any, and the associated potential costs.

 

Revenue Recognition

 

Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“Topic 606”), was adopted by the Company as of September 6, 2019. The Company’s revenue recognition disclosure reflects its updated accounting policies that are affected by this new standard. The Company applied the “modified retrospective” transition method for open contracts for the implementation of Topic 606. As revenues are and have been primarily from consulting and management services, and the Company has no significant post-delivery obligations, this new standard did not result in a material recognition of revenue on the Company’s accompanying financial statements for the cumulative impact of applying this new standard. The Company made no adjustments to its previously reported total revenues, as those periods continue to be presented in accordance with its historical accounting practices under Topic 605, Revenue Recognition.

 

The Company has no revenue in this period, however, when the Company has revenue from providing consulting and management services under Topic 606 will be recognized in a manner that reasonably reflects the delivery of services to customers in return for expected consideration and includes the following elements: 

 

 

-

executed contracts with the Company’s customers that it believes are legally enforceable;

 

-

identification of performance obligations in the respective contract;

 

-

determination of the transaction price for each performance obligation in the respective contract;

 

-

allocation of the transaction price to each performance obligation; and

 

-

recognition of revenue only when the Company satisfies each performance obligation.

 

These five elements as applied to the Company’s consulting and management services results in revenue recorded as services are provided.

 

Income Taxes

 

The Company uses the asset and liability method of accounting for income taxes pursuant to ASC 740 “Income Taxes”. ASC 740 requires an asset and liability approach for financial accounting and reporting for income taxes and allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Valuation allowances are provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The provision for income taxes represents current taxes payable net of the change during the period in deferred tax assets and liabilities.

 

 
6

Table of Contents

 

Earnings per Share

 

Basic earnings per share are computed by dividing income available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. If applicable, diluted earnings per share assume the conversion, exercise or issuance of all common stock instruments unless the effect is to reduce a loss or increase earnings per share. .

 

Recently Issued Accounting Pronouncements

 

In June 2018, the Financial Accounting Standards Board (the “FASB”) issued ASU 2018-07, “Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting”, to include share-based payment transactions for acquiring goods and services from nonemployees. ASU 2018-07 simplifies the accounting for nonemployee share-based payments, aligning it more closely with the accounting for employee awards. 

 

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force) did not or are not expected to have a material impact on the Company’s present or future financial statements.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

We conducted an evaluation, under the supervision and with the participation of our management, of the effectiveness of the design and operation of our disclosure controls and procedures. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as amended (“Exchange Act”), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by the company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures also include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Based on this evaluation, our principal executive and principal financial officers concluded as of September 30, 2022, that our disclosure controls and procedures were not effective at the reasonable assurance level due to the material weaknesses in our internal controls over financial reporting discussed immediately below.

 

Identified Material Weakness

 

A material weakness in our internal control over financial reporting is a control deficiency, or combination of control deficiencies, that results in more than a remote likelihood that a material misstatement of the financial statements will not be prevented or detected.

 

Management identified the following material weakness during its assessment of internal controls over financial reporting, which are primarily due to the size of the Company and available resources:

 

Personnel: We do not employ a full time Chief Financial Officer. Shannon Wilkinson serves as President and Chief Executive Officer. We recently appointed Dr. Earl Johnson as Chief Financial Officer. He initially will be employed on a part-time basis until our operations warrant a full time CFO. We utilize a consultant to assist with our financial reporting. There are limited personnel to assist with the accounting and financial reporting function, which results in: (i) a lack of segregation of duties and (ii) controls that may not be adequately designed or operating effectively. Despite the existence of material weaknesses, the Company believes the financial information presented herein is materially correct and fairly presents the financial position and operating results of the three months ended September 30, 2022, in accordance with GAAP. The Company intends to seek qualified accounting staff to expand its internal accounting and reporting functions.

 

 
7

Table of Contents

 

Audit Committee: We do not yet have an audit committee, and we lack a financial expert. During 2022-2023, the Board expects to appoint an Audit Committee and to identify a committee Chairman who is an “audit committee financial expert” as defined by the Securities and Exchange Commission (“SEC”) and as adopted under the Sarbanes-Oxley Act of 2002.

 

Management’s Report on Internal Control Over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934. Our internal control over financial reporting is a process designed by, or under the supervision of, our CEO and CFO, or persons performing similar functions, and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America (GAAP). Our internal control over financial reporting includes those policies and procedures that: (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and disposition of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP and that receipts and expenditures of the Company are being made only in accordance with authorization of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

 

Management assessed the effectiveness of the Company’s internal control over financial reporting as of September 30, 2022. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in the 2013 Internal Control-Integrated Framework. Based on its evaluation, management has concluded that the Company’s internal control over financial reporting was not effective as of September 30, 2022.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate. A control system, no matter how well designed and operated can provide only reasonable, but not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their cost.

 

Changes in Internal Control over Financial Reporting

 

There have been no changes in our internal control over financial reporting subsequent to the three month period ended September 30, 2022, which were identified in connection with our management’s evaluation required by paragraph (d) of rules 13a-15 and 15d-15 under the Exchange Act, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

We are not required by current SEC rules to include an auditor’s attestation report. Our registered public accounting firm has not attested to Management’s reports on our internal control over financial reporting.

 

 
8

Table of Contents

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

From time to time, we may become subject to various legal proceedings that are incidental to the ordinary conduct of its business. Although we cannot accurately predict the amount of any liability that may ultimately arise with respect to any of these matters, it makes provision for potential liabilities when it deems them probable and reasonably estimable. These provisions are based on current information and legal advice and may be adjusted from time to time according to developments.

 

We know of no material, existing or pending legal proceedings against our company, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial stockholder, is an adverse party or has a material interest adverse to our interest. 

 

Item 1A. Risk Factors.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. 

 

On October 15, 2021, the Company issued 125,000 common shares at a price of $0.80 per share for prepaid marketing services valued at $100,000.

 

On October 28, 2021, the Company issued 28,572 common shares at a price of $0.70 per share for legal services valued at $20,000.

 

On December 8, 2021, the Company issued 50,000 common shares at a price of $0.71 per share for prepaid consulting services valued at $35,250.

 

On December 31, 2021, the Company issued 937,151 common shares for the conversion of debt at a conversion price of $0.10 per share for a total value of $93,715.

 

On January 1, 2022, the Company issued 100,000 common shares at a price of $0.65 per share for consulting services valued at $65,000.

 

On March 25, 2022, the Company issued 12,000 common shares at a price of $0.60 per share for services valued at $7,200.

 

On July 12, 2022, the Company issued 350,000 common shares at a relative fair value of $0.22 per share for transaction costs associated with the issuance of a note payable.

 

On July 15, 2022, the Company issued 175,000 common shares at a relative fair value of $0.22  per share for transaction costs associated with the issuance of a note payable.

 

On July 18, 2022, the Company issued 175,000 common shares at a relative fair value of $0.22 per share for transaction costs associated with the issuance of a note payable.

 

On July 26, 2022, the Company issued 275,000 common shares at a price of $0.50 per share for marketing and branding services valued at $137,500.

 

On October 12, 2022, the Company issued 416,667 common shares at a price of $0.30 per share for transaction costs associated with the issuance of a note payable.

 

 
9

Table of Contents

 

On October 13, 2022, the Company issued 208,333 common shares at a price of $0.30 per share for transaction costs associated with the issuance of a note payable.

 

On October 13, 2022, the Company issued 208,333 common shares at a price of $0.30 per share for transaction costs associated with the issuance of a note payable.

 

On November 29, 2022, the Company completed a private placement whereby a total of 100,000 common shares were issued for cash at a price of $0.10 per share for a total value of $10,000.

 

On December 5, 2022, the Company completed a private placement whereby a total of 400,000 common shares were issued for cash at a price of $0.10 per share for a total value of $40,000.

 

On January 6, 2023, the Company completed a private placement whereby a total of 100,000 common shares were sold for cash at a price of $0.10 per share for a total value of $10,000. Shares have yet to be issued.

 

On January 9, 2023, the Company issued 500,000 shares with a fair value of $100,000 to a non-related party in exchange for services.

 

On January 9, 2023, the Company issued 45,000 shares with a fair value of $9,000 to a non-related party in exchange for settlement of a debt.

 

On January 11, 2023, the Company completed a private placement whereby a total of 300,000 common shares were sold for cash at a price of $0.10 per share for a total value of $30,000.

 

On January 15, 2023, the Company completed a private placement whereby a total of 600,000 common shares were sold for cash at a price of $0.10 per share for a total value of $60,000.

 

On January 16, 2023, the Company completed a private placement whereby a total of 150,000 common shares were sold for cash at a price of $0.10 per share for a total value of $15,000.

 

On January 17, 2023, the Company completed various a private placement whereby a total of 70,000 common shares were sold for cash at a price of $0.10 per share for a total value of $7,000.

 

On January 21, 2023, the Company completed various private placements whereby a total of 1,115,000 common shares were issued for cash at a price of $0.10 per share for a total value of $111,500.

 

On January 22, 2023, the Company completed a private placement whereby a total of 15,000 common shares were sold for cash at a price of $0.10 per share for a total value of $1,500.

 

On January 23, 2023, the Company completed various private placements whereby a total of 430,000 common shares were sold for cash at a price of $0.10 per share for a total value of $43,000.

 

On January 24, 2023, the Company completed a private placement whereby a total of 1,000,000 common shares were sold for cash at a price of $0.10 per share for a total value of $100,000.

 

On January 25, 2023, the Company completed a private placement whereby a total of 100,000 common shares were sold for cash at a price of $0.10 per share for a total value of $10,000.

 

On January 28, 2023, the Company completed a private placement whereby a total of 150,000 common shares were sold for cash at a price of $0.10 per share for a total value of $15,000.

 

On January 30, 2023, the Company completed various private placement whereby a total of 850,000 common shares were sold for cash at a price of $0.10 per share for a total value of $85,000.

 

On February 6, 2023, the Company completed a private placement whereby a total of 225,000 common shares were sold for cash at a price of $0.10 per share for a total value of $22,500.

  

 
10

Table of Contents

 

On February 6, 2023, the Company issued 1,000,000 shares with a fair value of $200,000 to a non-related party in exchange for services.

 

On February 7, 2023, the Company completed a private placement whereby a total of 215,000 common shares were sold for cash at a price of $0.10 per share for a total value of $21,500.

 

Item 3. Defaults Upon Senior Securities. 

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

None.

 

 
11

Table of Contents

 

Item 6. Exhibits.

 

Exhibit

Number

 

Description

3.1

 

Articles of Incorporation filed with the Nevada Secretary of State on September 6, 2019 (2) 

3.2

 

Bylaws (2)

4.1

 

2021 Equity Compensation Plan (3)

10.1

 

Compilation of Website or Software Development Agreement and Addendum between Company and Cistck, dated June 4, 2020 (4)

10.2

 

Compilation of FirstFire Global Opportunities Fund, LLC Securities Purchase Agreement, Convertible Promissory Note and Other Agreements (5)

10.3

 

Compilation of GS Capital Partners, LLC Securities Purchase Agreement, Convertible Promissory Note and Other Agreements (6)

10.4

 

Compilation of Analytico Services Conseils Inc. Securities Purchase Agreement, Convertible Promissory Note and Warrant (7)

10.5

 

Compilation of Reynald Thauvette and Dominique Joyal  Securities Purchase Agreement, Convertible Promissory Note and Warrant (8)

10.6

 

Master Services Agreement between the Company and IONnovate, LLC dated September 3, 2021 (9)

10.7

 

Employment Agreement between the Company and Shannon Wilkinson dated January 3, 2022 (10)

10.8

 

Employment Agreement between the Company and Chris C. White dated January 3, 2022 (11)

10.9

 

Employment Agreement between the Company and Earl R. Johnson dated April 26, 2022 (12)

10.10

 

Compilation of AJB Capital Investments, LLC  Securities Purchase Agreement, Convertible Promissory Note and Warrant (13)

10.11

 

Compilation of Bigger Capital Fund, LP  Securities Purchase Agreement, Convertible Promissory Note and Warrant (14)

10.12

 

Compilation of District 2 Capital Fund LP Securities Purchase Agreement, Convertible Promissory Note and Warrant (15)

10.13

 

Employment Agreement between the Company and Alissa V. Knight dated July 26, 2022 (16)

10.14

 

Amendment to Employment Agreement between the Company and Chris C. White dated August 1,  2022 (17)

10.15

 

Compilation of AJB Capital Investments, LLC  Securities Purchase Agreement, Convertible Promissory Note and Warrant (18)

10.16

 

Compilation of Bigger Capital Fund, LP  Securities Purchase Agreement, Convertible Promissory Note and Warrant (19)

10.17

 

Compilation of District 2 Capital Fund LP Securities Purchase Agreement, Convertible Promissory Note and Warrant (20)

31.1

 

Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (1)

31.2

 

Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (1)

32.1

 

Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (1)

32.2

 Certification of the Chief  Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (1)

 

101.INS*

 

Inline XBRL Instance Document

 

 

 

101.SCH*

 

Inline XBRL Taxonomy Extension Schema Document

 

 

101.CAL*

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

101.DEF*

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

101.LAB*

 

Inline XBRL Taxonomy Extension Label Linkbase Document

 

 

 

101.PRE*

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

104*

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

(1)/*

Filed herewith.

 

(2)

Previously filed as an exhibit to our Form S-1 on September 21, 2020.

 

(3)

Previously filed as an exhibit to our Post Effective Form S-8 Amendment No 1. on February 18, 2022

 

(4)

Previously filed as an exhibit to our Form S-1 Amendment No. 1 on October 27, 2020

 

(5)

Previously filed with the SEC on December 31, 2020 as an exhibit to our Form 8-K.

 

(6)

Previously filed with the SEC on March 30, 2021 as an exhibit to our Form 8-K.

 

(7)

Previously filed with the SEC on April 26, 2021 as an exhibit to our Form 8-K.

 

(8)

Previously filed with the SEC on April 30, 2021 as an exhibit to our Form 8-K.

 

(9)

Previously filed with the SEC on September 16, 2021 as an exhibit to our Form 8-K.

 

(10)

Previously filed with the SEC on January 4, 2022 as an exhibit to our Form 8-K.

 

(11)

Previously filed with the SEC on January 4, 2022 as an exhibit to our Form 8-K.

 

(12)

Previously filed with the SEC on April 27, 2022 as an exhibit to our Form 8-K.

 

(13)

Previously filed with the SEC on July 15, 2022 as an exhibit to our Form 8-K.

 

(14)

Previously filed with the SEC on July 19, 2022 as an exhibit to our Form 8-K.

 

(15)

Previously filed with the SEC on July 20, 2022 as an exhibit to our Form 8-K.

 

(16)

Previously filed with the SEC on July 28, 2022 as an exhibit to our Form 8-K.

 

(17)

Previously filed with the SEC on August 2, 2022 as an exhibit to our Form 8-K.

 

(18)

Previously filed with the SEC on October 14, 2022 as an exhibit to our Form 8-K.

 

(19)

Previously filed with the SEC on October 17, 2022 as an exhibit to our Form 8-K.

 

(20)

Previously filed with the SEC on October 18, 2022 as an exhibit to our Form 8-K.

 

 
12

Table of Contents

 

SIGNATURES

 

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Tego Cyber Inc.

 

 

 

 

 

Date: February 24, 2023

By:

/s/ Shannon Wilkinson

 

 

 

Shannon Wilkinson 

 

 

 

Chief Executive Officer

(Principal Executive Officer)

 

 

 

Tego Cyber Inc.

 

 

 

 

 

Date: February 24, 2023

By:

/s/ Earl R. Johnson

 

 

 

Earl R. Johnson 

 

 

 

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 

 

 
13

 

EX-31.1 2 tgcb_ex311.htm CERTIFICATION tgcb_ex311.htm

EXHIBIT 31.1

 

CERTIFICATION OF

PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002

 

I, Shannon Wilkinson, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q/A of the Registrant for the period ended September 30, 2022;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

 

 

4.

As the Registrant’s certifying officer, I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

 

 

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

c.

Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

d.

Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

 

5.

As the Registrant’s certifying officer, I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant auditors and the audit committee of the Registrant’s Board of Directors (or persons performing the equivalent functions):

 

 

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

 

 

 

Tego Cyber Inc.

 Date: February 24, 2023

By:

/s/ Shannon Wilkinson

 

 

Name:

Shannon Wilkinson

 

 

Title:

Chief Executive Officer 

(Principal Executive Officer)

 

 

EX-31.2 3 tgcb_ex312.htm CERTIFICATION tgcb_ex312.htm

 EXHIBIT 31.2

 

CERTIFICATION OF

PRINCIPAL ACCOUNTING OFFICER

PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002

 

I, Earl R. Johnson, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q/A of the Registrant for the period ended September 30, 2022;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

 

 

4.

As the Registrant’s certifying officer, I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

 

 

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

c.

Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

d.

Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

 

5.

As the Registrant’s certifying officer, I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant auditors and the audit committee of the Registrant’s Board of Directors (or persons performing the equivalent functions):

 

 

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

 

 

Tego Cyber Inc.

 

 

 Date: February 24, 2023

By:

/s/ Earl R. Johnson

 

 

Name:

Earl R. Johnson

 

 

Title:

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 

EX-32.1 4 tgcb_ex321.htm CERTIFICATION tgcb_ex321.htm

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Tego Cyber Inc. (the “Company”) on Form 10-Q/A for the quarterly period ended September 30, 2022, as filed with the Securities and Exchange Commission (the “Report”), each of the undersigned officers of Tego Cyber Inc., certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

 

 

Tego Cyber Inc.

Date: February 24, 2023

 

 

By:

/s/ Shannon Wilkinson

 

 

Name:

Shannon Wilkinson

 

 

Title:

Chief Executive Officer

(Principal Executive Officer)

 

 

 

Tego Cyber Inc.

Date: February 24 , 2023

 

 

By:

/s/ Earl R. Johnson

 

 

Name:

Earl R. Johnson

 

 

Title:

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 

 

EX-101.SCH 5 tgcb-20220930.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 000009 - Disclosure - PREPAID EXPENSES link:presentationLink link:calculationLink link:definitionLink 000010 - Disclosure - SOFTWARE link:presentationLink link:calculationLink link:definitionLink 000011 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES link:presentationLink link:calculationLink link:definitionLink 000012 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 000013 - Disclosure - NOTES PAYABLE (convertible only at default) link:presentationLink link:calculationLink link:definitionLink 000014 - Disclosure - COMMON SHARES link:presentationLink link:calculationLink link:definitionLink 000015 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 000016 - Disclosure - RECLASSIFICATION OF PRIOR YEAR PRESENTATION link:presentationLink link:calculationLink link:definitionLink 000017 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 000019 - Disclosure - PREPAID EXPENSES (Tables) link:presentationLink link:calculationLink link:definitionLink 000020 - Disclosure - SOFTWARE (Tables) link:presentationLink link:calculationLink link:definitionLink 000021 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 000022 - Disclosure - COMMON SHARES (Tables) link:presentationLink link:calculationLink link:definitionLink 000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000024 - Disclosure - PREPAID EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 000025 - Disclosure - SOFTWARE (Details) link:presentationLink link:calculationLink link:definitionLink 000026 - Disclosure - ACCOUNTS PAYABLE ACCRUED LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 000027 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000028 - Disclosure - NOTES PAYABLE (convertible only at default) (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000029 - Disclosure - COMMON SHARES (Details) link:presentationLink link:calculationLink link:definitionLink 000030 - Disclosure - COMMON SHARES (Details 1) link:presentationLink link:calculationLink link:definitionLink 000031 - Disclosure - COMMON SHARES (Details 2) link:presentationLink link:calculationLink link:definitionLink 000032 - Disclosure - COMMON SHARES (Details 3) link:presentationLink link:calculationLink link:definitionLink 000033 - Disclosure - COMMON SHARES (Details 4) link:presentationLink link:calculationLink link:definitionLink 000034 - Disclosure - COMMON SHARES (Details 5) link:presentationLink link:calculationLink link:definitionLink 000035 - Disclosure - COMMON SHARES (Details 6) link:presentationLink link:calculationLink link:definitionLink 000036 - Disclosure - COMMON SHARES (Details 7) link:presentationLink link:calculationLink link:definitionLink 000037 - Disclosure - COMMON SHARES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000038 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000039 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 6 tgcb-20220930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Current Fiscal Year End Date Entity Small Business Entity Shell Company Entity Emerging Growth Company Entity Current Reporting Status Document Period End Date Entity Filer Category Document Fiscal Period Focus Document Fiscal Year Focus Entity Ex Transition Period Entity Common Stock Shares Outstanding Document Quarterly Report Document Transition Report Entity File Number Entity Incorporation State Country Code Entity Tax Identification Number Entity Interactive Data Current Entity Address Address Line 1 Entity Address Address Line 2 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Local Phone Number Amendment Description CONDENSED CONSOLIDATED BALANCE SHEETS ASSETS Current assets Cash Accounts receivable Prepaid expenses (Note 5) Total current assets [Assets, Current] Computer equipment, net Software (Note 6) TOTAL ASSETS [Assets] LIABILITIES & SHAREHOLDERS' DEFICIT Accounts payable & accrued liabilities (Note 7) Notes payable, net (Note 9) TOTAL LIABILITIES [Liabilities] SHAREHOLDERS' EQUITY Common shares 50,000,000 shares authorized $0.001 par value 26,483,044 shares issued and outstanding at September 30, 2022 and 25,508,044 shares at June 30, 2022 Additional paid in capital Accumulated deficit TOTAL SHAREHOLDERS' EQUITY [Stockholders' Equity Attributable to Parent] TOTAL LIABILITIES & SHAREHOLDERS' EQUITY [Liabilities and Equity] Common stock, par value Common stock, authorized Common stock, issued Common stock, outstanding CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) OPERATING EXPENSES General & administration Professional fees Sales & marketing TOTAL OPERATING EXPENSES [Operating Expenses] NET OPERATING LOSS [Operating Income (Loss)] OTHER EXPENSE Accretion expense [Accretion Expense] TOTAL OTHER EXPENSE [Other Nonoperating Income (Expense)] NET LOSS [Net Income (Loss) Attributable to Parent] BASIC AND DILUTED LOSS PER COMMON SHARE WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY (UNAUDITED) Statement [Table] Statement [Line Items] Equity Components [Axis] Common Stock [Member] Additional Paid-In Capital [Member] Subscription Receivable [Member] Accumulated Deficit [Member] Balance, shares [Shares, Issued] Balance, amount Shares issued for cash, shares Shares issued for cash, amount Net loss Shares issued as transaction costs for notes payable, shares Shares issued as transaction costs for notes payable, amount Shares issued for services, shares Shares issued for services, amount Share-based compensation Shares issued with notes payable Warrants issued with promissory notes Balance, shares Balance, amount CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) CASH FLOWS FROM OPERATING ACTIVITIES Net loss [Net Income (Loss), Including Portion Attributable to Noncontrolling Interest] Adjustments to reconcile net loss to net cash used in operating activities Shares issued for services Interest on short term debt Amortization Accretion expense [Accretion expense] Amortization of discount of debt issuance Share-based compensation [Share-Based Payment Arrangement, Noncash Expense] Changes in operating assets and liabilities: Accounts receivable [Increase (Decrease) in Accounts Receivable] Prepaid expenses [Increase (Decrease) in Prepaid Expense] Accounts payable and accrued liabilities NET CASH USED IN OPERATING ACTIVITIES [Net Cash Provided by (Used in) Operating Activities] CASH FLOWS FROM INVESTING ACTIVITIES Capitalized software development costs [Payments to Develop Software] NET CASH USED IN INVESTING ACTIVITIES [Net Cash Provided by (Used in) Investing Activities] CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from shares issued Cash received from issuance of notes payable Cash Costs for promissory notes [Cash Costs for promissory notes] NET CASH PROVIDED BY FINANCING ACTIVITIES [Net Cash Provided by (Used in) Financing Activities] NET INCREASE (DECREASE) IN CASH [Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect] CASH AT BEGINNING OF THE PERIOD [Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents] CASH AT END OF THE PERIOD SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION Cash paid for interest Cash paid for taxes NON-CASH TRANSACTIONS Shares issued as transaction costs for notes payable Shares issued for services [Shares issued for services] Warrants issued with notes payable ORGANIZATION AND DESCRIPTION OF BUSINESS ORGANIZATION AND DESCRIPTION OF BUSINESS Business Description and Basis of Presentation [Text Block] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] PREPAID EXPENSES PREPAID EXPENSES [PREPAID EXPENSES] SOFTWARE SOFTWARE [SOFTWARE] ACCOUNTS PAYABLE AND ACCRUED LIABILITIES ACCOUNTS PAYABLE RELATED PARTY TRANSACTIONS RELATED PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] NOTES PAYABLE (convertible only at default) NOTES PAYABLE (convertible only at default) Debt Disclosure [Text Block] COMMON SHARES Stockholders' Equity Note Disclosure [Text Block] INCOME TAXES INCOME TAXES Income Tax Disclosure [Text Block] RECLASSIFICATION OF PRIOR YEAR PRESENTATION RECLASSIFICATION OF PRIOR YEAR PRESENTATION [RECLASSIFICATION OF PRIOR YEAR PRESENTATION] SUBSEQUENT EVENTS SUBSEQUENT EVENTS Subsequent Events [Text Block] Basis of Preparation Going Concern Use of Estimates Concentrations of Credit Risk Cash Cash and Cash Equivalents, Policy [Policy Text Block] Receivables and Allowance for Doubtful Accounts Software Leases Fair Value of Financial Instruments Revenue Recognition Income Taxes Earnings (Loss) per Share Recently Issued Accounting Pronouncements Schedule of prepaid expenses Schedule of software Accounts payable and accrued liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] schedule for the Company's exercise warrant data schedule for the Company's outstanding warrants: schedule for the Company's outstanding non-qualified stock options: Schedule of stock options outstanding: Schedule of weighted average assumptions schedule for the Company's outstanding performance stock units: schedule for the Company's performance units outstanding schedule of fair value of the performance units granted Capitalized Contract Cost [Axis] Software [Member] Negative working capital (Surplus) Allowance for doubtful accounts Estimated useful life Advertising and promotion Consultants and contractors Platform costs Software Development Total Software, Beginning Balance [Software, Beginning Balance] Additions Depreciation Software, Ending Balance [Software, Ending Balance] ACCOUNTS PAYABLE ACCRUED LIABILITIES (Details) Exchange & listing fees Legal and accounting Platform cost Software development Total [Accounts Payable, Trade, Current] Related Party Transaction Axis Troy Wilkinson Shannon Wilkinson Chris White Earl Johnson Management Fees Gross Wages Short-Term Debt, Type [Axis] Notes Payable [Member] Notes Payable One [Member] Notes Payable Two [Member] Original issue discount Notes payable in exchange for cash Notes payable interest rate Notes payable in exchange for cash, fair value Additional cash proceeds Common shares issue Total common shares issued Common shares issue value Warrants indexed issued Commitment fee Carrying value of note payable Unamortized discounts Warrants relative fair value Common stock relative fair value Warrants issued Warrant exercisable Exercise price Debt related interest rate Fair value of warrants Range Axis Minimum [Member] Maximum [Member] Expected Life Expected Dividend Rate Stock Price Risk-free Interest Rate Expected Volatility Number Of Warrants Outstanding, Beginning [Number Of Warrants Outstanding, Beginning] Number Of Warrants Granted Number of warrants expired Number of warrants Exercised Number Of Warrants Outstanding,Ending Balance [Number Of Warrants Outstanding,Ending Balance] Weighted Average Exercise Price Outstanding, Beginning [Weighted Average Exercise Price Outstanding, Beginning] Weighted Average Exercise Price Granted Weighted Average Exercise Price Exercised Weighted Average Exercise Price Expired Weighted Average Exercise Price Outstanding, ending Weighted Average Exercise Price Outstanding, Beginning Balance [Weighted Average Exercise Price Outstanding, Beginning Balance] Weighted Average Exercise Price Granted [Weighted Average Exercise Price Granted] Weighted Average Exercise Price Exercised Weighted Average Exercise Price Cancelled Weighted Average Exercise Price Outstanding, Ending Balance [Weighted Average Exercise Price Outstanding, Ending Balance] Number Of Warrants Outstanding, Beginning [Number Of Warrants Outstanding, Beginning 1] Number Of Warrants Granted Number Of Warrants Exercised Number Of Warrants Cancelled Number Of Warrants Outstanding, Ending Balance [Number Of Warrants Outstanding, Ending Balance] Award Date Axis January 3, 2022 [Member] January 4, 2022 [Member] Weighted Average life [Weighted Average life] Number of option outstanding Exercise Weighted Average life Number of option Exercisable Expiry Date Expected volatility Expected life Expected dividend yield Risk-free interest rate Number Of Warrants Granted [Number Of Warrants Granted] Number Of Warrants Released Number Of Warrants Forfeited or cancelled Number Of Warrants Outstanding,Ending [Number Of Warrants Outstanding,Ending] Weighted Average Exercise Price Beginning balance [Weighted Average Exercise Price Beginning balance] Weighted Average Exercise Price Granted [Weighted Average Exercise Price Granted 1] Weighted Average Exercise Price Released Weighted Average Exercise Price Forfeited or Cancelled Number Of Warrants Outstanding, beginning [Number Of Warrants Outstanding, beginning] Weighted Average Exercise Price Ending, Balance March 8, 2022 [Member] Number Exercisable Exercise [Exercise] Number of option outstanding [Number of option outstanding] Weighted Average Life (Years) Weighted Average Life (Years) Expiry date Expected volatility [Expected volatility] Expected life [Expected life] Risk-free interest rate [Risk-free interest rate] Expected dividend rate Statement Class Of Stock Axis Derivative Instrument Risk Axis October 15, 2021 October 28, 2021 December 8, 2021 January 1, 2022 March 25, 2022 December 31, 2021 A December 31, 2021 B Common Shares [Member] Warrant [Member] July 12, 2022 July 15, 2022 July 18, 2022 July 26, 2022 May 19, 2022 Weighted average remaining contractual life of warrants outstanding Common stock, authorized Share-based compensation [Share-based compensation] Common stock, par value Share-based compensation non qualified stock options Share price Legal services valued Total value Services valued Services valued [Services valued] Warrants intrinsic value Common stock, issued Marketing And Branding Services Prepaid marketing services Conversion price Conversion price [Conversion price] Stock issued Proceeds from share issued Number of warrants granted Additional paid in capital Weighted average exercise price granted Fair value of warrant granted Net Operating Loss Carry Forward Research And Development Arrangement Contract To Perform For Others By Type Axis Subsequent Event Type Axis Securities Purchase Agreement With Non-Related Party [Member] Subsequent Event [Member] Securities Purchase Agreement With Non-Related Party One [Member] Securities Purchase Agreement With Non-Related Party Two [Member] Principal amount Original issue discount Shares issued Shares issued, value Warrants exercisable issued Warrant exercise price per share Debt instrument interest rate Maturity Date Debt instrument interest rate increase Notes payble Additional amount paid in cash transaction costs Common stock, issued Common stock, sold Share price Common stock, total value Common stock, fair value EX-101.CAL 7 tgcb-20220930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 8 tgcb-20220930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 9 tgcb-20220930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Cover - shares
3 Months Ended
Sep. 30, 2022
Feb. 24, 2023
Cover [Abstract]    
Entity Registrant Name TEGO CYBER INC.  
Entity Central Index Key 0001815632  
Document Type 10-Q/A  
Amendment Flag true  
Current Fiscal Year End Date --06-30  
Entity Small Business true  
Entity Shell Company false  
Entity Emerging Growth Company true  
Entity Current Reporting Status No  
Document Period End Date Sep. 30, 2022  
Entity Filer Category Non-accelerated Filer  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2023  
Entity Ex Transition Period false  
Entity Common Stock Shares Outstanding   34,681,377
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 000-56370  
Entity Incorporation State Country Code NV  
Entity Tax Identification Number 84-2678167  
Entity Interactive Data Current Yes  
Entity Address Address Line 1 8565 South Eastern Avenue  
Entity Address Address Line 2 Suite 150  
Entity Address City Or Town Las Vegas  
Entity Address State Or Province NV  
Entity Address Postal Zip Code 89123  
City Area Code 855  
Local Phone Number 939-0100  
Amendment Description Tego Cyber Inc. is filing this Amendment No. 1 on Form 10-Q/A for the period ended September 30, 2022, as filed with the Securities and Exchange Commission (the “SEC”) on November 21, 2022 (the “Original Filing”). This Amendment No. 1 on Form 10-Q/A is to amend the accounting treatment of the issuance of three promissory notes issued by the Company during the fiscal quarter ended September 30, 2022. In the original Form 10-Q filing, the promissory notes were reported as convertible which is incorrect.  For convenience and ease of reference, the Company is filing this Form 10-Q/A in its entirety with all applicable changes and unless otherwise stated, all information contained in this amendment is as of November 21, 2022, the filing date of the Original Filing. Except as stated herein, this Form 10-Q/A does not reflect events or transactions occurring after such filing date or modify or update those disclosures in the original Form 10-Q that may have been affected by events or transactions occurring subsequent to such filing date.  
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.22.4
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2022
Jun. 30, 2022
Current assets    
Cash $ 37,459 $ 47,742
Accounts receivable 0 1,150
Prepaid expenses (Note 5) 111,978 66,119
Total current assets 149,437 115,011
Computer equipment, net 1,398 3,207
Software (Note 6) 507,185 411,122
TOTAL ASSETS 658,020 529,340
LIABILITIES & SHAREHOLDERS' DEFICIT    
Accounts payable & accrued liabilities (Note 7) 67,677 66,066
Notes payable, net (Note 9) 342,702 0
TOTAL LIABILITIES 410,379 66,066
SHAREHOLDERS' EQUITY    
Common shares 50,000,000 shares authorized $0.001 par value 26,483,044 shares issued and outstanding at September 30, 2022 and 25,508,044 shares at June 30, 2022 26,483 25,508
Additional paid in capital 5,687,572 4,586,049
Accumulated deficit (5,466,414) (4,148,283)
TOTAL SHAREHOLDERS' EQUITY 247,641 463,274
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY $ 658,020 $ 529,340
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.22.4
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Sep. 30, 2022
Jun. 30, 2022
CONDENSED CONSOLIDATED BALANCE SHEETS    
Common stock, par value $ 0.001 $ 0.001
Common stock, authorized 50,000,000 50,000,000
Common stock, issued 26,483,044 25,508,044
Common stock, outstanding 26,483,044 25,508,044
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.4
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended
Sep. 30, 2022
Sep. 30, 2021
OPERATING EXPENSES    
General & administration $ 880,512 $ 260,341
Professional fees 64,962 117,274
Sales & marketing 180,324 65,382
TOTAL OPERATING EXPENSES 1,125,798 442,997
NET OPERATING LOSS (1,125,798) (442,997)
OTHER EXPENSE    
Accretion expense (192,332) (29,215)
TOTAL OTHER EXPENSE (192,332) (29,215)
NET LOSS $ (1,318,130) $ (472,212)
BASIC AND DILUTED LOSS PER COMMON SHARE $ (0.05) $ (0.02)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING 26,305,571 19,335,634
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.4
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY (UNAUDITED) - USD ($)
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Subscription Receivable [Member]
Accumulated Deficit [Member]
Balance, shares at Jun. 30, 2021   18,296,511      
Balance, amount at Jun. 30, 2021 $ 728,046 $ 18,297 $ 1,720,631 $ (10,500) $ (1,000,382)
Shares issued for cash, shares   5,458,810      
Shares issued for cash, amount 1,355,202 $ 5,459 1,359,243 (9,500) 0
Net loss (472,212) $ 0 0 0 (472,212)
Balance, shares at Sep. 30, 2021   23,755,321      
Balance, amount at Sep. 30, 2021 1,611,036 $ 23,756 3,079,874 (20,000) (1,472,594)
Balance, shares at Jun. 30, 2022   25,508,044      
Balance, amount at Jun. 30, 2022 463,274 $ 25,508 4,586,049 0 (4,148,284)
Net loss (1,318,130) $ 0 0 0 (1,318,130)
Shares issued as transaction costs for notes payable, shares   700,000      
Shares issued as transaction costs for notes payable, amount 152,142 $ 700 151,442 0 0
Shares issued for services, shares   275,000      
Shares issued for services, amount 137,500 $ 275 137,225 0 0
Share-based compensation 625,367 0 625,367 0 0
Shares issued with notes payable 0 0 0 0 0
Warrants issued with promissory notes 187,489 $ 0 187,489 0 0
Balance, shares at Sep. 30, 2022   26,483,044      
Balance, amount at Sep. 30, 2022 $ 247,641 $ 26,483 $ 5,687,572 $ 0 $ (5,466,414)
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
3 Months Ended
Sep. 30, 2022
Sep. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (1,318,130) $ (472,212)
Adjustments to reconcile net loss to net cash used in operating activities    
Shares issued for services 137,500 0
Interest on short term debt 0 1,816
Amortization 1,809 0
Accretion expense 0 29,215
Amortization of discount of debt issuance 192,332 0
Share-based compensation 625,367 0
Changes in operating assets and liabilities:    
Accounts receivable 1,150 300
Prepaid expenses (45,859) 9,273
Accounts payable and accrued liabilities 1,611 14,928
NET CASH USED IN OPERATING ACTIVITIES (404,220) (416,680)
CASH FLOWS FROM INVESTING ACTIVITIES    
Capitalized software development costs (96,063) (36,950)
NET CASH USED IN INVESTING ACTIVITIES (96,063) (36,950)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from shares issued 0 1,355,202
Cash received from issuance of notes payable 540,000 0
Cash Costs for promissory notes (50,000) 0
NET CASH PROVIDED BY FINANCING ACTIVITIES 490,000 1,355,202
NET INCREASE (DECREASE) IN CASH (10,283) 901,572
CASH AT BEGINNING OF THE PERIOD 47,742 583,015
CASH AT END OF THE PERIOD 37,459 1,484,587
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION    
Cash paid for interest 12,666 0
Cash paid for taxes 0 0
NON-CASH TRANSACTIONS    
Shares issued as transaction costs for notes payable 152,142 0
Shares issued for services 137,500 0
Warrants issued with notes payable $ 187,489 $ 0
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.4
ORGANIZATION AND DESCRIPTION OF BUSINESS
3 Months Ended
Sep. 30, 2022
ORGANIZATION AND DESCRIPTION OF BUSINESS  
ORGANIZATION AND DESCRIPTION OF BUSINESS

NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS

 

Tego Cyber Inc. (the “Company”) was incorporated in the State of Nevada on September 6, 2019. It was created to capitalize on the emerging cyber threat intelligence market and has developed a state-of-the-art cyber threat intelligence application that enriches threat data to help enterprises identify cyber threats within their environments. Tego Guardian is a proactive intelligent cyberthreat hunting tool that gives enterprises the ability to quickly track threats throughout their networks, mapping out exposures and expediting remediation. Tego Guardian integrates with the widely used Splunk Security Information and Event Management (SIEM) platform. Tego Guardian is a Splunk approved app and available for download through Splunk’s marketplace. The Company plans on developing future versions of Tego Guardian for integration with other established SIEM systems and platforms including: Elastic, IBM QRadar, AT&T AlienVault, Exabeam, and Google Chronical.

 

The Company’s head office is at 8565 S. Eastern Ave. #150, Las Vegas, Nevada, 89123.

XML 17 R8.htm IDEA: XBRL DOCUMENT v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended
Sep. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Preparation

The Company prepares its financial statements in accordance with rules and regulations of the Securities and Exchange Commission (“SEC”) and GAAP in the United States of America. The accompanying interim financial statements have been prepared in accordance with GAAP for interim financial information in accordance with Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the Company’s opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2022, are not necessarily indicative of the results for the full year. While management of the Company believes that the disclosures presented herein are adequate and not misleading, these interim financial statements should be read in conjunction with the audited financial statements and the footnotes thereto for the year ended June 30, 2022.

Going Concern

 

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of the business. The Company has incurred material losses from operations and has an accumulated deficit. At September 30, 2022, the Company had a negative working capital of $260,942. For the three months ended September 30, 2022, the Company sustained net losses and generated negative cash flows from operations. In March 2020, the World Health Organization recognized the outbreak of COVID-19 as a global pandemic. The COVID-19 pandemic and government actions implemented to contain the further spread of COVID-19 have severely restricted economic activity around the world. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that may be necessary should the Company be unable to continue as a going concern. These adjustments could be material. The Company’s continuation as a going concern is contingent upon its ability to earn adequate revenues from operations and to obtain additional financing. There is no assurance that the Company will be able to obtain such financings or obtain them on favorable terms.

Use of Estimates

 

In preparing financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements, as well as the reported amounts of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. However, actual results could differ materially from those estimates.

 

Concentrations of Credit Risk

 

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and accounts receivable. As at September 30, 2022, substantially all of the Company’s cash was held by major financial institutions located in the United States, which management believes are of high credit quality. With respect to accounts receivable, the Company extended credit based on an evaluation of the customer’s financial condition. The Company generally did not require collateral for accounts receivable and maintained an allowance for doubtful accounts of accounts receivable if necessary.

 

Cash

 

Cash consists of cash held at major financial institutions and is subject to insignificant risk of changes in value.

 

Receivables and Allowance for Doubtful Accounts

 

Trade accounts receivable are recorded at net realizable value and do not bear interest. No allowance for doubtful accounts was made during the three-month period ended September 30, 2022 and the year ended June 30, 2022, based on management’s best estimate of the amount of probable credit losses in accounts receivable. The Company evaluates its allowance for doubtful accounts based upon knowledge of its customers and their compliance with credit terms. The evaluation process includes a review of customers’ accounts on a regular basis. The review process evaluates all account balances with amounts outstanding for more than 60 days and other specific amounts for which information obtained indicates that the balance may be uncollectible. As of September 30, 2022 and June 30, 2022, there was no allowance for doubtful accounts and the Company does not have any off-balance-sheet credit exposure related to its customers.

 

Software

 

Software is stated at cost less accumulated amortization and is amortized using the straight-line method over the estimated useful life of the asset. The estimated useful life of the asset is 5 years and is not amortized until it is available for use by the Company.

 

Leases

 

The Company determines if an arrangement is a lease at inception. Operating and financing right-of-use assets and lease liabilities are included on the balance sheet. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company uses its incremental borrowing rate, based on the information available at the commencement date, in determining the present value of future lease payments. Right-of-use assets include any prepaid lease payments and exclude any lease incentives and initial direct costs incurred. Operating lease expenses are recognized on a straight-line basis over the term of the lease, consisting of interest accrued on the lease liability and amortization of the right-of-use asset. The lease terms may include options to extend or terminate the lease is it is reasonably certain the Company will exercise that option. The Company leases its corporate office located at 8565 S. Eastern Ave. #150, Las Vegas, Nevada. The initial lease term is for 12 months commencing on September 8, 2019 after which the term is on a month-to-month basis. After the initial term, the Company may cancel the lease agreement at any time by providing 30 days written notice. The Company has elected the short-term lease practical expedient of 12 months and has not recorded a lease.

Fair Value of Financial Instruments

 

Accounting Standards Codification (“ASC”) 820 “Fair Value Measurements and Disclosures”, adopted January 1, 2008, defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The Company’s financial instruments include cash, current receivables and payables. These financial instruments are measured at their respective fair values. The three levels are defined as follows:

 

Level 1 - inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.

 

Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.

 

Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value.

 

For cash, accounts receivable, accounts payable and accrued liabilities and due to related parties, it is management’s opinion that the carrying values are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and if applicable, their stated interest rate approximates current rates available.

 

For convertible debts, the carrying values, excluding any unamortized discounts, approximate the respective fair value. The convertible debts have been discounted to reflect their net present value as at September 30, 2022. The carrying values of embedded conversion features not considered to be derivative instruments were determined by allocating the remaining carrying value of the convertible debt after deducting the estimated carrying value of the liability portion.

 

Estimating fair value for warrants require determining the most appropriate valuation model which is dependent on the terms and conditions of the grant. This estimate requires determining the most appropriate inputs to the valuation model including the expected life of the warrant, volatility, dividend yield, and rate of forfeitures and making assumptions about them.

 

Revenue Recognition

 

Revenue is recognized under ASC 606, “Revenue from Contracts with Customers” using the modified retrospective method. Under this method, the Company follows the five-step model provided by ASC Topic 606 in order to recognize revenue in the following manner: 1) identify the contract; 2) identify the performance obligations of the contract; 3) determine the transaction price of the contract; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue. The Company recognizes revenue for the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services.

 

The Company currently has not generated any revenue from its threat intelligence software.

 

Income Taxes

 

The Company uses the asset and liability method of accounting for income taxes pursuant to ASC 740 “Income Taxes”. ASC 740 requires an asset and liability approach for financial accounting and reporting for income taxes and allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Valuation allowances are provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The provision for income taxes represents current taxes payable net of the change during the period in deferred tax assets and liabilities.

Earnings (Loss) per Share

 

Basic earnings (loss) per share is computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. If applicable, diluted earnings (loss) per share assume the conversion, exercise or issuance of all common stock instruments unless the effect is to reduce a loss or increase earnings (loss) per share.

 

Recently Issued Accounting Pronouncements

 

In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes which amends ASC 740 Income Taxes (ASC 740). This update is intended to simplify accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and amending existing guidance to improve consistent application of ASC 740. This update is effective for fiscal years beginning after December 15, 2021. The guidance in this update has various elements, some of which are applied on a prospective basis and others on a retrospective basis with earlier application permitted. The Company’s management is currently evaluating the effect of this ASU on the Company’s financial statements and related disclosures.

 

In June 2020, the FASB issued ASU 2020-05 in response to the ongoing impacts to U.S. businesses in response to the COVID-19 pandemic. ASU 2020-05, Revenue from Contracts with Customers (Topic 606) and Leases (Topic 842) Effective Dates for Certain Entities provide a limited deferral of the effective dates for implementing previously issued ASU 606 and ASU 842 to give some relief to businesses considering the difficulties they are facing during the pandemic. These entities may defer application to fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. As the Company has already adopted ASU 606 and ASU 842, the Company does not anticipate any effect on its financial statements.

 

In August 2020, the FASB issued ASU 2020-06Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. ASU 2020-06 reduces the number of accounting models for convertible debt instruments and convertible preferred stock. For convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital, the embedded conversion features no longer are separated from the host contract. ASU 2020-06 also removes certain conditions that should be considered in the derivatives scope exception evaluation under Subtopic 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity, and clarify the scope and certain requirements under Subtopic 815-40. In addition, ASU 2020-06 improves the guidance related to the disclosures and earnings-per-share (EPS) for convertible instruments and contract in entity’s own equity. ASU 2020-06 is effective for public business entities that meet the definition of a SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Board specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Company’s management is currently evaluating the impact this ASU will have on its financial statements.

 

Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying consolidated financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

XML 18 R9.htm IDEA: XBRL DOCUMENT v3.22.4
PREPAID EXPENSES
3 Months Ended
Sep. 30, 2022
PREPAID EXPENSES  
PREPAID EXPENSES

NOTE 5 – PREPAID EXPENSES

 

Prepaid expense balance as of September 30, 2022 and June 30, 2022 consisted of the following:

 

 

 

September 30, 2022

 

 

June 30, 2022

 

Advertising & promotion

 

$10,109

 

 

$5,500

 

Consultants & contractors

 

 

10,055

 

 

 

5,301

 

Platform costs

 

 

21,814

 

 

 

30,318

 

Software development

 

 

70,000

 

 

 

25,000

 

Total

 

$111,978

 

 

$66,119

 

XML 19 R10.htm IDEA: XBRL DOCUMENT v3.22.4
SOFTWARE
3 Months Ended
Sep. 30, 2022
SOFTWARE  
SOFTWARE

NOTE 6 – SOFTWARE

 

The Company has developed an automated threat intelligence defense platform, marketed as Tego Guardian. Tego Guardian is a threat correlation and threat hunting application that integrates directly into existing Security Information and Event Management (SIEM) platforms to provide threat tracking, mapping of exposures, and assist with expediting remediation. With performance capable of querying over 1 million records in just 4 seconds, Tego Guardian saves security operations teams time and money in an environment where timing is everything as efforts are made to lower mean-time-to-detection (MTTD) and mean-time-to-response (MTTR). What makes Tego Guardian different from other cyber threat correlation applications, is that it is the first commercially available solution that was specifically developed for the customer’s existing SIEM platform. It operates within the platform environment, so security operations teams do not have to use multiple tools and views to complete a specific task or research a threat. Tego Guardian cross-correlates threats in real time and not only looks forward but also backwards in order to see if the organization’s network has been previously exposed (active foresight and hindsight). The first version of Tego Guardian integrates with the industry leading Splunk® SIEM platform. Tego Guardian is now available for download through Splunk’s app store and is compatible with Splunk Cloud and Splunk Enterprise versions: 9.0, 8.2, 8.1, and 8.0.

 

Balance, June 30, 2021

 

$75,750

 

Additions

 

 

335,372

 

Amortization

 

 

-

 

Balance, June 30, 2022

 

$411,122

 

Additions

 

 

96,063

 

Amortization

 

 

-

 

Balance, September 30, 2022

 

$507,185

 

 

As at September 30, 2022, the software was not generating revenue and no amortization has been recorded for the periods then ended. It is expected the software will begin to generate revenue in the quarter ending December 31, 2022.

XML 20 R11.htm IDEA: XBRL DOCUMENT v3.22.4
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
3 Months Ended
Sep. 30, 2022
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES  
ACCOUNTS PAYABLE

NOTE 7 – ACCOUNTS PAYABLE & ACCRUED LIABILITIES

 

Accounts payable & accrued liabilities balance as of September 30, 2022 and June 30, 2022 consisted of the following:

 

 

 

September 30, 2022

 

 

June 30, 2022

 

Exchange & listing fees

 

 

710

 

 

 

-

 

Legal & accounting

 

 

13,213

 

 

 

23,247

 

Platform costs

 

 

2,856

 

 

 

-

 

Software development

 

 

50,898

 

 

 

42,819

 

Total

 

$67,677

 

 

$66,066

 

XML 21 R12.htm IDEA: XBRL DOCUMENT v3.22.4
RELATED PARTY TRANSACTIONS
3 Months Ended
Sep. 30, 2022
RELATED PARTY TRANSACTIONS  
RELATED PARTY TRANSACTIONS

NOTE 8 – RELATED PARTY TRANSACTIONS

 

Related party transactions are measured at the exchange amount, which is the amount of consideration established and agreed to by the related parties. Related parties are natural persons or other entities that have the ability, directly, or indirectly, to control another party or exercise significant influence over the party in making financial and operating decisions. Related parties include other parties that are subject to common control or that are subject to common significant influences.

During the three-month period ended September 30, 2022, there were transactions incurred between the Company and Shannon Wilkinson, Director, CEO, President, Secretary and Treasurer of the Company for management fees of $Nil (September 30, 2021 - $45,000) and gross wages of $30,000 (September 30, 2021 - $8,692).

 

During the three-month period ended September 30, 2022, there were transactions incurred between the Company and Earl Johnson, Chief Financial Officer of the Company for gross wages of $9,000 (September 30, 2021 - $Nil).

 

During the three-month period ended September 30, 2022, there were transactions incurred between the Company and Chris White, Director and Chief Information Security Officer of the Company for management fees of $Nil (September 30, 2021 - $12,500) and gross wages of $12,500 (September 30, 2021 - $6,519).

 

During the three-month period ended September 30, 2022, there were transactions incurred between the Company and Troy Wilkinson, Director of the Company for management fees of $10,000 (September 30, 2021 - $20,000).

XML 22 R13.htm IDEA: XBRL DOCUMENT v3.22.4
NOTES PAYABLE (convertible only at default)
3 Months Ended
Sep. 30, 2022
NOTES PAYABLE (convertible only at default)  
NOTES PAYABLE (convertible only at default)

NOTE 9 – NOTES PAYABLE (convertible only at default)

 

(a)

On July 12, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $300,000 at $270,000 with a $30,000 original issue discount. In connection with this note, the Company paid an additional $27,500 in cash transaction costs, issued 350,000 common shares valued at $175,000 in transaction costs, and issued 500,000 warrants exercisable at $0.25 per share, expiring on July 12, 2027. The warrants were calculated to have a fair value of $215,638 as at September 30, 2022. This note payable is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly.

 

 

 

The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.

 

 

 

The proceeds were allocated between the note payable, warrants and shares issued on a relative fair value basis. The fair value of the note payable was calculated using the present value of the debt and related interest at 12% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 10) and the shares issued were allocated proportionately for issuance cost for liability and equity portions under ASC 470-20 Debt with Conversion and Other Options. The shares are valued based on a relative fair market value of the shares on the issuance date.

 

 

 

In connection with the notes, the Company issued warrants indexed to an aggregate 500,000 shares of common stock. The warrants have a term of five years and an exercise price of $0.25. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair value of $93,740.

 

 

 

The Company also agreed to pay a commitment fee of $175,000 by issuing that number of shares of the Company’s common stock equal to such amount, aggregating to a total of 350,000 common shares of the Company. Under ASC 1.2.2 Debt Issuance Costs, the Company recognized the commitment fee as incremental costs specifically attributable to issuing the promissory note, while the commitment fee share were recorded in additional paid-in capital under their aggregate relative fair value of $76,074.

 

 

 

As at September 30, 2022, the carrying value of this note payable was $171,518 (September 30, 2021 - $Nil) net of $128,482 unamortized discounts.

(b)

On July 15, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $150,000 at $135,000 with $15,000 original issue discount. In connection with this note, the Company paid an additional $11,250 in cash transaction costs, issued 175,000 common shares valued at $87,500 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on July 15, 2027. This promissory note is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly.

 

 

 

The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.

 

 

 

The proceeds were allocated between the note payable, warrants and shares issued on a relative fair value basis. The fair value of the note payable was calculated using the present value of the debt and related interest at 12% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 10) and the shares issued were allocated proportionately for issuance cost for liability and equity portions under ASC 470-20 Debt with Conversion and Other Options. The shares are valued based on a fair market value of the shares on the issuance date.

 

 

 

In connection with the notes, the Company issued warrants indexed to an aggregate 250,000 shares of common stock. The warrants have a term of five years and an exercise price of $0.25. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair value of $46,878.

 

 

 

The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.

 

 

 

The Company also agreed to pay a commitment fee of $87,500 by issuing that number of shares of the Company’s common stock equal to such amount, aggregating to a total of 175,000 common shares of the Company. Under ASC 1.2.2 Debt Issuance Costs, the Company recognized the commitment fee as incremental costs specifically attributable to issuing the promissory note, while the commitment fee share were recorded in additional paid-in capital under their aggregate relative fair value of $38,033.

 

 

 

As at September 30, 2022, the carrying value of this note payable was $86,129 (September 30, 2021 - $Nil) net of $63,871 unamortized discounts.

 

 

(c)

On July 18, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable e in the principal amount of $150,000 at $135,000 with $15,000 original issue discount. In connection with this note, the Company paid an additional $11,250 in cash transaction costs, issued 175,000 common shares valued at $87,500 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on July 18, 2027. This note payable is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly.

 

The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.

 

 

 

The proceeds were allocated between the note payable, warrants and shares issued on a relative fair value basis. The fair value of the note payable was calculated using the present value of the debt and related interest at 12% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 10) and the shares issued were allocated proportionately for issuance cost for liability and equity portions under ASC 470-20 Debt with Conversion and Other Options. The shares are valued based on a fair market value of the shares on the issuance date.

 

 

 

In connection with the notes, the Company issued warrants indexed to an aggregate 250,000 shares of common stock. The warrants have a term of five years and an exercise price of $0.25. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair value of $46,871.

 

 

 

The Company also agreed to pay a commitment fee of $87,500 by issuing that number of shares of the Company’s common stock equal to such amount, aggregating to a total of 175,000 common shares of the Company. Under ASC 1.2.2 Debt Issuance Costs, the Company recognized the commitment fee as incremental costs specifically attributable to issuing the promissory note, while the commitment fee share were recorded in additional paid-in capital under their aggregate relative fair value of $38,034.

 

 

 

As at September 30, 2022, the carrying value of this note payable was $85,055 (September 30, 2021 - $Nil) net of $64,945 unamortized discounts.
XML 23 R14.htm IDEA: XBRL DOCUMENT v3.22.4
COMMON SHARES
3 Months Ended
Sep. 30, 2022
SHAREHOLDERS' EQUITY  
COMMON SHARES

NOTE 10 – COMMON SHARES

 

Common Stock

 

At September 30, 2022, the Company’s authorized capital consisted of 50,000,000 of common shares with a par value of $0.001

 

During the three-month period ended September 30, 2022, the Company incurred the following transactions:

 

On July 12, 2022, the Company issued 350,000 common shares at a relative fair value of $0.22 per share for transaction costs associated with the issuance of a note payable.

 

On July 15, 2022, the Company issued 175,000 common shares at a relative fair value of $0.22 per share for transaction costs associated with the issuance of a note payable.

 

On July 18, 2022, the Company issued 175,000 common shares at a relative fair value of $0.22 per share for transaction costs associated with the issuance of a note payable.

 

On July 26, 2022, the Company issued 275,000 common shares at a price of $0.50 per share for marketing and branding services valued at $137,500.

During the year ended June 30, 2022, the Company incurred the following transactions:

 

During the period July 1, 2021 to October 28, 2021, the Company completed various private placements whereby a total of 5,558,810 common shares were issued for a total proceeds of $1,425,202.

 

On October 15, 2021, the Company issued 125,000 common shares at a price of $0.80 per share for marketing services valued at $100,000.

 

On October 28, 2021, the Company issued 28,572 common shares at a price of $0.70 per share for legal services valued at $20,000.

 

On December 8, 2021, the Company issued 50,000 common shares at a price of $0.71 per share for consulting services valued at $35,250.

 

On December 31, 2021, the Company issued 583,936 common shares for the conversion of debt at a conversion price of $0.10 per share for a total value of $58,394.

 

On December 31, 2021, the Company issued 353,215 common shares for the conversion of debt at a conversion price of $0.10 per share for a total value of $35,321. See Note 10 (b).

 

On January 1, 2022, the Company issued 100,000 common shares at a price of $0.65 per share for consulting services valued at $65,000.

 

On March 25, 2022, the Company issued 12,000 shares to a non-related party at a price of $0.60 per share for a total value of $7,200 in exchange for services.

 

On May 19, 2022, the Company issued 400,000 shares to a non-related party at a price of $0.577 per share for investor relations services valued at $230,800.

 

Warrants

 

On December 28, 2020, the Company granted 1,100,000 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction. The warrants were valued at $146,942 using the Black Scholes Option Pricing Model.

 

On March 25, 2021, the Company granted 1,100,000 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction. The warrants were valued at $148,438 using the Black Scholes Option Pricing Model.

 

On April 22, 2021, the Company granted 506,838 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction. The warrants were valued at $399,087 using the Black Scholes Option Pricing Model.

 

On April 28, 2021, the Company granted 307,408 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction. The warrants were valued at $196,399 using the Black Scholes Option Pricing Model.

 

On July 12, 2022, the Company granted 500,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $215,638 using the Black Scholes Option Pricing Model and they were recorded at $93,740 in additional paid-in capital under using the relative fair value method.

 

On July 15, 2022, the Company granted 250,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a   note payable financing transaction (Note 9). The warrants were valued at $107,848 using the Black Scholes Option Pricing Model and they were recorded at $46,878 in additional paid-in capital under using the relative fair value method.

 

On July 18, 2022, the Company granted 250,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $107,831 using the Black Scholes Option Pricing Model and they were recorded at $46,871 in additional paid-in capital under the using relative fair value method.

The Black Scholes Option Pricing Model assumptions used in the valuation of the warrants are outlined below. The stock price was based on recent issuances. Expected life was based on the expiry date of the warrants as the Company did not have historical exercise data of such warrants.

 

 

 

September 30, 2022

 

 

Stock price

 

$0.50 - $0.51

 

 

Risk-free interest rate

 

3.19%-3.22

 

Expected life

 

5 Years

 

 

Expected dividend rate

 

0

 

 

Expected volatility

 

103.20% - 103.28

%

 

 

Continuity of the Company’s common stock purchase warrants issued and outstanding is as follows:

 

 

 

Number

of

Warrants

 

 

Weighted

Average

Exercise

Price

 

Outstanding, June 30, 2022

 

 

3,014,246

 

 

$0.25

 

Granted

 

 

1,000,000

 

 

 

0.25

 

Exercised

 

 

-

 

 

 

-

 

Expired

 

 

-

 

 

 

-

 

Outstanding, September 30, 2022

 

 

4,014,246

 

 

$0.25

 

 

As at September 30, 2022, the weighted average remaining contractual life of warrants outstanding was 4.80 years with an intrinsic value of $0.25.

 

Stock Options

 

On December 8, 2021, the Board of Directors of the Company approved the adoption of the 2021 Equity Compensation Plan (the “Equity Compensation Plan”) to provide employees, certain consultants and advisors who perform services for the Company, and non-employee members of the Board of Directors of the Company with the opportunity to receive grants of incentive stock options, nonqualified stock options, stock appreciation rights, stock awards, stock units and other stock-based awards.

 

The following is a continuity schedule for the Company’s outstanding non-qualified stock options:

 

 

 

Number of

options

 

 

Weighted

Average

Exercise Price

 

Outstanding, June 30, 2022

 

 

6,000,000

 

 

$0.65

 

Granted

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

Cancelled

 

 

-

 

 

 

-

 

Outstanding, September 30, 2022

 

 

6,000,000

 

 

$0.65

 

At September 30, 2022, the Company had the following stock options outstanding:

 

Grant

Date

 

Number

Outstanding

 

 

Number

Exercisable

 

 

Exercise

Price

 

 

Weighted

Average Life

(Years)

 

 

Expiry Date

 

January 3, 2022

 

 

125,000

 

 

 

125,000

 

 

$0.65

 

 

 

9.27

 

 

January 3, 2032

 

January 4, 2022

 

 

5,875,000

 

 

 

5,875,000

 

 

 

0.65

 

 

 

9.27

 

 

January 4, 2032

 

Total

 

 

6,000,000

 

 

 

6,000,000

 

 

$0.65

 

 

 

9.27

 

 

 

 

 

During the three-month period ended September 30, 2022, the Company recorded $382,577 as share-based compensation relating to the issuance of the non-qualified stock options.

 

The fair value of the options granted during the year ended September 30, 2022 was estimated on the date of the grant date using the Black-Scholes option pricing model with the following weighted average assumptions:

 

Expected volatility

 

 

91.03%

Expected option life (years)

 

6 years

 

Risk-free interest rate (10-year U.S. treasury yield)

 

1.55 - 1.66

%

Expected dividend yield

 

 

0%

 

Performance Stock Units

 

On December 8, 2021, the Board of Directors of the Company approved the adoption of the 2021 Equity Compensation Plan (the “Equity Compensation Plan”) to provide employees, certain consultants and advisors who perform services for the Company, and non-employee members of the Board of Directors of the Company with the opportunity to receive grants of incentive stock options, nonqualified stock options, stock appreciation rights, stock awards, stock units and other stock-based awards.

 

The following is a continuity schedule for the Company’s outstanding performance stock units:

 

 

 

Number of

Performance

Units

 

 

Weighted

Average Exercise

Price

 

Outstanding, June 30, 2022

 

 

4,000,000

 

 

$-

 

Granted

 

 

-

 

 

 

-

 

Released

 

 

-

 

 

 

-

 

Forfeited or cancelled

 

 

-

 

 

 

-

 

Outstanding, September 30, 2022

 

 

4,000,000

 

 

$-

 

 

At September 30, 2022, the Company had the following performance units outstanding:

 

Grant

Date

 

Number

Outstanding

 

 

Number

Exercisable

 

 

Exercise

Price

 

Weighted Average Life (Years)

 

 

Expiry Date

 

March 8, 2022

 

 

4,000,000

 

 

 

4,000,000

 

 

USD $0.00

 

 

4.25

 

 

December 31, 2026

 

Total

 

 

4,000,000

 

 

 

4,000,000

 

 

USD $0.00

 

 

4.25

 

 

 

 

 

During the three-month period ended September 30, 2022, the Company recorded $242,790 as share-based compensation relating to the issuance of the performance units.

 

The fair value of the performance units granted during the year ended September 30, 2022 was estimated on the date of the grant date using N(d2) output from a Black-Sholes model to calculate the value of the award multiplying N(d2) by the current stock price as of the valuation date with the following weighted average assumptions:

 

Expected volatility

 

 

85.0%

Requisite period

 

4.25 years

 

Risk-free interest rate (US Treasury Bond rate as of the grant date)

 

 

1.80%

Expected dividend yield

 

 

0%
XML 24 R15.htm IDEA: XBRL DOCUMENT v3.22.4
INCOME TAXES
3 Months Ended
Sep. 30, 2022
INCOME TAXES  
INCOME TAXES

NOTE 11 – INCOME TAXES

 

As of September 30, 2022, the Company was in a loss position; therefore, no deferred tax liability was recognized related to the undistributed earnings subject to withholding tax.

 

Net operating loss carry forward of the Company, amounted to $3,406,686 (June 30, 2022 - $2,909,935) for the three-month period ended September 30, 2022. The net operating loss carry forwards are available to be utilized against future taxable income for years through calendar year 2042. In assessing the reliability of deferred income tax assets, management considers whether it is more likely than not that some portion or all of the deferred income tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled projected future taxable income, and tax planning strategies in making this assessment.

XML 25 R16.htm IDEA: XBRL DOCUMENT v3.22.4
RECLASSIFICATION OF PRIOR YEAR PRESENTATION
3 Months Ended
Sep. 30, 2022
RECLASSIFICATION OF PRIOR YEAR PRESENTATION  
RECLASSIFICATION OF PRIOR YEAR PRESENTATION

NOTE 12 – RECLASSIFICATION OF PRIOR YEAR PRESENTATION

 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications are limited to the Statement of Operations and have no effect on the reported results of operations.

XML 26 R17.htm IDEA: XBRL DOCUMENT v3.22.4
SUBSEQUENT EVENTS
3 Months Ended
Sep. 30, 2022
SUBSEQUENT EVENTS  
SUBSEQUENT EVENTS

NOTE 13 – SUBSEQUENT EVENTS

 

On October 13, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $150,000 at $135,000 with $15,000 original issue discount. In connection with this note, the Company paid an additional $23,750 in cash transaction costs, issued 416,667 common shares valued at $50,000 in transaction costs, and issued 500,000 warrants exercisable at $0.25 per share, expiring on October 13, 2027. This note payable is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly, and matures on April 13, 2023 (the “Maturity Date”). The Maturity Date may be extended by up to 6 months following the date of the original Maturity Date. In the event that the Maturity Date is extended, the interest rate shall increase to 18% per annum for any period following the original Maturity Date, payable monthly.

 

On October 13, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $75,000 at $135,000 with $7,500 original issue discount. In connection with this note, the Company paid an additional $5,625 in cash transaction costs, issued 208,300 common shares valued at $25,000 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on October July 13, 2027. This note payable is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly, , and matures on April 13, 2023 (the “Maturity Date”). The Maturity Date may be extended by up to 6 months following the date of the original Maturity Date. In the event that the Maturity Date is extended, the interest rate shall increase to 18% per annum for any period following the original Maturity Date, payable monthly.

 

On October 13, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $75,000 at $135,000 with $7,500 original issue discount. In connection with this note, the Company paid an additional $5,625 in cash transaction costs, issued 208,300 common shares valued at $25,000 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on October July 13, 2027. This note payable is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly,  and matures on April 13, 2023 (the “Maturity Date”). The Maturity Date may be extended by up to 6 months following the date of the original Maturity Date. In the event that the Maturity Date is extended, the interest rate shall increase to 18% per annum for any period following the original Maturity Date, payable monthly.

 

On November 29, 2022, the Company completed a private placement whereby a total of 100,000 common shares were issued for cash at a price of $0.10 per share for a total value of $10,000.

 

On December 5, 2022, the Company completed a private placement whereby a total of 400,000 common shares were issued for cash at a price of $0.10 per share for a total value of $40,000.

 

On January 6, 2023, the Company completed a private placement whereby a total of 100,000 common shares were sold for cash at a price of $0.10 per share for a total value of $10,000. Shares have yet to be issued.

On January 9, 2023, the Company issued 500,000 shares with a fair value of $100,000 to a non-related party in exchange for services.

 

On January 9, 2023, the Company issued 45,000 shares with a fair value of $9,000 to a non-related party in exchange for settlement of a debt.

 

On January 11, 2023, the Company completed a private placement whereby a total of 300,000 common shares were sold for cash at a price of $0.10 per share for a total value of $30,000.

 

On January 15, 2023, the Company completed a private placement whereby a total of 600,000 common shares were sold for cash at a price of $0.10 per share for a total value of $60,000.

 

On January 16, 2023, the Company completed a private placement whereby a total of 150,000 common shares were sold for cash at a price of $0.10 per share for a total value of $15,000.

 

On January 17, 2023, the Company completed various a private placement whereby a total of 70,000 common shares were sold for cash at a price of $0.10 per share for a total value of $7,000.

 

On January 21, 2023, the Company completed various private placements whereby a total of 1,115,000 common shares were issued for cash at a price of $0.10 per share for a total value of $111,500.

 

On January 22, 2023, the Company completed a private placement whereby a total of 15,000 common shares were sold for cash at a price of $0.10 per share for a total value of $1,500.

 

On January 23, 2023, the Company completed various private placements whereby a total of 430,000 common shares were sold for cash at a price of $0.10 per share for a total value of $43,000.

 

On January 24, 2023, the Company completed a private placement whereby a total of 1,000,000 common shares were sold for cash at a price of $0.10 per share for a total value of $100,000.

 

On January 25, 2023, the Company completed a private placement whereby a total of 100,000 common shares were sold for cash at a price of $0.10 per share for a total value of $10,000.

 

On January 28, 2023, the Company completed a private placement whereby a total of 150,000 common shares were sold for cash at a price of $0.10 per share for a total value of $15,000.

 

On January 30, 2023, the Company completed various private placement whereby a total of 850,000 common shares were sold for cash at a price of $0.10 per share for a total value of $85,000.

 

On February 6, 2023, the Company completed a private placement whereby a total of 225,000 common shares were sold for cash at a price of $0.10 per share for a total value of $22,500. Shares have yet to be issued.

 

On February 6, 2023, the Company issued 1,000,000 shares with a fair value of $200,000 to a non-related party in exchange for services.

 

On February 7, 2023, the Company completed a private placement whereby a total of 215,000 common shares were sold for cash at a price of $0.10 per share for a total value of $21,500.

 

On February 14, 2023, the Company completed a private placement whereby a total of 1,000,000 common shares were sold for cash at a price of $0.10 per share for a total value of $100,000. Shares have yet to be issued.

XML 27 R18.htm IDEA: XBRL DOCUMENT v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
3 Months Ended
Sep. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Basis of Preparation

The Company prepares its financial statements in accordance with rules and regulations of the Securities and Exchange Commission (“SEC”) and GAAP in the United States of America. The accompanying interim financial statements have been prepared in accordance with GAAP for interim financial information in accordance with Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the Company’s opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2022, are not necessarily indicative of the results for the full year. While management of the Company believes that the disclosures presented herein are adequate and not misleading, these interim financial statements should be read in conjunction with the audited financial statements and the footnotes thereto for the year ended June 30, 2022.

Going Concern

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of the business. The Company has incurred material losses from operations and has an accumulated deficit. At September 30, 2022, the Company had a negative working capital of $260,942. For the three months ended September 30, 2022, the Company sustained net losses and generated negative cash flows from operations. In March 2020, the World Health Organization recognized the outbreak of COVID-19 as a global pandemic. The COVID-19 pandemic and government actions implemented to contain the further spread of COVID-19 have severely restricted economic activity around the world. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that may be necessary should the Company be unable to continue as a going concern. These adjustments could be material. The Company’s continuation as a going concern is contingent upon its ability to earn adequate revenues from operations and to obtain additional financing. There is no assurance that the Company will be able to obtain such financings or obtain them on favorable terms.

Use of Estimates

In preparing financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements, as well as the reported amounts of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. However, actual results could differ materially from those estimates.

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and accounts receivable. As at September 30, 2022, substantially all of the Company’s cash was held by major financial institutions located in the United States, which management believes are of high credit quality. With respect to accounts receivable, the Company extended credit based on an evaluation of the customer’s financial condition. The Company generally did not require collateral for accounts receivable and maintained an allowance for doubtful accounts of accounts receivable if necessary.

Cash

Cash consists of cash held at major financial institutions and is subject to insignificant risk of changes in value.

Receivables and Allowance for Doubtful Accounts

Trade accounts receivable are recorded at net realizable value and do not bear interest. No allowance for doubtful accounts was made during the three-month period ended September 30, 2022 and the year ended June 30, 2022, based on management’s best estimate of the amount of probable credit losses in accounts receivable. The Company evaluates its allowance for doubtful accounts based upon knowledge of its customers and their compliance with credit terms. The evaluation process includes a review of customers’ accounts on a regular basis. The review process evaluates all account balances with amounts outstanding for more than 60 days and other specific amounts for which information obtained indicates that the balance may be uncollectible. As of September 30, 2022 and June 30, 2022, there was no allowance for doubtful accounts and the Company does not have any off-balance-sheet credit exposure related to its customers.

Software

Software is stated at cost less accumulated amortization and is amortized using the straight-line method over the estimated useful life of the asset. The estimated useful life of the asset is 5 years and is not amortized until it is available for use by the Company.

Leases

The Company determines if an arrangement is a lease at inception. Operating and financing right-of-use assets and lease liabilities are included on the balance sheet. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company uses its incremental borrowing rate, based on the information available at the commencement date, in determining the present value of future lease payments. Right-of-use assets include any prepaid lease payments and exclude any lease incentives and initial direct costs incurred. Operating lease expenses are recognized on a straight-line basis over the term of the lease, consisting of interest accrued on the lease liability and amortization of the right-of-use asset. The lease terms may include options to extend or terminate the lease is it is reasonably certain the Company will exercise that option. The Company leases its corporate office located at 8565 S. Eastern Ave. #150, Las Vegas, Nevada. The initial lease term is for 12 months commencing on September 8, 2019 after which the term is on a month-to-month basis. After the initial term, the Company may cancel the lease agreement at any time by providing 30 days written notice. The Company has elected the short-term lease practical expedient of 12 months and has not recorded a lease.

Fair Value of Financial Instruments

Accounting Standards Codification (“ASC”) 820 “Fair Value Measurements and Disclosures”, adopted January 1, 2008, defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The Company’s financial instruments include cash, current receivables and payables. These financial instruments are measured at their respective fair values. The three levels are defined as follows:

 

Level 1 - inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.

 

Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.

 

Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value.

 

For cash, accounts receivable, accounts payable and accrued liabilities and due to related parties, it is management’s opinion that the carrying values are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and if applicable, their stated interest rate approximates current rates available.

 

For convertible debts, the carrying values, excluding any unamortized discounts, approximate the respective fair value. The convertible debts have been discounted to reflect their net present value as at September 30, 2022. The carrying values of embedded conversion features not considered to be derivative instruments were determined by allocating the remaining carrying value of the convertible debt after deducting the estimated carrying value of the liability portion.

 

Estimating fair value for warrants require determining the most appropriate valuation model which is dependent on the terms and conditions of the grant. This estimate requires determining the most appropriate inputs to the valuation model including the expected life of the warrant, volatility, dividend yield, and rate of forfeitures and making assumptions about them.

Revenue Recognition

Revenue is recognized under ASC 606, “Revenue from Contracts with Customers” using the modified retrospective method. Under this method, the Company follows the five-step model provided by ASC Topic 606 in order to recognize revenue in the following manner: 1) identify the contract; 2) identify the performance obligations of the contract; 3) determine the transaction price of the contract; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue. The Company recognizes revenue for the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services.

 

The Company currently has not generated any revenue from its threat intelligence software.

Income Taxes

The Company uses the asset and liability method of accounting for income taxes pursuant to ASC 740 “Income Taxes”. ASC 740 requires an asset and liability approach for financial accounting and reporting for income taxes and allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Valuation allowances are provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The provision for income taxes represents current taxes payable net of the change during the period in deferred tax assets and liabilities.

Earnings (Loss) per Share

Basic earnings (loss) per share is computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. If applicable, diluted earnings (loss) per share assume the conversion, exercise or issuance of all common stock instruments unless the effect is to reduce a loss or increase earnings (loss) per share.

Recently Issued Accounting Pronouncements

In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes which amends ASC 740 Income Taxes (ASC 740). This update is intended to simplify accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and amending existing guidance to improve consistent application of ASC 740. This update is effective for fiscal years beginning after December 15, 2021. The guidance in this update has various elements, some of which are applied on a prospective basis and others on a retrospective basis with earlier application permitted. The Company’s management is currently evaluating the effect of this ASU on the Company’s financial statements and related disclosures.

 

In June 2020, the FASB issued ASU 2020-05 in response to the ongoing impacts to U.S. businesses in response to the COVID-19 pandemic. ASU 2020-05, Revenue from Contracts with Customers (Topic 606) and Leases (Topic 842) Effective Dates for Certain Entities provide a limited deferral of the effective dates for implementing previously issued ASU 606 and ASU 842 to give some relief to businesses considering the difficulties they are facing during the pandemic. These entities may defer application to fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. As the Company has already adopted ASU 606 and ASU 842, the Company does not anticipate any effect on its financial statements.

 

In August 2020, the FASB issued ASU 2020-06Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. ASU 2020-06 reduces the number of accounting models for convertible debt instruments and convertible preferred stock. For convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in capital, the embedded conversion features no longer are separated from the host contract. ASU 2020-06 also removes certain conditions that should be considered in the derivatives scope exception evaluation under Subtopic 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity, and clarify the scope and certain requirements under Subtopic 815-40. In addition, ASU 2020-06 improves the guidance related to the disclosures and earnings-per-share (EPS) for convertible instruments and contract in entity’s own equity. ASU 2020-06 is effective for public business entities that meet the definition of a SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Board specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Company’s management is currently evaluating the impact this ASU will have on its financial statements.

 

Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying consolidated financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.

XML 28 R19.htm IDEA: XBRL DOCUMENT v3.22.4
PREPAID EXPENSES (Tables)
3 Months Ended
Sep. 30, 2022
PREPAID EXPENSES  
Schedule of prepaid expenses

 

 

September 30, 2022

 

 

June 30, 2022

 

Advertising & promotion

 

$10,109

 

 

$5,500

 

Consultants & contractors

 

 

10,055

 

 

 

5,301

 

Platform costs

 

 

21,814

 

 

 

30,318

 

Software development

 

 

70,000

 

 

 

25,000

 

Total

 

$111,978

 

 

$66,119

 

XML 29 R20.htm IDEA: XBRL DOCUMENT v3.22.4
SOFTWARE (Tables)
3 Months Ended
Sep. 30, 2022
SOFTWARE  
Schedule of software

Balance, June 30, 2021

 

$75,750

 

Additions

 

 

335,372

 

Amortization

 

 

-

 

Balance, June 30, 2022

 

$411,122

 

Additions

 

 

96,063

 

Amortization

 

 

-

 

Balance, September 30, 2022

 

$507,185

 

XML 30 R21.htm IDEA: XBRL DOCUMENT v3.22.4
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)
3 Months Ended
Sep. 30, 2022
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES  
Accounts payable and accrued liabilities

 

 

September 30, 2022

 

 

June 30, 2022

 

Exchange & listing fees

 

 

710

 

 

 

-

 

Legal & accounting

 

 

13,213

 

 

 

23,247

 

Platform costs

 

 

2,856

 

 

 

-

 

Software development

 

 

50,898

 

 

 

42,819

 

Total

 

$67,677

 

 

$66,066

 

XML 31 R22.htm IDEA: XBRL DOCUMENT v3.22.4
COMMON SHARES (Tables)
3 Months Ended
Sep. 30, 2022
SHAREHOLDERS' EQUITY  
schedule for the Company's exercise warrant data

 

 

September 30, 2022

 

 

Stock price

 

$0.50 - $0.51

 

 

Risk-free interest rate

 

3.19%-3.22

 

Expected life

 

5 Years

 

 

Expected dividend rate

 

0

 

 

Expected volatility

 

103.20% - 103.28

%

 

schedule for the Company's outstanding warrants:

 

 

Number

of

Warrants

 

 

Weighted

Average

Exercise

Price

 

Outstanding, June 30, 2022

 

 

3,014,246

 

 

$0.25

 

Granted

 

 

1,000,000

 

 

 

0.25

 

Exercised

 

 

-

 

 

 

-

 

Expired

 

 

-

 

 

 

-

 

Outstanding, September 30, 2022

 

 

4,014,246

 

 

$0.25

 

schedule for the Company's outstanding non-qualified stock options:

 

 

Number of

options

 

 

Weighted

Average

Exercise Price

 

Outstanding, June 30, 2022

 

 

6,000,000

 

 

$0.65

 

Granted

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

Cancelled

 

 

-

 

 

 

-

 

Outstanding, September 30, 2022

 

 

6,000,000

 

 

$0.65

 

Schedule of stock options outstanding:

Grant

Date

 

Number

Outstanding

 

 

Number

Exercisable

 

 

Exercise

Price

 

 

Weighted

Average Life

(Years)

 

 

Expiry Date

 

January 3, 2022

 

 

125,000

 

 

 

125,000

 

 

$0.65

 

 

 

9.27

 

 

January 3, 2032

 

January 4, 2022

 

 

5,875,000

 

 

 

5,875,000

 

 

 

0.65

 

 

 

9.27

 

 

January 4, 2032

 

Total

 

 

6,000,000

 

 

 

6,000,000

 

 

$0.65

 

 

 

9.27

 

 

 

 
Schedule of weighted average assumptions

Expected volatility

 

 

91.03%

Expected option life (years)

 

6 years

 

Risk-free interest rate (10-year U.S. treasury yield)

 

1.55 - 1.66

%

Expected dividend yield

 

 

0%
schedule for the Company's outstanding performance stock units:

 

 

Number of

Performance

Units

 

 

Weighted

Average Exercise

Price

 

Outstanding, June 30, 2022

 

 

4,000,000

 

 

$-

 

Granted

 

 

-

 

 

 

-

 

Released

 

 

-

 

 

 

-

 

Forfeited or cancelled

 

 

-

 

 

 

-

 

Outstanding, September 30, 2022

 

 

4,000,000

 

 

$-

 

schedule for the Company's performance units outstanding

Grant

Date

 

Number

Outstanding

 

 

Number

Exercisable

 

 

Exercise

Price

 

Weighted Average Life (Years)

 

 

Expiry Date

 

March 8, 2022

 

 

4,000,000

 

 

 

4,000,000

 

 

USD $0.00

 

 

4.25

 

 

December 31, 2026

 

Total

 

 

4,000,000

 

 

 

4,000,000

 

 

USD $0.00

 

 

4.25

 

 

 

 
schedule of fair value of the performance units granted

Expected volatility

 

 

85.0%

Requisite period

 

4.25 years

 

Risk-free interest rate (US Treasury Bond rate as of the grant date)

 

 

1.80%

Expected dividend yield

 

 

0%
XML 32 R23.htm IDEA: XBRL DOCUMENT v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Sep. 30, 2022
Jun. 30, 2022
Negative working capital (Surplus) $ 260,942  
Allowance for doubtful accounts $ 0 $ 0
Software [Member]    
Estimated useful life 5 years  
XML 33 R24.htm IDEA: XBRL DOCUMENT v3.22.4
PREPAID EXPENSES (Details) - USD ($)
Sep. 30, 2022
Jun. 30, 2022
PREPAID EXPENSES    
Advertising and promotion $ 10,109 $ 5,500
Consultants and contractors 10,055 5,301
Platform costs 21,814 30,318
Software Development 70,000 25,000
Total $ 111,978 $ 66,119
XML 34 R25.htm IDEA: XBRL DOCUMENT v3.22.4
SOFTWARE (Details) - USD ($)
3 Months Ended 12 Months Ended
Sep. 30, 2022
Jun. 30, 2022
SOFTWARE    
Software, Beginning Balance $ 411,122 $ 75,750
Additions 96,063 335,372
Depreciation 0 0
Software, Ending Balance $ 507,185 $ 411,122
XML 35 R26.htm IDEA: XBRL DOCUMENT v3.22.4
ACCOUNTS PAYABLE ACCRUED LIABILITIES (Details) - USD ($)
Sep. 30, 2022
Jun. 30, 2022
ACCOUNTS PAYABLE ACCRUED LIABILITIES (Details)    
Exchange & listing fees $ 710 $ 0
Legal and accounting 13,213 23,247
Platform cost 2,856 0
Software development 50,898 42,819
Total $ 67,677 $ 66,066
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.22.4
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
3 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Troy Wilkinson    
Management Fees $ 10,000 $ 20,000
Shannon Wilkinson    
Management Fees 0 45,000
Gross Wages 30,000 8,692
Chris White    
Management Fees 0 12,500
Gross Wages 12,500 6,519
Earl Johnson    
Gross Wages $ 9,000 $ 0
XML 37 R28.htm IDEA: XBRL DOCUMENT v3.22.4
NOTES PAYABLE (convertible only at default) (Details Narrative) - USD ($)
1 Months Ended
Jul. 15, 2022
Jul. 12, 2022
Jul. 18, 2022
Sep. 30, 2022
Sep. 30, 2021
Notes Payable [Member]          
Original issue discount   $ 30,000      
Notes payable in exchange for cash   $ 300,000      
Notes payable interest rate   10.00%      
Notes payable in exchange for cash, fair value   $ 270,000      
Additional cash proceeds   $ 27,500      
Common shares issue   350,000      
Total common shares issued   350,000      
Common shares issue value   $ 175,000      
Warrants indexed issued   500,000      
Commitment fee   $ 175,000      
Carrying value of note payable       $ 171,518 $ 0
Unamortized discounts       128,482  
Warrants relative fair value   93,740      
Common stock relative fair value   $ 76,074      
Warrants issued   500,000      
Warrant exercisable   $ 0.25      
Exercise price   $ 0.25      
Debt related interest rate   12.00%      
Notes Payable One [Member]          
Original issue discount $ 15,000        
Notes payable in exchange for cash $ 150,000        
Notes payable interest rate 10.00%        
Notes payable in exchange for cash, fair value $ 135,000        
Additional cash proceeds $ 11,250        
Common shares issue 175,000        
Total common shares issued 175,000        
Common shares issue value $ 87,500        
Warrants indexed issued 250,000        
Commitment fee $ 87,500        
Carrying value of note payable       86,129 0
Unamortized discounts       63,871  
Warrants relative fair value 46,878        
Common stock relative fair value $ 38,033        
Warrants issued 250,000        
Warrant exercisable $ 0.25        
Exercise price $ 0.25        
Debt related interest rate 12.00%        
Fair value of warrants       215,638  
Notes Payable Two [Member]          
Original issue discount     $ 15,000    
Notes payable in exchange for cash     $ 150,000    
Notes payable interest rate     10.00%    
Notes payable in exchange for cash, fair value     $ 135,000    
Additional cash proceeds     $ 11,250    
Common shares issue     175,000    
Total common shares issued     175,000    
Common shares issue value     $ 87,500    
Warrants indexed issued     250,000    
Commitment fee     $ 87,500    
Carrying value of note payable       85,055 $ 0
Unamortized discounts       $ 64,945  
Warrants relative fair value     46,871    
Common stock relative fair value     $ 38,034    
Warrants issued     250,000    
Warrant exercisable     $ 0.25    
Exercise price     $ 0.25    
Debt related interest rate     12.00%    
XML 38 R29.htm IDEA: XBRL DOCUMENT v3.22.4
COMMON SHARES (Details)
3 Months Ended
Sep. 30, 2022
$ / shares
Expected Life 5 years
Expected Dividend Rate 0.00%
Minimum [Member]  
Stock Price $ 0.50
Risk-free Interest Rate 3.19%
Expected Volatility 103.20%
Maximum [Member]  
Stock Price $ 0.51
Risk-free Interest Rate 3.22%
Expected Volatility 103.28%
XML 39 R30.htm IDEA: XBRL DOCUMENT v3.22.4
COMMON SHARES (Details 1)
3 Months Ended
Sep. 30, 2022
$ / shares
shares
SHAREHOLDERS' EQUITY  
Number Of Warrants Outstanding, Beginning | shares 3,014,246
Number Of Warrants Granted | shares 1,000,000
Number Of Warrants Outstanding,Ending Balance | shares 4,014,246
Weighted Average Exercise Price Outstanding, Beginning $ 0.25
Weighted Average Exercise Price Granted 0.25
Weighted Average Exercise Price Exercised 0
Weighted Average Exercise Price Expired 0
Weighted Average Exercise Price Outstanding, ending $ 0.25
XML 40 R31.htm IDEA: XBRL DOCUMENT v3.22.4
COMMON SHARES (Details 2)
3 Months Ended
Sep. 30, 2022
$ / shares
shares
SHAREHOLDERS' EQUITY  
Weighted Average Exercise Price Outstanding, Beginning Balance $ 0.65
Weighted Average Exercise Price Granted 0
Weighted Average Exercise Price Exercised 0
Weighted Average Exercise Price Cancelled 0
Weighted Average Exercise Price Outstanding, Ending Balance $ 0.65
Number Of Warrants Outstanding, Beginning | shares 6,000,000
Number Of Warrants Granted | shares 1,000,000
Number Of Warrants Outstanding, Ending Balance | shares 6,000,000
XML 41 R32.htm IDEA: XBRL DOCUMENT v3.22.4
COMMON SHARES (Details 3)
3 Months Ended
Sep. 30, 2022
$ / shares
shares
Weighted Average life 9 years 3 months 7 days
Number of option outstanding 6,000,000
Exercise | $ / shares $ 0.65
Weighted Average life 4 years 3 months
Number of option Exercisable 6,000,000
January 3, 2022 [Member]  
Number of option outstanding 125,000
Exercise | $ / shares $ 0.65
Weighted Average life 9 years 3 months 7 days
Number of option Exercisable 125,000
Expiry Date January 3, 2032
January 4, 2022 [Member]  
Number of option outstanding 5,875,000
Exercise | $ / shares $ 0.65
Weighted Average life 9 years 3 months 7 days
Number of option Exercisable 5,875,000
Expiry Date January 4, 2032
XML 42 R33.htm IDEA: XBRL DOCUMENT v3.22.4
COMMON SHARES (Details 4)
3 Months Ended
Sep. 30, 2022
Expected volatility 91.03%
Expected life 6 years
Expected dividend yield 0.00%
Minimum [Member]  
Risk-free interest rate 1.55%
Maximum [Member]  
Risk-free interest rate 1.66%
XML 43 R34.htm IDEA: XBRL DOCUMENT v3.22.4
COMMON SHARES (Details 5)
3 Months Ended
Sep. 30, 2022
USD ($)
$ / shares
shares
SHAREHOLDERS' EQUITY  
Number Of Warrants Granted | $ $ 0
Number Of Warrants Released | $ 0
Number Of Warrants Forfeited or cancelled | $ $ 0
Number Of Warrants Outstanding,Ending | shares 4,000,000
Weighted Average Exercise Price Beginning balance $ 0
Weighted Average Exercise Price Granted 0
Weighted Average Exercise Price Released 0
Weighted Average Exercise Price Forfeited or Cancelled $ 0
Number Of Warrants Outstanding, beginning | shares 4,000,000
Weighted Average Exercise Price Ending, Balance $ 0
XML 44 R35.htm IDEA: XBRL DOCUMENT v3.22.4
COMMON SHARES (Details 6)
3 Months Ended
Sep. 30, 2022
$ / shares
shares
Number Exercisable 4,000,000
Exercise | $ / shares $ 0.00
Number of option outstanding 4,000,000
Weighted Average Life (Years) 4 years 3 months
March 8, 2022 [Member]  
Number Exercisable 4,000,000
Exercise | $ / shares $ 0.00
Number of option outstanding 4,000,000
Weighted Average Life (Years) 4 years 3 months
Expiry date December 31, 2026
XML 45 R36.htm IDEA: XBRL DOCUMENT v3.22.4
COMMON SHARES (Details 7)
3 Months Ended
Sep. 30, 2022
SHAREHOLDERS' EQUITY  
Expected volatility 85.00%
Expected life 4 years 3 months
Risk-free interest rate 1.80%
Expected dividend rate 0.00%
XML 46 R37.htm IDEA: XBRL DOCUMENT v3.22.4
COMMON SHARES (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Jul. 15, 2022
Jul. 12, 2022
Apr. 28, 2021
Apr. 22, 2021
Mar. 25, 2021
Dec. 28, 2020
Jul. 18, 2022
Oct. 28, 2021
Sep. 30, 2022
Feb. 06, 2023
Jan. 09, 2023
Jun. 30, 2022
Weighted average remaining contractual life of warrants outstanding                 4 years 9 months 18 days      
Common stock, authorized                 50,000,000     50,000,000
Share-based compensation                 $ 242,790      
Common stock, par value                 $ 0.001     $ 0.001
Share-based compensation non qualified stock options                 $ 382,577      
Warrants intrinsic value                 $ 0.25      
Common stock, issued                 26,483,044 1,000,000 45,000 25,508,044
Number of warrants granted                 1,000,000      
Additional paid in capital                 $ 5,687,572     $ 4,586,049
Warrant [Member]                        
Number of warrants granted 250,000 500,000 307,408 506,838 1,100,000 1,100,000 250,000          
Additional paid in capital $ 46,878 $ 93,740         $ 46,871          
Weighted average exercise price granted $ 0.25 $ 0.25 $ 0.25 $ 0.25 $ 0.25 $ 0.25 $ 0.25          
Fair value of warrant granted $ 107,848 $ 215,638 $ 196,399 $ 399,087 $ 148,438 $ 146,942 $ 107,831          
Common Shares [Member]                        
Stock issued               5,558,810        
Proceeds from share issued               $ 1,425,202        
October 15, 2021                        
Share price                 $ 0.80      
Common stock, issued                 125,000      
Prepaid marketing services                 $ 100,000      
October 28, 2021                        
Share price                 $ 0.70      
Legal services valued                 $ 20,000      
Common stock, issued                 28,572      
December 8, 2021                        
Share price                 $ 0.71      
Legal services valued                 $ 35,250      
Common stock, issued                 50,000      
January 1, 2022                        
Share price                 $ 0.65      
Legal services valued                 $ 65,000      
Common stock, issued                 100,000      
March 25, 2022                        
Share price                 $ 0.60      
Services valued                 $ 7,200      
Common stock, issued                 12,000      
December 31, 2021 A                        
Total value                 $ 58,394      
Common stock, issued                 583,936      
Conversion price                 $ 0.10      
December 31, 2021 B                        
Total value                 $ 35,321      
Common stock, issued                 353,215      
Conversion price                 $ 0.10      
July 12, 2022                        
Share price                 $ 0.22      
Common stock, issued                 350,000      
July 15, 2022                        
Share price                 $ 0.22      
Common stock, issued                 175,000      
July 18, 2022                        
Share price                 $ 0.22      
Common stock, issued                 175,000      
July 26, 2022                        
Share price                 $ 0.50      
Common stock, issued                 275,000      
Marketing And Branding Services                 $ 137,500      
May 19, 2022                        
Share price                 $ 0.577      
Services valued                 $ 230,800      
Common stock, issued                 400,000      
XML 47 R38.htm IDEA: XBRL DOCUMENT v3.22.4
INCOME TAXES (Details Narrative) - USD ($)
Sep. 30, 2022
Jun. 30, 2022
INCOME TAXES    
Net Operating Loss Carry Forward $ 3,406,686 $ 2,909,935
XML 48 R39.htm IDEA: XBRL DOCUMENT v3.22.4
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Feb. 07, 2023
Feb. 06, 2023
Jan. 15, 2023
Jan. 11, 2023
Jan. 09, 2023
Jan. 06, 2023
Dec. 05, 2022
Oct. 13, 2022
Feb. 14, 2023
Jan. 30, 2023
Jan. 28, 2023
Jan. 25, 2023
Jan. 24, 2023
Jan. 23, 2023
Jan. 22, 2023
Jan. 21, 2023
Jan. 17, 2023
Jan. 16, 2023
Nov. 29, 2022
Sep. 30, 2021
Sep. 30, 2022
Jun. 30, 2022
Shares issued, value                                       $ 1,355,202    
Common stock, issued   1,000,000     45,000                               26,483,044 25,508,044
Common stock, total value   $ 200,000                                        
Common stock, fair value         $ 9,000                                  
Subsequent Event [Member]                                            
Common stock, issued         500,000   400,000                 1,115,000     100,000      
Common stock, sold 215,000 225,000 600,000 300,000   100,000     1,000,000 850,000 150,000 100,000 1,000,000 430,000 15,000   70,000 150,000        
Share price $ 0.10 $ 0.10 $ 0.10 $ 0.10   $ 0.10 $ 0.10   $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10 $ 0.10      
Common stock, total value $ 21,500 $ 22,500 $ 60,000 $ 30,000   $ 10,000 $ 40,000   $ 100,000 $ 85,000 $ 15,000 $ 10,000 $ 100,000 $ 43,000 $ 1,500 $ 111,500 $ 7,000 $ 15,000 $ 10,000      
Common stock, fair value         $ 100,000                                  
Securities Purchase Agreement With Non-Related Party [Member] | Subsequent Event [Member]                                            
Principal amount               $ 135,000                            
Original issue discount               $ 15,000                            
Shares issued               416,667                            
Shares issued, value               $ 50,000                            
Warrants exercisable issued               500,000                            
Warrant exercise price per share               $ 0.25                            
Debt instrument interest rate               10.00%                            
Maturity Date               Apr. 13, 2023                            
Debt instrument interest rate increase               18.00%                            
Notes payble               $ 150,000                            
Additional amount paid in cash transaction costs               23,750                            
Securities Purchase Agreement With Non-Related Party One [Member] | Subsequent Event [Member]                                            
Principal amount               135,000                            
Original issue discount               $ 7,500                            
Shares issued               208,300                            
Shares issued, value               $ 25,000                            
Warrants exercisable issued               250,000                            
Warrant exercise price per share               $ 0.25                            
Debt instrument interest rate               10.00%                            
Maturity Date               Apr. 13, 2023                            
Debt instrument interest rate increase               18.00%                            
Notes payble               $ 75,000                            
Additional amount paid in cash transaction costs               5,625                            
Securities Purchase Agreement With Non-Related Party Two [Member] | Subsequent Event [Member]                                            
Principal amount               135,000                            
Original issue discount               $ 7,500                            
Shares issued               208,300                            
Shares issued, value               $ 25,000                            
Warrants exercisable issued               250,000                            
Warrant exercise price per share               $ 0.25                            
Debt instrument interest rate               10.00%                            
Maturity Date               Apr. 13, 2023                            
Debt instrument interest rate increase               18.00%                            
Notes payble               $ 75,000                            
Additional amount paid in cash transaction costs               $ 5,625                            
XML 49 tgcb_10qa_htm.xml IDEA: XBRL DOCUMENT 0001815632 2022-07-01 2022-09-30 0001815632 tgcb:SecuritiesPurchaseAgreementWithNonRelatedPartyTwoMember us-gaap:SubsequentEventMember 2022-10-01 2022-10-13 0001815632 tgcb:SecuritiesPurchaseAgreementWithNonRelatedPartyTwoMember us-gaap:SubsequentEventMember 2022-10-13 0001815632 tgcb:SecuritiesPurchaseAgreementWithNonRelatedPartyMember us-gaap:SubsequentEventMember 2022-10-01 2022-10-13 0001815632 tgcb:SecuritiesPurchaseAgreementWithNonRelatedPartyMember us-gaap:SubsequentEventMember 2022-10-13 0001815632 us-gaap:SubsequentEventMember 2022-12-01 2022-12-05 0001815632 us-gaap:SubsequentEventMember 2022-11-01 2022-11-29 0001815632 2023-01-01 2023-01-09 0001815632 us-gaap:SubsequentEventMember 2023-01-01 2023-01-09 0001815632 us-gaap:SubsequentEventMember 2023-02-01 2023-02-14 0001815632 us-gaap:SubsequentEventMember 2023-02-01 2023-02-07 0001815632 2023-02-01 2023-02-06 0001815632 us-gaap:SubsequentEventMember 2023-02-01 2023-02-06 0001815632 us-gaap:SubsequentEventMember 2023-01-01 2023-01-30 0001815632 us-gaap:SubsequentEventMember 2023-01-01 2023-01-28 0001815632 us-gaap:SubsequentEventMember 2023-01-01 2023-01-25 0001815632 us-gaap:SubsequentEventMember 2023-01-01 2023-01-24 0001815632 us-gaap:SubsequentEventMember 2023-01-01 2023-01-23 0001815632 us-gaap:SubsequentEventMember 2023-01-01 2023-01-22 0001815632 us-gaap:SubsequentEventMember 2023-01-01 2023-01-21 0001815632 us-gaap:SubsequentEventMember 2023-01-01 2023-01-17 0001815632 us-gaap:SubsequentEventMember 2023-01-01 2023-01-16 0001815632 us-gaap:SubsequentEventMember 2023-01-01 2023-01-15 0001815632 us-gaap:SubsequentEventMember 2023-01-01 2023-01-11 0001815632 us-gaap:SubsequentEventMember 2023-01-01 2023-01-06 0001815632 us-gaap:SubsequentEventMember 2022-11-29 0001815632 2023-01-09 0001815632 us-gaap:SubsequentEventMember 2023-01-09 0001815632 us-gaap:SubsequentEventMember 2023-02-14 0001815632 us-gaap:SubsequentEventMember 2023-02-07 0001815632 2023-02-06 0001815632 us-gaap:SubsequentEventMember 2023-02-06 0001815632 us-gaap:SubsequentEventMember 2023-01-30 0001815632 us-gaap:SubsequentEventMember 2023-01-28 0001815632 us-gaap:SubsequentEventMember 2023-01-25 0001815632 us-gaap:SubsequentEventMember 2023-01-24 0001815632 us-gaap:SubsequentEventMember 2023-01-23 0001815632 us-gaap:SubsequentEventMember 2023-01-22 0001815632 us-gaap:SubsequentEventMember 2023-01-21 0001815632 us-gaap:SubsequentEventMember 2023-01-17 0001815632 us-gaap:SubsequentEventMember 2023-01-16 0001815632 us-gaap:SubsequentEventMember 2023-01-15 0001815632 us-gaap:SubsequentEventMember 2023-01-11 0001815632 us-gaap:SubsequentEventMember 2023-01-06 0001815632 us-gaap:SubsequentEventMember 2022-12-05 0001815632 tgcb:SecuritiesPurchaseAgreementWithNonRelatedPartyOneMember us-gaap:SubsequentEventMember 2022-10-01 2022-10-13 0001815632 tgcb:SecuritiesPurchaseAgreementWithNonRelatedPartyOneMember us-gaap:SubsequentEventMember 2022-10-13 0001815632 tgcb:WarrantsMember 2021-04-27 2021-04-28 0001815632 tgcb:WarrantsMember 2021-04-21 2021-04-22 0001815632 tgcb:WarrantsMember 2021-03-24 2021-03-25 0001815632 tgcb:WarrantsMember 2022-07-18 0001815632 tgcb:WarrantsMember 2022-07-15 0001815632 tgcb:WarrantsMember 2022-07-12 0001815632 tgcb:WarrantsMember 2022-07-01 2022-07-18 0001815632 tgcb:WarrantsMember 2022-07-01 2022-07-15 0001815632 tgcb:WarrantsMember 2022-07-01 2022-07-12 0001815632 tgcb:WarrantsMember 2020-12-27 2020-12-28 0001815632 tgcb:CommonSharesMember 2021-10-01 2021-10-28 0001815632 tgcb:CommonSharesMember 2021-10-28 0001815632 tgcb:OctoberFifteenTwoZeroTwentyOneMember 2022-07-01 2022-09-30 0001815632 tgcb:DecemberThirtyOneTwoZeroTwentyOneBMember 2022-09-30 0001815632 tgcb:DecemberThirtyOneTwoZeroTwentyOneAMember 2022-09-30 0001815632 tgcb:JulyTwentySixTwoThousandTwentyTwoMember 2022-07-01 2022-09-30 0001815632 tgcb:MayNineteenTwoZeroTwentyTwoMember 2022-07-01 2022-09-30 0001815632 tgcb:MarchTwentyFiveTwoZeroTwentyTwoMember 2022-07-01 2022-09-30 0001815632 tgcb:DecemberThirtyOneTwoZeroTwentyOneBMember 2022-07-01 2022-09-30 0001815632 tgcb:DecemberThirtyOneTwoZeroTwentyOneAMember 2022-07-01 2022-09-30 0001815632 tgcb:JanuaryOneTwoZeroTwentyTwoMember 2022-07-01 2022-09-30 0001815632 tgcb:DecemberEightTwoZeroTwentyOneMember 2022-07-01 2022-09-30 0001815632 tgcb:OctoberTwetyEightTwoZeroTwentyOneMember 2022-07-01 2022-09-30 0001815632 tgcb:MayNineteenTwoZeroTwentyTwoMember 2022-09-30 0001815632 tgcb:JulyTwentySixTwoThousandTwentyTwoMember 2022-09-30 0001815632 tgcb:JulyEighteenTwoThousandTwentyTwoMember 2022-09-30 0001815632 tgcb:JulyFifteenTwoThousandTwentyTwoMember 2022-09-30 0001815632 tgcb:JulyTwelveTwoThousandTwentyTwoMember 2022-09-30 0001815632 tgcb:MarchTwentyFiveTwoZeroTwentyTwoMember 2022-09-30 0001815632 tgcb:JanuaryOneTwoZeroTwentyTwoMember 2022-09-30 0001815632 tgcb:DecemberEightTwoZeroTwentyOneMember 2022-09-30 0001815632 tgcb:OctoberTwetyEightTwoZeroTwentyOneMember 2022-09-30 0001815632 tgcb:OctoberFifteenTwoZeroTwentyOneMember 2022-09-30 0001815632 tgcb:MarchEightTwoZeroTwentyTwoMember 2022-07-01 2022-09-30 0001815632 tgcb:MarchEightTwoZeroTwentyTwoMember 2022-09-30 0001815632 tgcb:JanuaryFourTwoZeroTwentyTwoMember 2022-07-01 2022-09-30 0001815632 tgcb:JanuaryFourTwoZeroTwentyTwoMember 2022-09-30 0001815632 tgcb:JanuaryThreeTwoZeroTwentyTwoMember 2022-07-01 2022-09-30 0001815632 tgcb:JanuaryThreeTwoZeroTwentyTwoMember 2022-09-30 0001815632 srt:MaximumMember 2022-07-01 2022-09-30 0001815632 srt:MinimumMember 2022-07-01 2022-09-30 0001815632 srt:MaximumMember 2022-09-30 0001815632 srt:MinimumMember 2022-09-30 0001815632 tgcb:NotesPayableTwoMember 2021-09-30 0001815632 tgcb:NotesPayableOneMember 2021-09-30 0001815632 tgcb:NotesPayableTwoMember 2022-09-30 0001815632 tgcb:NotesPayableTwoMember 2022-07-18 0001815632 tgcb:NotesPayableOneMember 2022-09-30 0001815632 tgcb:NotesPayableOneMember 2022-07-15 0001815632 tgcb:NotesPayableTwoMember 2022-07-01 2022-07-18 0001815632 tgcb:NotesPayableOneMember 2022-07-01 2022-07-15 0001815632 tgcb:NotesPayableMember 2021-09-30 0001815632 tgcb:NotesPayableMember 2022-09-30 0001815632 tgcb:NotesPayableMember 2022-07-12 0001815632 tgcb:NotesPayableMember 2022-07-01 2022-07-12 0001815632 tgcb:EarlJohnsonMember 2022-07-01 2022-09-30 0001815632 tgcb:EarlJohnsonMember 2021-07-01 2021-09-30 0001815632 tgcb:TroyWilkinsonMember 2022-07-01 2022-09-30 0001815632 tgcb:ChrisWhiteMember 2021-07-01 2021-09-30 0001815632 tgcb:ChrisWhiteMember 2022-07-01 2022-09-30 0001815632 tgcb:ShannonWilkinsonMember 2021-07-01 2021-09-30 0001815632 tgcb:ShannonWilkinsonMember 2022-07-01 2022-09-30 0001815632 tgcb:TroyWilkinsonMember 2021-07-01 2021-09-30 0001815632 tgcb:SoftwareMember 2022-07-01 2022-09-30 0001815632 2021-07-01 2022-06-30 0001815632 us-gaap:RetainedEarningsMember 2022-09-30 0001815632 tgcb:SubscriptionReceivableMember 2022-09-30 0001815632 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001815632 us-gaap:CommonStockMember 2022-09-30 0001815632 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001815632 tgcb:SubscriptionReceivableMember 2022-07-01 2022-09-30 0001815632 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001815632 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001815632 us-gaap:RetainedEarningsMember 2022-06-30 0001815632 tgcb:SubscriptionReceivableMember 2022-06-30 0001815632 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001815632 us-gaap:CommonStockMember 2022-06-30 0001815632 2021-09-30 0001815632 us-gaap:RetainedEarningsMember 2021-09-30 0001815632 tgcb:SubscriptionReceivableMember 2021-09-30 0001815632 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001815632 us-gaap:CommonStockMember 2021-09-30 0001815632 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001815632 tgcb:SubscriptionReceivableMember 2021-07-01 2021-09-30 0001815632 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001815632 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001815632 2021-06-30 0001815632 us-gaap:RetainedEarningsMember 2021-06-30 0001815632 tgcb:SubscriptionReceivableMember 2021-06-30 0001815632 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001815632 us-gaap:CommonStockMember 2021-06-30 0001815632 2021-07-01 2021-09-30 0001815632 2022-06-30 0001815632 2022-09-30 0001815632 2023-02-24 iso4217:USD shares iso4217:USD shares pure 0001815632 true --06-30 Q1 2023 0.001 50000000 25508044 26483044 0 0 411122 0 0 0 0 0 0 10-Q/A true 2022-09-30 false 000-56370 TEGO CYBER INC. NV 84-2678167 8565 South Eastern Avenue Suite 150 Las Vegas NV 89123 855 939-0100 No Yes Non-accelerated Filer true true false false 34681377 Tego Cyber Inc. is filing this Amendment No. 1 on Form 10-Q/A for the period ended September 30, 2022, as filed with the Securities and Exchange Commission (the “SEC”) on November 21, 2022 (the “Original Filing”). This Amendment No. 1 on Form 10-Q/A is to amend the accounting treatment of the issuance of three promissory notes issued by the Company during the fiscal quarter ended September 30, 2022. In the original Form 10-Q filing, the promissory notes were reported as convertible which is incorrect.  For convenience and ease of reference, the Company is filing this Form 10-Q/A in its entirety with all applicable changes and unless otherwise stated, all information contained in this amendment is as of November 21, 2022, the filing date of the Original Filing. Except as stated herein, this Form 10-Q/A does not reflect events or transactions occurring after such filing date or modify or update those disclosures in the original Form 10-Q that may have been affected by events or transactions occurring subsequent to such filing date. 37459 47742 0 1150 111978 66119 149437 115011 1398 3207 507185 411122 658020 529340 67677 66066 342702 0 410379 66066 50000000 0.001 26483044 25508044 26483 25508 5687572 4586049 -5466414 -4148283 247641 463274 658020 529340 880512 260341 64962 117274 180324 65382 1125798 442997 -1125798 -442997 192332 29215 -192332 -29215 -1318130 -472212 -0.05 -0.02 26305571 19335634 18296511 18297 1720631 -10500 -1000382 728046 5458810 5459 1359243 -9500 0 1355202 0 0 0 -472212 -472212 23755321 23756 3079874 -20000 -1472594 1611036 25508044 25508 4586049 0 -4148284 463274 700000 700 151442 0 0 152142 275000 275 137225 0 0 137500 0 625367 0 0 625367 0 0 0 0 0 0 187489 0 0 187489 0 0 0 -1318130 -1318130 26483044 26483 5687572 0 -5466414 247641 1318130 472212 137500 0 0 1816 1809 0 0 29215 192332 0 625367 0 -1150 -300 45859 -9273 1611 14928 -404220 -416680 96063 36950 -96063 -36950 0 1355202 540000 0 50000 0 490000 1355202 -10283 901572 47742 583015 37459 1484587 12666 0 0 0 152142 0 137500 0 187489 0 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Tego Cyber Inc. (the “Company”) was incorporated in the State of Nevada on September 6, 2019. It was created to capitalize on the emerging cyber threat intelligence market and has developed a state-of-the-art cyber threat intelligence application that enriches threat data to help enterprises identify cyber threats within their environments. Tego Guardian is a proactive intelligent cyberthreat hunting tool that gives enterprises the ability to quickly track threats throughout their networks, mapping out exposures and expediting remediation. Tego Guardian integrates with the widely used Splunk Security Information and Event Management (SIEM) platform. Tego Guardian is a Splunk approved app and available for download through Splunk’s marketplace. The Company plans on developing future versions of Tego Guardian for integration with other established SIEM systems and platforms including: Elastic, IBM QRadar, AT&amp;T AlienVault, Exabeam, and Google Chronical.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s head office is at 8565 S. Eastern Ave. #150, Las Vegas, Nevada, 89123.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><span style="text-decoration:underline">Basis of Preparation</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company prepares its financial statements in accordance with rules and regulations of the Securities and Exchange Commission (“SEC”) and GAAP in the United States of America. The accompanying interim financial statements have been prepared in accordance with GAAP for interim financial information in accordance with Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the Company’s opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2022, are not necessarily indicative of the results for the full year. While management of the Company believes that the disclosures presented herein are adequate and not misleading, these interim financial statements should be read in conjunction with the audited financial statements and the footnotes thereto for the year ended June 30, 2022. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Going Concern</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of the business. The Company has incurred material losses from operations and has an accumulated deficit. At September 30, 2022, the Company had a negative working capital of $260,942. For the three months ended September 30, 2022, the Company sustained net losses and generated negative cash flows from operations. In March 2020, the World Health Organization recognized the outbreak of COVID-19 as a global pandemic. The COVID-19 pandemic and government actions implemented to contain the further spread of COVID-19 have severely restricted economic activity around the world. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that may be necessary should the Company be unable to continue as a going concern. These adjustments could be material. The Company’s continuation as a going concern is contingent upon its ability to earn adequate revenues from operations and to obtain additional financing. There is no assurance that the Company will be able to obtain such financings or obtain them on favorable terms.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Use of Estimates</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In preparing financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements, as well as the reported amounts of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. However, actual results could differ materially from those estimates.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Concentrations of Credit Risk</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and accounts receivable. As at September 30, 2022, substantially all of the Company’s cash was held by major financial institutions located in the United States, which management believes are of high credit quality. With respect to accounts receivable, the Company extended credit based on an evaluation of the customer’s financial condition. The Company generally did not require collateral for accounts receivable and maintained an allowance for doubtful accounts of accounts receivable if necessary.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Cash</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cash consists of cash held at major financial institutions and is subject to insignificant risk of changes in value.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Receivables and Allowance for Doubtful Accounts</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Trade accounts receivable are recorded at net realizable value and do not bear interest. No allowance for doubtful accounts was made during the three-month period ended September 30, 2022 and the year ended June 30, 2022, based on management’s best estimate of the amount of probable credit losses in accounts receivable. The Company evaluates its allowance for doubtful accounts based upon knowledge of its customers and their compliance with credit terms. The evaluation process includes a review of customers’ accounts on a regular basis. The review process evaluates all account balances with amounts outstanding for more than 60 days and other specific amounts for which information obtained indicates that the balance may be uncollectible. As of September 30, 2022 and June 30, 2022, there was no allowance for doubtful accounts and the Company does not have any off-balance-sheet credit exposure related to its customers.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Software</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Software is stated at cost less accumulated amortization and is amortized using the straight-line method over the estimated useful life of the asset. The estimated useful life of the asset is 5 years and is not amortized until it is available for use by the Company.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Leases</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company determines if an arrangement is a lease at inception. Operating and financing right-of-use assets and lease liabilities are included on the balance sheet. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company uses its incremental borrowing rate, based on the information available at the commencement date, in determining the present value of future lease payments. Right-of-use assets include any prepaid lease payments and exclude any lease incentives and initial direct costs incurred. Operating lease expenses are recognized on a straight-line basis over the term of the lease, consisting of interest accrued on the lease liability and amortization of the right-of-use asset. The lease terms may include options to extend or terminate the lease is it is reasonably certain the Company will exercise that option. The Company leases its corporate office located at 8565 S. Eastern Ave. #150, Las Vegas, Nevada. The initial lease term is for 12 months commencing on September 8, 2019 after which the term is on a month-to-month basis. After the initial term, the Company may cancel the lease agreement at any time by providing 30 days written notice. The Company has elected the short-term lease practical expedient of 12 months and has not recorded a lease.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Fair Value of Financial Instruments</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounting Standards Codification (“ASC”) 820 “Fair Value Measurements and Disclosures”, adopted January 1, 2008, defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The Company’s financial instruments include cash, current receivables and payables. These financial instruments are measured at their respective fair values. The three levels are defined as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 1 - inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For cash, accounts receivable, accounts payable and accrued liabilities and due to related parties, it is management’s opinion that the carrying values are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and if applicable, their stated interest rate approximates current rates available.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For convertible debts, the carrying values, excluding any unamortized discounts, approximate the respective fair value. The convertible debts have been discounted to reflect their net present value as at September 30, 2022. The carrying values of embedded conversion features not considered to be derivative instruments were determined by allocating the remaining carrying value of the convertible debt after deducting the estimated carrying value of the liability portion.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Estimating fair value for warrants require determining the most appropriate valuation model which is dependent on the terms and conditions of the grant. This estimate requires determining the most appropriate inputs to the valuation model including the expected life of the warrant, volatility, dividend yield, and rate of forfeitures and making assumptions about them.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Revenue Recognition</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Revenue is recognized under ASC 606, “<em>Revenue from Contracts with Customers</em>” using the modified retrospective method. Under this method, the Company follows the five-step model provided by ASC Topic 606 in order to recognize revenue in the following manner: 1) identify the contract; 2) identify the performance obligations of the contract; 3) determine the transaction price of the contract; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue. The Company recognizes revenue for the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company currently has not generated any revenue from its threat intelligence software. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Income Taxes</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company uses the asset and liability method of accounting for income taxes pursuant to ASC 740 “Income Taxes”. ASC 740 requires an asset and liability approach for financial accounting and reporting for income taxes and allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Valuation allowances are provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The provision for income taxes represents current taxes payable net of the change during the period in deferred tax assets and liabilities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Earnings (Loss) per Share</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Basic earnings (loss) per share is computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. If applicable, diluted earnings (loss) per share assume the conversion, exercise or issuance of all common stock instruments unless the effect is to reduce a loss or increase earnings (loss) per share. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Recently Issued Accounting Pronouncements</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In December 2019, the FASB issued ASU 2019-12, <em>Simplifying the Accounting for Income Taxes</em> which amends ASC 740 <em>Income Taxes</em> (ASC 740). This update is intended to simplify accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and amending existing guidance to improve consistent application of ASC 740. This update is effective for fiscal years beginning after December 15, 2021. The guidance in this update has various elements, some of which are applied on a prospective basis and others on a retrospective basis with earlier application permitted. The Company’s management is currently evaluating the effect of this ASU on the Company’s financial statements and related disclosures.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In June 2020, the FASB issued ASU 2020-05 in response to the ongoing impacts to U.S. businesses in response to the COVID-19 pandemic. ASU 2020-05, Revenue from Contracts with Customers (Topic 606) and Leases (Topic 842) Effective Dates for Certain Entities provide a limited deferral of the effective dates for implementing previously issued ASU 606 and ASU 842 to give some relief to businesses considering the difficulties they are facing during the pandemic. These entities may defer application to fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. As the Company has already adopted ASU 606 and ASU 842, the Company does not anticipate any effect on its financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In August 2020, the FASB issued ASU 2020-06<strong>, </strong><em>Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity.</em> ASU 2020-06 reduces the number of accounting models for convertible debt instruments and convertible preferred stock. For convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, <em>Derivatives and Hedging</em>, or that do not result in substantial premiums accounted for as paid-in capital, the embedded conversion features no longer are separated from the host contract. ASU 2020-06 also removes certain conditions that should be considered in the derivatives scope exception evaluation under Subtopic 815-40, <em>Derivatives and Hedging—Contracts in Entity’s Own Equity</em>, and clarify the scope and certain requirements under Subtopic 815-40. In addition, ASU 2020-06 improves the guidance related to the disclosures and earnings-per-share (EPS) for convertible instruments and contract in entity’s own equity. ASU 2020-06 is effective for public business entities that meet the definition of a SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Board specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Company’s management is currently evaluating the impact this ASU will have on its financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying consolidated financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company prepares its financial statements in accordance with rules and regulations of the Securities and Exchange Commission (“SEC”) and GAAP in the United States of America. The accompanying interim financial statements have been prepared in accordance with GAAP for interim financial information in accordance with Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the Company’s opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2022, are not necessarily indicative of the results for the full year. While management of the Company believes that the disclosures presented herein are adequate and not misleading, these interim financial statements should be read in conjunction with the audited financial statements and the footnotes thereto for the year ended June 30, 2022. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of the business. The Company has incurred material losses from operations and has an accumulated deficit. At September 30, 2022, the Company had a negative working capital of $260,942. For the three months ended September 30, 2022, the Company sustained net losses and generated negative cash flows from operations. In March 2020, the World Health Organization recognized the outbreak of COVID-19 as a global pandemic. The COVID-19 pandemic and government actions implemented to contain the further spread of COVID-19 have severely restricted economic activity around the world. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that may be necessary should the Company be unable to continue as a going concern. These adjustments could be material. The Company’s continuation as a going concern is contingent upon its ability to earn adequate revenues from operations and to obtain additional financing. There is no assurance that the Company will be able to obtain such financings or obtain them on favorable terms.</p> 260942 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In preparing financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements, as well as the reported amounts of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. However, actual results could differ materially from those estimates.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and accounts receivable. As at September 30, 2022, substantially all of the Company’s cash was held by major financial institutions located in the United States, which management believes are of high credit quality. With respect to accounts receivable, the Company extended credit based on an evaluation of the customer’s financial condition. The Company generally did not require collateral for accounts receivable and maintained an allowance for doubtful accounts of accounts receivable if necessary.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Cash consists of cash held at major financial institutions and is subject to insignificant risk of changes in value.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Trade accounts receivable are recorded at net realizable value and do not bear interest. No allowance for doubtful accounts was made during the three-month period ended September 30, 2022 and the year ended June 30, 2022, based on management’s best estimate of the amount of probable credit losses in accounts receivable. The Company evaluates its allowance for doubtful accounts based upon knowledge of its customers and their compliance with credit terms. The evaluation process includes a review of customers’ accounts on a regular basis. The review process evaluates all account balances with amounts outstanding for more than 60 days and other specific amounts for which information obtained indicates that the balance may be uncollectible. As of September 30, 2022 and June 30, 2022, there was no allowance for doubtful accounts and the Company does not have any off-balance-sheet credit exposure related to its customers.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Software is stated at cost less accumulated amortization and is amortized using the straight-line method over the estimated useful life of the asset. The estimated useful life of the asset is 5 years and is not amortized until it is available for use by the Company.</p> P5Y <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company determines if an arrangement is a lease at inception. Operating and financing right-of-use assets and lease liabilities are included on the balance sheet. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company uses its incremental borrowing rate, based on the information available at the commencement date, in determining the present value of future lease payments. Right-of-use assets include any prepaid lease payments and exclude any lease incentives and initial direct costs incurred. Operating lease expenses are recognized on a straight-line basis over the term of the lease, consisting of interest accrued on the lease liability and amortization of the right-of-use asset. The lease terms may include options to extend or terminate the lease is it is reasonably certain the Company will exercise that option. The Company leases its corporate office located at 8565 S. Eastern Ave. #150, Las Vegas, Nevada. The initial lease term is for 12 months commencing on September 8, 2019 after which the term is on a month-to-month basis. After the initial term, the Company may cancel the lease agreement at any time by providing 30 days written notice. The Company has elected the short-term lease practical expedient of 12 months and has not recorded a lease.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounting Standards Codification (“ASC”) 820 “Fair Value Measurements and Disclosures”, adopted January 1, 2008, defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The Company’s financial instruments include cash, current receivables and payables. These financial instruments are measured at their respective fair values. The three levels are defined as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 1 - inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For cash, accounts receivable, accounts payable and accrued liabilities and due to related parties, it is management’s opinion that the carrying values are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and if applicable, their stated interest rate approximates current rates available.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For convertible debts, the carrying values, excluding any unamortized discounts, approximate the respective fair value. The convertible debts have been discounted to reflect their net present value as at September 30, 2022. The carrying values of embedded conversion features not considered to be derivative instruments were determined by allocating the remaining carrying value of the convertible debt after deducting the estimated carrying value of the liability portion.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Estimating fair value for warrants require determining the most appropriate valuation model which is dependent on the terms and conditions of the grant. This estimate requires determining the most appropriate inputs to the valuation model including the expected life of the warrant, volatility, dividend yield, and rate of forfeitures and making assumptions about them.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Revenue is recognized under ASC 606, “<em>Revenue from Contracts with Customers</em>” using the modified retrospective method. Under this method, the Company follows the five-step model provided by ASC Topic 606 in order to recognize revenue in the following manner: 1) identify the contract; 2) identify the performance obligations of the contract; 3) determine the transaction price of the contract; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue. The Company recognizes revenue for the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company currently has not generated any revenue from its threat intelligence software. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company uses the asset and liability method of accounting for income taxes pursuant to ASC 740 “Income Taxes”. ASC 740 requires an asset and liability approach for financial accounting and reporting for income taxes and allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Valuation allowances are provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The provision for income taxes represents current taxes payable net of the change during the period in deferred tax assets and liabilities.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Basic earnings (loss) per share is computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. If applicable, diluted earnings (loss) per share assume the conversion, exercise or issuance of all common stock instruments unless the effect is to reduce a loss or increase earnings (loss) per share. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In December 2019, the FASB issued ASU 2019-12, <em>Simplifying the Accounting for Income Taxes</em> which amends ASC 740 <em>Income Taxes</em> (ASC 740). This update is intended to simplify accounting for income taxes by removing certain exceptions to the general principles in ASC 740 and amending existing guidance to improve consistent application of ASC 740. This update is effective for fiscal years beginning after December 15, 2021. The guidance in this update has various elements, some of which are applied on a prospective basis and others on a retrospective basis with earlier application permitted. The Company’s management is currently evaluating the effect of this ASU on the Company’s financial statements and related disclosures.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In June 2020, the FASB issued ASU 2020-05 in response to the ongoing impacts to U.S. businesses in response to the COVID-19 pandemic. ASU 2020-05, Revenue from Contracts with Customers (Topic 606) and Leases (Topic 842) Effective Dates for Certain Entities provide a limited deferral of the effective dates for implementing previously issued ASU 606 and ASU 842 to give some relief to businesses considering the difficulties they are facing during the pandemic. These entities may defer application to fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. As the Company has already adopted ASU 606 and ASU 842, the Company does not anticipate any effect on its financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In August 2020, the FASB issued ASU 2020-06<strong>, </strong><em>Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity.</em> ASU 2020-06 reduces the number of accounting models for convertible debt instruments and convertible preferred stock. For convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815, <em>Derivatives and Hedging</em>, or that do not result in substantial premiums accounted for as paid-in capital, the embedded conversion features no longer are separated from the host contract. ASU 2020-06 also removes certain conditions that should be considered in the derivatives scope exception evaluation under Subtopic 815-40, <em>Derivatives and Hedging—Contracts in Entity’s Own Equity</em>, and clarify the scope and certain requirements under Subtopic 815-40. In addition, ASU 2020-06 improves the guidance related to the disclosures and earnings-per-share (EPS) for convertible instruments and contract in entity’s own equity. ASU 2020-06 is effective for public business entities that meet the definition of a SEC filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Board specified that an entity should adopt the guidance as of the beginning of its annual fiscal year. The Company’s management is currently evaluating the impact this ASU will have on its financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Management does not believe that any recently issued, but not yet effective, accounting standards could have a material effect on the accompanying consolidated financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 5 – PREPAID EXPENSES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Prepaid expense balance as of September 30, 2022 and June 30, 2022 consisted of the following: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30, 2022</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30, 2022</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Advertising &amp; promotion </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10,109</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Consultants &amp; contractors</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10,055</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,301</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Platform costs</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">21,814</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">30,318</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Software development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">70,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">25,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>111,978</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>66,119</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30, 2022</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30, 2022</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Advertising &amp; promotion </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10,109</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Consultants &amp; contractors</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10,055</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,301</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Platform costs</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">21,814</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">30,318</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Software development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">70,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">25,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>111,978</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>66,119</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 10109 5500 10055 5301 21814 30318 70000 25000 111978 66119 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 6 – SOFTWARE</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has developed an automated threat intelligence defense platform, marketed as Tego Guardian. Tego Guardian is a threat correlation and threat hunting application that integrates directly into existing Security Information and Event Management (SIEM) platforms to provide threat tracking, mapping of exposures, and assist with expediting remediation. With performance capable of querying over 1 million records in just 4 seconds, Tego Guardian saves security operations teams time and money in an environment where timing is everything as efforts are made to lower mean-time-to-detection (MTTD) and mean-time-to-response (MTTR). What makes Tego Guardian different from other cyber threat correlation applications, is that it is the first commercially available solution that was specifically developed for the customer’s existing SIEM platform. It operates within the platform environment, so security operations teams do not have to use multiple tools and views to complete a specific task or research a threat. Tego Guardian cross-correlates threats in real time and not only looks forward but also backwards in order to see if the organization’s network has been previously exposed (active foresight and hindsight). The first version of Tego Guardian integrates with the industry leading Splunk® SIEM platform. Tego Guardian is now available for download through Splunk’s app store and is compatible with Splunk Cloud and Splunk Enterprise versions: 9.0, 8.2, 8.1, and 8.0. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance, June 30, 2021</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>75,750</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Additions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">335,372</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Amortization</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance, June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>411,122</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Additions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">96,063</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Amortization</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance, September 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>507,185</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As at September 30, 2022, the software was not generating revenue and no amortization has been recorded for the periods then ended. It is expected the software will begin to generate revenue in the quarter ending December 31, 2022. </p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance, June 30, 2021</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>75,750</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Additions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">335,372</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Amortization</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance, June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>411,122</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Additions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">96,063</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Amortization</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance, September 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>507,185</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 75750 335372 0 411122 96063 0 507185 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 7 – ACCOUNTS PAYABLE &amp; ACCRUED LIABILITIES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts payable &amp; accrued liabilities balance as of September 30, 2022 and June 30, 2022 consisted of the following: </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30, 2022</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30, 2022</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exchange &amp; listing fees</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">710</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Legal &amp; accounting </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">13,213</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">23,247</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Platform costs</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,856</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Software development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">50,898</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">42,819</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>67,677</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>66,066</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30, 2022</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30, 2022</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exchange &amp; listing fees</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">710</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Legal &amp; accounting </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">13,213</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">23,247</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Platform costs</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,856</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Software development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">50,898</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">42,819</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>67,677</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>66,066</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 710 0 13213 23247 2856 0 50898 42819 67677 66066 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 8 – RELATED PARTY TRANSACTIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Related party transactions are measured at the exchange amount, which is the amount of consideration established and agreed to by the related parties. Related parties are natural persons or other entities that have the ability, directly, or indirectly, to control another party or exercise significant influence over the party in making financial and operating decisions. Related parties include other parties that are subject to common control or that are subject to common significant influences.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three-month period ended September 30, 2022, there were transactions incurred between the Company and Shannon Wilkinson, Director, CEO, President, Secretary and Treasurer of the Company for management fees of $Nil (September 30, 2021 - $45,000) and gross wages of $30,000 (September 30, 2021 - $8,692). </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three-month period ended September 30, 2022, there were transactions incurred between the Company and Earl Johnson, Chief Financial Officer of the Company for gross wages of $9,000 (September 30, 2021 - $Nil).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three-month period ended September 30, 2022, there were transactions incurred between the Company and Chris White, Director and Chief Information Security Officer of the Company for management fees of $Nil (September 30, 2021 - $12,500) and gross wages of $12,500 (September 30, 2021 - $6,519). </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three-month period ended September 30, 2022, there were transactions incurred between the Company and Troy Wilkinson, Director of the Company for management fees of $10,000 (September 30, 2021 - $20,000). </p> 45000 30000 8692 9000 12500 12500 6519 10000 20000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 9 – NOTES PAYABLE (convertible only at default)</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:justify;font:10pt times new roman;margin-left:auto;margin-right:auto;width:100%"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(a)</p></td><td style="vertical-align:top;">On July 12, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $300,000 at $270,000 with a $30,000 original issue discount. In connection with this note, the Company paid an additional $27,500 in cash transaction costs, issued 350,000 common shares valued at $175,000 in transaction costs, and issued 500,000 warrants exercisable at $0.25 per share, expiring on July 12, 2027. The warrants were calculated to have a fair value of $215,638 as at September 30, 2022. This note payable is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly.</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;">The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;">The proceeds were allocated between the note payable, warrants and shares issued on a relative fair value basis. The fair value of the note payable was calculated using the present value of the debt and related interest at 12% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 10) and the shares issued were allocated proportionately for issuance cost for liability and equity portions under ASC 470-20 Debt with Conversion and Other Options. The shares are valued based on a relative fair market value of the shares on the issuance date.</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;">In connection with the notes, the Company issued warrants indexed to an aggregate 500,000 shares of common stock. The warrants have a term of five years and an exercise price of $0.25. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair value of $93,740.</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;">The Company also agreed to pay a commitment fee of $175,000 by issuing that number of shares of the Company’s common stock equal to such amount, aggregating to a total of 350,000 common shares of the Company. Under ASC 1.2.2 Debt Issuance Costs, the Company recognized the commitment fee as incremental costs specifically attributable to issuing the promissory note, while the commitment fee share were recorded in additional paid-in capital under their aggregate relative fair value of $76,074.</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;">As at September 30, 2022, the carrying value of this note payable was $171,518 (September 30, 2021 - $Nil) net of $128,482 unamortized discounts.</td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:justify;font:10pt times new roman;margin-left:auto;margin-right:auto;width:100%"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(b)</p></td><td style="vertical-align:top;">On July 15, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $150,000 at $135,000 with $15,000 original issue discount. In connection with this note, the Company paid an additional $11,250 in cash transaction costs, issued 175,000 common shares valued at $87,500 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on July 15, 2027. This promissory note is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly.</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;">The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;">The proceeds were allocated between the note payable, warrants and shares issued on a relative fair value basis. The fair value of the note payable was calculated using the present value of the debt and related interest at 12% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 10) and the shares issued were allocated proportionately for issuance cost for liability and equity portions under ASC 470-20 Debt with Conversion and Other Options. The shares are valued based on a fair market value of the shares on the issuance date.</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;">In connection with the notes, the Company issued warrants indexed to an aggregate 250,000 shares of common stock. The warrants have a term of five years and an exercise price of $0.25. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair value of $46,878.</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;">The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;">The Company also agreed to pay a commitment fee of $87,500 by issuing that number of shares of the Company’s common stock equal to such amount, aggregating to a total of 175,000 common shares of the Company. Under ASC 1.2.2 Debt Issuance Costs, the Company recognized the commitment fee as incremental costs specifically attributable to issuing the promissory note, while the commitment fee share were recorded in additional paid-in capital under their aggregate relative fair value of $38,033.</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;">As at September 30, 2022, the carrying value of this note payable was $86,129 (September 30, 2021 - $Nil) net of $63,871 unamortized discounts.</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(c)</p></td><td style="vertical-align:top;">On July 18, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable e in the principal amount of $150,000 at $135,000 with $15,000 original issue discount. In connection with this note, the Company paid an additional $11,250 in cash transaction costs, issued 175,000 common shares valued at $87,500 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on July 18, 2027. This note payable is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly.</td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:justify;font:10pt times new roman;margin-left:auto;margin-right:auto;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;">The Company evaluated the agreement under ASC 815 Derivatives and Hedging (“ASC 815”). ASC 815 generally requires the analysis embedded terms and features that have characteristics of derivatives to be evaluated for bifurcation and separate accounting in instances where their economic risks and characteristics are not clearly and closely related to the risks of the host contract. None of the embedded terms required bifurcation and liability classification.</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;">The proceeds were allocated between the note payable, warrants and shares issued on a relative fair value basis. The fair value of the note payable was calculated using the present value of the debt and related interest at 12% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 10) and the shares issued were allocated proportionately for issuance cost for liability and equity portions under ASC 470-20 Debt with Conversion and Other Options. The shares are valued based on a fair market value of the shares on the issuance date.</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;">In connection with the notes, the Company issued warrants indexed to an aggregate 250,000 shares of common stock. The warrants have a term of five years and an exercise price of $0.25. The Company evaluated the warrants under ASC 815 Derivatives and Hedging (“ASC 815”) and determined that they did not require liability classification. The warrants were recorded in additional paid-in capital under their aggregate relative fair value of $46,871.</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;">The Company also agreed to pay a commitment fee of $87,500 by issuing that number of shares of the Company’s common stock equal to such amount, aggregating to a total of 175,000 common shares of the Company. Under ASC 1.2.2 Debt Issuance Costs, the Company recognized the commitment fee as incremental costs specifically attributable to issuing the promissory note, while the commitment fee share were recorded in additional paid-in capital under their aggregate relative fair value of $38,034.</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;">As at September 30, 2022, the carrying value of this note payable was $85,055 (September 30, 2021 - $Nil) net of $64,945 unamortized discounts.</td></tr></tbody></table> 300000 270000 30000 27500 350000 175000 500000 0.25 215638 0.10 0.12 500000 0.25 93740 175000 350000 76074 171518 128482 150000 135000 15000 11250 175000 87500 250000 0.25 0.10 0.12 250000 0.25 46878 87500 175000 38033 86129 63871 150000 135000 15000 11250 175000 87500 250000 0.25 0.10 0.12 250000 0.25 46871 87500 175000 38034 85055 64945 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 10 – COMMON SHARES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Common Stock</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At September 30, 2022, the Company’s authorized capital consisted of 50,000,000 of common shares with a par value of $0.001 </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">During the three-month period ended September 30, 2022, the Company incurred the following transactions:</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On July 12, 2022, the Company issued 350,000 common shares at a relative fair value of $0.22 per share for transaction costs associated with the issuance of a note payable. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On July 15, 2022, the Company issued 175,000 common shares at a relative fair value of $0.22 per share for transaction costs associated with the issuance of a note payable.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On July 18, 2022, the Company issued 175,000 common shares at a relative fair value of $0.22 per share for transaction costs associated with the issuance of a note payable.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On July 26, 2022, the Company issued 275,000 common shares at a price of $0.50 per share for marketing and branding services valued at $137,500. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">During the year ended June 30, 2022, the Company incurred the following transactions:</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the period July 1, 2021 to October 28, 2021, the Company completed various private placements whereby a total of 5,558,810 common shares were issued for a total proceeds of $1,425,202. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 15, 2021, the Company issued 125,000 common shares at a price of $0.80 per share for marketing services valued at $100,000. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 28, 2021, the Company issued 28,572 common shares at a price of $0.70 per share for legal services valued at $20,000. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 8, 2021, the Company issued 50,000 common shares at a price of $0.71 per share for consulting services valued at $35,250. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 31, 2021, the Company issued 583,936 common shares for the conversion of debt at a conversion price of $0.10 per share for a total value of $58,394. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 31, 2021, the Company issued 353,215 common shares for the conversion of debt at a conversion price of $0.10 per share for a total value of $35,321. See Note 10 (b).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 1, 2022, the Company issued 100,000 common shares at a price of $0.65 per share for consulting services valued at $65,000. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 25, 2022, the Company issued 12,000 shares to a non-related party at a price of $0.60 per share for a total value of $7,200 in exchange for services.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On May 19, 2022, the Company issued 400,000 shares to a non-related party at a price of $0.577 per share for investor relations services valued at $230,800.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Warrants</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 28, 2020, the Company granted 1,100,000 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction. The warrants were valued at $146,942 using the Black Scholes Option Pricing Model.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 25, 2021, the Company granted 1,100,000 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction. The warrants were valued at $148,438 using the Black Scholes Option Pricing Model.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On April 22, 2021, the Company granted 506,838 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction. The warrants were valued at $399,087 using the Black Scholes Option Pricing Model.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On April 28, 2021, the Company granted 307,408 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction. The warrants were valued at $196,399 using the Black Scholes Option Pricing Model.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On July 12, 2022, the Company granted 500,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $215,638 using the Black Scholes Option Pricing Model and they were recorded at $93,740 in additional paid-in capital under using the relative fair value method.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On July 15, 2022, the Company granted 250,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a   note payable financing transaction (Note 9). The warrants were valued at $107,848 using the Black Scholes Option Pricing Model and they were recorded at $46,878 in additional paid-in capital under using the relative fair value method.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On July 18, 2022, the Company granted 250,000 warrants with a contractual life of five years and exercise price of $0.25 per share to a lender as part of a note payable financing transaction (Note 9). The warrants were valued at $107,831 using the Black Scholes Option Pricing Model and they were recorded at $46,871 in additional paid-in capital under the using relative fair value method.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Black Scholes Option Pricing Model assumptions used in the valuation of the warrants are outlined below. The stock price was based on recent issuances. Expected life was based on the expiry date of the warrants as the Company did not have historical exercise data of such warrants.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: #000000 1px solid;width:15%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30, 2022</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock price</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">$0.50 - $0.51</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk-free interest rate</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3.19%-3.22</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected life</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">5 Years</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected dividend rate</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected volatility</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">103.20% - 103.28</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Continuity of the Company’s common stock purchase warrants issued and outstanding is as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Warrants</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Outstanding, June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>3,014,246</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>0.25</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.25</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Outstanding, September 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>4,014,246</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>0.25</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As at September 30, 2022, the weighted average remaining contractual life of warrants outstanding was 4.80 years with an intrinsic value of $0.25.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Stock Options</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 8, 2021, the Board of Directors of the Company approved the adoption of the 2021 Equity Compensation Plan (the “Equity Compensation Plan”) to provide employees, certain consultants and advisors who perform services for the Company<strong>,</strong> and non-employee members of the Board of Directors of the Company with the opportunity to receive grants of incentive stock options, nonqualified stock options, stock appreciation rights, stock awards, stock units and other stock-based awards. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following is a continuity schedule for the Company’s outstanding non-qualified stock options:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>options</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Outstanding, June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>6,000,000</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>0.65</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cancelled</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Outstanding, September 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>6,000,000</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>0.65</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At September 30, 2022, the Company had the following stock options outstanding:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Grant</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Date</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Outstanding</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercisable</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average Life </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(Years)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Expiry Date</strong></p></td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">January 3, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">125,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">125,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.65</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9.27</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">January 3, 2032</p></td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">January 4, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,875,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,875,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.65</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9.27</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">January 4, 2032</p></td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>6,000,000</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>6,000,000</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>0.65</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>9.27</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"> </td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three-month period ended September 30, 2022, the Company recorded $382,577 as share-based compensation relating to the issuance of the non-qualified stock options.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The fair value of the options granted during the year ended September 30, 2022 was estimated on the date of the grant date using the Black-Scholes option pricing model with the following weighted average assumptions:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">91.03</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected option life (years)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">6 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Risk-free interest rate (10-year U.S. treasury yield)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.55 - 1.66</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Performance Stock Units</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 8, 2021, the Board of Directors of the Company approved the adoption of the 2021 Equity Compensation Plan (the “Equity Compensation Plan”) to provide employees, certain consultants and advisors who perform services for the Company<strong>,</strong> and non-employee members of the Board of Directors of the Company with the opportunity to receive grants of incentive stock options, nonqualified stock options, stock appreciation rights, stock awards, stock units and other stock-based awards. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following is a continuity schedule for the Company’s outstanding performance stock units:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Performance </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Units</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average Exercise </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Outstanding, June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>4,000,000</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Released</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Forfeited or cancelled</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Outstanding, September 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>4,000,000</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At September 30, 2022, the Company had the following performance units outstanding:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Grant</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Date</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Outstanding</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercisable</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Life (Years)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Expiry Date</strong></p></td><td> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">March 8, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">USD $0.00</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.25</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:15%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">December 31, 2026</p></td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Total</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;"><strong>4,000,000</strong></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;"><strong>4,000,000</strong></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>USD $0.00</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;"><strong>4.25</strong></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td> </td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three-month period ended September 30, 2022, the Company recorded $242,790 as share-based compensation relating to the issuance of the performance units.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The fair value of the performance units granted during the year ended September 30, 2022 was estimated on the date of the grant date using N(d2) output from a Black-Sholes model to calculate the value of the award multiplying N(d2) by the current stock price as of the valuation date with the following weighted average assumptions:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">85.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Requisite period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">4.25 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Risk-free interest rate (US Treasury Bond rate as of the grant date)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.80</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table> 50000000 0.001 350000 0.22 175000 0.22 175000 0.22 275000 0.50 137500 5558810 1425202 125000 0.80 100000 28572 0.70 20000 50000 0.71 35250 583936 0.10 58394 353215 0.10 35321 100000 0.65 65000 12000 0.60 7200 400000 0.577 230800 1100000 0.25 146942 1100000 0.25 148438 506838 0.25 399087 307408 0.25 196399 500000 0.25 215638 93740 250000 0.25 107848 46878 250000 0.25 107831 46871 <table cellpadding="0" style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: #000000 1px solid;width:15%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30, 2022</strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock price</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">$0.50 - $0.51</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk-free interest rate</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3.19%-3.22</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">% </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected life</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">5 Years</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected dividend rate</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected volatility</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">103.20% - 103.28</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 0.50 0.51 0.0319 0.0322 P5Y 0 1.0320 1.0328 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Warrants</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Outstanding, June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>3,014,246</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>0.25</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.25</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Outstanding, September 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>4,014,246</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>0.25</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 3014246 0.25 1000000 0.25 0 0 4014246 0.25 P4Y9M18D 0.25 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>options</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Outstanding, June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>6,000,000</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>0.65</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cancelled</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Outstanding, September 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>6,000,000</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>0.65</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 6000000 0.65 0 0 0 6000000 0.65 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Grant</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Date</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Outstanding</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercisable</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average Life </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(Years)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Expiry Date</strong></p></td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">January 3, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">125,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">125,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.65</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9.27</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">January 3, 2032</p></td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">January 4, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,875,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,875,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.65</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9.27</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">January 4, 2032</p></td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>6,000,000</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>6,000,000</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>0.65</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>9.27</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"> </td></tr></tbody></table> 125000 125000 0.65 P9Y3M7D January 3, 2032 5875000 5875000 0.65 P9Y3M7D January 4, 2032 6000000 6000000 0.65 P9Y3M7D 382577 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">91.03</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected option life (years)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">6 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Risk-free interest rate (10-year U.S. treasury yield)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.55 - 1.66</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table> 0.9103 P6Y 0.0155 0.0166 0 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Performance </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Units</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average Exercise </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Outstanding, June 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>4,000,000</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Released</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Forfeited or cancelled</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Outstanding, September 30, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>4,000,000</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 4000000 0 0 0 0 0 0 0 4000000 0 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Grant</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Date</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Outstanding</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercisable</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Life (Years)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Expiry Date</strong></p></td><td> </td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">March 8, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">USD $0.00</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.25</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:15%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">December 31, 2026</p></td><td style="width:1%;"> </td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Total</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;"><strong>4,000,000</strong></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;"><strong>4,000,000</strong></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>USD $0.00</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;"><strong>4.25</strong></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td> </td></tr></tbody></table> 4000000 4000000 0.00 P4Y3M December 31, 2026 4000000 4000000 0.00 P4Y3M 242790 <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">85.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Requisite period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">4.25 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Risk-free interest rate (US Treasury Bond rate as of the grant date)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.80</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table> 0.850 P4Y3M 0.0180 0 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 11 – INCOME TAXES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of September 30, 2022, the Company was in a loss position; therefore, no deferred tax liability was recognized related to the undistributed earnings subject to withholding tax.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Net operating loss carry forward of the Company, amounted to $3,406,686 (June 30, 2022 - $2,909,935) for the three-month period ended September 30, 2022. The net operating loss carry forwards are available to be utilized against future taxable income for years through calendar year 2042. In assessing the reliability of deferred income tax assets, management considers whether it is more likely than not that some portion or all of the deferred income tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled projected future taxable income, and tax planning strategies in making this assessment.</p> 3406686 2909935 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 12 – RECLASSIFICATION OF PRIOR YEAR PRESENTATION</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications are limited to the Statement of Operations and have no effect on the reported results of operations. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 13 – SUBSEQUENT EVENTS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 13, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $150,000 at $135,000 with $15,000 original issue discount. In connection with this note, the Company paid an additional $23,750 in cash transaction costs, issued 416,667 common shares valued at $50,000 in transaction costs, and issued 500,000 warrants exercisable at $0.25 per share, expiring on October 13, 2027. This note payable is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly, and matures on April 13, 2023 (the “Maturity Date”). The Maturity Date may be extended by up to 6 months following the date of the original Maturity Date. In the event that the Maturity Date is extended, the interest rate shall increase to 18% per annum for any period following the original Maturity Date, payable monthly.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 13, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $75,000 at $135,000 with $7,500 original issue discount. In connection with this note, the Company paid an additional $5,625 in cash transaction costs, issued 208,300 common shares valued at $25,000 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on October July 13, 2027. This note payable is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly, , and matures on April 13, 2023 (the “Maturity Date”). The Maturity Date may be extended by up to 6 months following the date of the original Maturity Date. In the event that the Maturity Date is extended, the interest rate shall increase to 18% per annum for any period following the original Maturity Date, payable monthly.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 13, 2022, the Company entered into a securities purchase agreement with a non-related party. Pursuant to this agreement, the Company issued a note payable in the principal amount of $75,000 at $135,000 with $7,500 original issue discount. In connection with this note, the Company paid an additional $5,625 in cash transaction costs, issued 208,300 common shares valued at $25,000 in transaction costs, and issued 250,000 warrants exercisable at $0.25 per share, expiring on October July 13, 2027. This note payable is unsecured, bears interest at 10% per annum compounded on the basis of a 365-day year and actual days lapsed payable monthly,  and matures on April 13, 2023 (the “Maturity Date”). The Maturity Date may be extended by up to 6 months following the date of the original Maturity Date. In the event that the Maturity Date is extended, the interest rate shall increase to 18% per annum for any period following the original Maturity Date, payable monthly.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On November 29, 2022, the Company completed a private placement whereby a total of 100,000 common shares were issued for cash at a price of $0.10 per share for a total value of $10,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 5, 2022, the Company completed a private placement whereby a total of 400,000 common shares were issued for cash at a price of $0.10 per share for a total value of $40,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 6, 2023, the Company completed a private placement whereby a total of 100,000 common shares were sold for cash at a price of $0.10 per share for a total value of $10,000. Shares have yet to be issued.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 9, 2023, the Company issued 500,000 shares with a fair value of $100,000 to a non-related party in exchange for services.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 9, 2023, the Company issued 45,000 shares with a fair value of $9,000 to a non-related party in exchange for settlement of a debt.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 11, 2023, the Company completed a private placement whereby a total of 300,000 common shares were sold for cash at a price of $0.10 per share for a total value of $30,000. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 15, 2023, the Company completed a private placement whereby a total of 600,000 common shares were sold for cash at a price of $0.10 per share for a total value of $60,000. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 16, 2023, the Company completed a private placement whereby a total of 150,000 common shares were sold for cash at a price of $0.10 per share for a total value of $15,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 17, 2023, the Company completed various a private placement whereby a total of 70,000 common shares were sold for cash at a price of $0.10 per share for a total value of $7,000. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 21, 2023, the Company completed various private placements whereby a total of 1,115,000 common shares were issued for cash at a price of $0.10 per share for a total value of $111,500.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 22, 2023, the Company completed a private placement whereby a total of 15,000 common shares were sold for cash at a price of $0.10 per share for a total value of $1,500. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 23, 2023, the Company completed various private placements whereby a total of 430,000 common shares were sold for cash at a price of $0.10 per share for a total value of $43,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 24, 2023, the Company completed a private placement whereby a total of 1,000,000 common shares were sold for cash at a price of $0.10 per share for a total value of $100,000. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 25, 2023, the Company completed a private placement whereby a total of 100,000 common shares were sold for cash at a price of $0.10 per share for a total value of $10,000. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 28, 2023, the Company completed a private placement whereby a total of 150,000 common shares were sold for cash at a price of $0.10 per share for a total value of $15,000. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 30, 2023, the Company completed various private placement whereby a total of 850,000 common shares were sold for cash at a price of $0.10 per share for a total value of $85,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 6, 2023, the Company completed a private placement whereby a total of 225,000 common shares were sold for cash at a price of $0.10 per share for a total value of $22,500. Shares have yet to be issued.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 6, 2023, the Company issued 1,000,000 shares with a fair value of $200,000 to a non-related party in exchange for services.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 7, 2023, the Company completed a private placement whereby a total of 215,000 common shares were sold for cash at a price of $0.10 per share for a total value of $21,500. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On February 14, 2023, the Company completed a private placement whereby a total of 1,000,000 common shares were sold for cash at a price of $0.10 per share for a total value of $100,000. Shares have yet to be issued.</p> 150000 135000 15000 23750 416667 50000 500000 0.25 0.10 2023-04-13 0.18 75000 135000 7500 5625 208300 25000 250000 0.25 0.10 2023-04-13 0.18 75000 135000 7500 5625 208300 25000 250000 0.25 0.10 2023-04-13 0.18 100000 0.10 10000 400000 0.10 40000 100000 0.10 10000 500000 100000 45000 9000 300000 0.10 30000 600000 0.10 60000 150000 0.10 15000 70000 0.10 7000 1115000 0.10 111500 15000 0.10 1500 430000 0.10 43000 1000000 0.10 100000 100000 0.10 10000 150000 0.10 15000 850000 0.10 85000 225000 0.10 22500 1000000 200000 215000 0.10 21500 1000000 0.10 100000 EXCEL 50 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 51 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 52 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 53 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 142 233 1 false 35 0 false 4 false false R1.htm 000001 - Document - Cover Sheet http://tegocyber.com/role/Cover Cover Cover 1 false false R2.htm 000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://tegocyber.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://tegocyber.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Sheet http://tegocyber.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Statements 4 false false R5.htm 000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY (UNAUDITED) Sheet http://tegocyber.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY (UNAUDITED) Statements 5 false false R6.htm 000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 6 false false R7.htm 000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS Sheet http://tegocyber.com/role/OrganizationAndDescriptionOfBusiness ORGANIZATION AND DESCRIPTION OF BUSINESS Notes 7 false false R8.htm 000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://tegocyber.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 000009 - Disclosure - PREPAID EXPENSES Sheet http://tegocyber.com/role/PrepaidExpenses PREPAID EXPENSES Notes 9 false false R10.htm 000010 - Disclosure - SOFTWARE Sheet http://tegocyber.com/role/SOFTWARE SOFTWARE Notes 10 false false R11.htm 000011 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Sheet http://tegocyber.com/role/AccountsPayableAndAccruedLiabilities ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Notes 11 false false R12.htm 000012 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://tegocyber.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 12 false false R13.htm 000013 - Disclosure - NOTES PAYABLE (convertible only at default) Notes http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefault NOTES PAYABLE (convertible only at default) Notes 13 false false R14.htm 000014 - Disclosure - COMMON SHARES Sheet http://tegocyber.com/role/CommonShares COMMON SHARES Notes 14 false false R15.htm 000015 - Disclosure - INCOME TAXES Sheet http://tegocyber.com/role/IncomeTaxes INCOME TAXES Notes 15 false false R16.htm 000016 - Disclosure - RECLASSIFICATION OF PRIOR YEAR PRESENTATION Sheet http://tegocyber.com/role/ReclassificationOfPriorYearPresentation RECLASSIFICATION OF PRIOR YEAR PRESENTATION Notes 16 false false R17.htm 000017 - Disclosure - SUBSEQUENT EVENTS Sheet http://tegocyber.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 17 false false R18.htm 000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 18 false false R19.htm 000019 - Disclosure - PREPAID EXPENSES (Tables) Sheet http://tegocyber.com/role/PrepaidExpensesTables PREPAID EXPENSES (Tables) Tables http://tegocyber.com/role/PrepaidExpenses 19 false false R20.htm 000020 - Disclosure - SOFTWARE (Tables) Sheet http://tegocyber.com/role/SoftwareTables SOFTWARE (Tables) Tables http://tegocyber.com/role/SOFTWARE 20 false false R21.htm 000021 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables) Sheet http://tegocyber.com/role/AccountsPayableAndAccruedLiabilitiesTables ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables) Tables http://tegocyber.com/role/AccountsPayableAndAccruedLiabilities 21 false false R22.htm 000022 - Disclosure - COMMON SHARES (Tables) Sheet http://tegocyber.com/role/CommonSharesTables COMMON SHARES (Tables) Tables http://tegocyber.com/role/CommonShares 22 false false R23.htm 000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesPolicies 23 false false R24.htm 000024 - Disclosure - PREPAID EXPENSES (Details) Sheet http://tegocyber.com/role/PrepaidExpensesDetails PREPAID EXPENSES (Details) Details http://tegocyber.com/role/PrepaidExpensesTables 24 false false R25.htm 000025 - Disclosure - SOFTWARE (Details) Sheet http://tegocyber.com/role/SoftwareDetails SOFTWARE (Details) Details http://tegocyber.com/role/SoftwareTables 25 false false R26.htm 000026 - Disclosure - ACCOUNTS PAYABLE ACCRUED LIABILITIES (Details) Sheet http://tegocyber.com/role/AccountsPayableAccruedLiabilitiesDetails ACCOUNTS PAYABLE ACCRUED LIABILITIES (Details) Details 26 false false R27.htm 000027 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://tegocyber.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://tegocyber.com/role/RelatedPartyTransactions 27 false false R28.htm 000028 - Disclosure - NOTES PAYABLE (convertible only at default) (Details Narrative) Notes http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative NOTES PAYABLE (convertible only at default) (Details Narrative) Details http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefault 28 false false R29.htm 000029 - Disclosure - COMMON SHARES (Details) Sheet http://tegocyber.com/role/CommonSharesDetails COMMON SHARES (Details) Details http://tegocyber.com/role/CommonSharesTables 29 false false R30.htm 000030 - Disclosure - COMMON SHARES (Details 1) Sheet http://tegocyber.com/role/CommonSharesDetails1 COMMON SHARES (Details 1) Details http://tegocyber.com/role/CommonSharesTables 30 false false R31.htm 000031 - Disclosure - COMMON SHARES (Details 2) Sheet http://tegocyber.com/role/CommonSharesDetails2 COMMON SHARES (Details 2) Details http://tegocyber.com/role/CommonSharesTables 31 false false R32.htm 000032 - Disclosure - COMMON SHARES (Details 3) Sheet http://tegocyber.com/role/CommonSharesDetails3 COMMON SHARES (Details 3) Details http://tegocyber.com/role/CommonSharesTables 32 false false R33.htm 000033 - Disclosure - COMMON SHARES (Details 4) Sheet http://tegocyber.com/role/CommonSharesDetails4 COMMON SHARES (Details 4) Details http://tegocyber.com/role/CommonSharesTables 33 false false R34.htm 000034 - Disclosure - COMMON SHARES (Details 5) Sheet http://tegocyber.com/role/CommonSharesDetails5 COMMON SHARES (Details 5) Details http://tegocyber.com/role/CommonSharesTables 34 false false R35.htm 000035 - Disclosure - COMMON SHARES (Details 6) Sheet http://tegocyber.com/role/CommonSharesDetails6 COMMON SHARES (Details 6) Details http://tegocyber.com/role/CommonSharesTables 35 false false R36.htm 000036 - Disclosure - COMMON SHARES (Details 7) Sheet http://tegocyber.com/role/CommonSharesDetails7 COMMON SHARES (Details 7) Details http://tegocyber.com/role/CommonSharesTables 36 false false R37.htm 000037 - Disclosure - COMMON SHARES (Details Narrative) Sheet http://tegocyber.com/role/CommonSharesDetailsNarrative COMMON SHARES (Details Narrative) Details http://tegocyber.com/role/CommonSharesTables 37 false false R38.htm 000038 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://tegocyber.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://tegocyber.com/role/IncomeTaxes 38 false false R39.htm 000039 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://tegocyber.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://tegocyber.com/role/SubsequentEvents 39 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 13 fact(s) appearing in ix:hidden were eligible for transformation: tgcb:AllowanceForDoubtfulAccounts, tgcb:CarryingValueOfNotePayable, tgcb:SoftwareEndingBalance, us-gaap:CommonStockParOrStatedValuePerShare, us-gaap:CommonStockSharesAuthorized, us-gaap:CommonStockSharesOutstanding, us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty, us-gaap:SalariesAndWages - tgcb_10qa.htm 1 tgcb_10qa.htm tgcb-20220930.xsd tgcb-20220930_cal.xml tgcb-20220930_def.xml tgcb-20220930_lab.xml tgcb-20220930_pre.xml tgcb_ex311.htm tgcb_ex312.htm tgcb_ex321.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 56 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tgcb_10qa.htm": { "axisCustom": 0, "axisStandard": 10, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 319, "http://xbrl.sec.gov/dei/2022": 29 }, "contextCount": 142, "dts": { "calculationLink": { "local": [ "tgcb-20220930_cal.xml" ] }, "definitionLink": { "local": [ "tgcb-20220930_def.xml" ] }, "inline": { "local": [ "tgcb_10qa.htm" ] }, "labelLink": { "local": [ "tgcb-20220930_lab.xml" ] }, "presentationLink": { "local": [ "tgcb-20220930_pre.xml" ] }, "schema": { "local": [ "tgcb-20220930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 322, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 7, "http://tegocyber.com/20220930": 6, "http://xbrl.sec.gov/dei/2022": 5, "total": 18 }, "keyCustom": 98, "keyStandard": 135, "memberCustom": 29, "memberStandard": 6, "nsprefix": "tgcb", "nsuri": "http://tegocyber.com/20220930", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://tegocyber.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "tgcb:CapitalizedComputerSoftwareNetDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000010 - Disclosure - SOFTWARE", "menuCat": "Notes", "order": "10", "role": "http://tegocyber.com/role/SOFTWARE", "shortName": "SOFTWARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "tgcb:CapitalizedComputerSoftwareNetDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000011 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES", "menuCat": "Notes", "order": "11", "role": "http://tegocyber.com/role/AccountsPayableAndAccruedLiabilities", "shortName": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000012 - Disclosure - RELATED PARTY TRANSACTIONS", "menuCat": "Notes", "order": "12", "role": "http://tegocyber.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000013 - Disclosure - NOTES PAYABLE (convertible only at default)", "menuCat": "Notes", "order": "13", "role": "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefault", "shortName": "NOTES PAYABLE (convertible only at default)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000014 - Disclosure - COMMON SHARES", "menuCat": "Notes", "order": "14", "role": "http://tegocyber.com/role/CommonShares", "shortName": "COMMON SHARES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000015 - Disclosure - INCOME TAXES", "menuCat": "Notes", "order": "15", "role": "http://tegocyber.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "tgcb:ReclassificationOfPriorYearPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000016 - Disclosure - RECLASSIFICATION OF PRIOR YEAR PRESENTATION", "menuCat": "Notes", "order": "16", "role": "http://tegocyber.com/role/ReclassificationOfPriorYearPresentation", "shortName": "RECLASSIFICATION OF PRIOR YEAR PRESENTATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "tgcb:ReclassificationOfPriorYearPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000017 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "17", "role": "http://tegocyber.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "18", "role": "http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "tgcb:PrepaidExpensesTextBlock", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "tgcb:PrepaidExpensesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000019 - Disclosure - PREPAID EXPENSES (Tables)", "menuCat": "Tables", "order": "19", "role": "http://tegocyber.com/role/PrepaidExpensesTables", "shortName": "PREPAID EXPENSES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "tgcb:PrepaidExpensesTextBlock", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "tgcb:PrepaidExpensesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "AsOf2022-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS", "menuCat": "Statements", "order": "2", "role": "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "AsOf2022-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "tgcb:CapitalizedComputerSoftwareNetDisclosureTextBlock", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "tgcb:ScheduleOfCapitalizedComputerSoftwareNetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000020 - Disclosure - SOFTWARE (Tables)", "menuCat": "Tables", "order": "20", "role": "http://tegocyber.com/role/SoftwareTables", "shortName": "SOFTWARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "tgcb:CapitalizedComputerSoftwareNetDisclosureTextBlock", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "tgcb:ScheduleOfCapitalizedComputerSoftwareNetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000021 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)", "menuCat": "Tables", "order": "21", "role": "http://tegocyber.com/role/AccountsPayableAndAccruedLiabilitiesTables", "shortName": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "tgcb:ScheduleForTheCompanysExerciseWarrantDataTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000022 - Disclosure - COMMON SHARES (Tables)", "menuCat": "Tables", "order": "22", "role": "http://tegocyber.com/role/CommonSharesTables", "shortName": "COMMON SHARES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "tgcb:ScheduleForTheCompanysExerciseWarrantDataTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "p", "tgcb:GoingConcernPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": "0", "first": true, "lang": null, "name": "tgcb:NegativeWorkingCapitalSurplus", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "menuCat": "Details", "order": "23", "role": "http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "tgcb:GoingConcernPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": "0", "first": true, "lang": null, "name": "tgcb:NegativeWorkingCapitalSurplus", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "tgcb:PrepaidExpensesTableTextBlock", "tgcb:PrepaidExpensesTextBlock", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "AsOf2022-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PrepaidAdvertising", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000024 - Disclosure - PREPAID EXPENSES (Details)", "menuCat": "Details", "order": "24", "role": "http://tegocyber.com/role/PrepaidExpensesDetails", "shortName": "PREPAID EXPENSES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "tgcb:PrepaidExpensesTableTextBlock", "tgcb:PrepaidExpensesTextBlock", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "AsOf2022-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PrepaidAdvertising", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "tgcb:ScheduleOfCapitalizedComputerSoftwareNetTableTextBlock", "tgcb:CapitalizedComputerSoftwareNetDisclosureTextBlock", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "tgcb:SoftwareBeginningBalance", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000025 - Disclosure - SOFTWARE (Details)", "menuCat": "Details", "order": "25", "role": "http://tegocyber.com/role/SoftwareDetails", "shortName": "SOFTWARE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "tgcb:ScheduleOfCapitalizedComputerSoftwareNetTableTextBlock", "tgcb:CapitalizedComputerSoftwareNetDisclosureTextBlock", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "tgcb:SoftwareBeginningBalance", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "AsOf2022-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedAdvertisingCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000026 - Disclosure - ACCOUNTS PAYABLE ACCRUED LIABILITIES (Details)", "menuCat": "Details", "order": "26", "role": "http://tegocyber.com/role/AccountsPayableAccruedLiabilitiesDetails", "shortName": "ACCOUNTS PAYABLE ACCRUED LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "AsOf2022-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedAdvertisingCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30_tgcb_TroyWilkinsonMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000027 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "menuCat": "Details", "order": "27", "role": "http://tegocyber.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30_tgcb_TroyWilkinsonMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-07-12_tgcb_NotesPayableMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtConversionOriginalDebtAmount1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000028 - Disclosure - NOTES PAYABLE (convertible only at default) (Details Narrative)", "menuCat": "Details", "order": "28", "role": "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative", "shortName": "NOTES PAYABLE (convertible only at default) (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-07-12_tgcb_NotesPayableMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtConversionOriginalDebtAmount1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "tgcb:ScheduleForTheCompanysExerciseWarrantDataTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000029 - Disclosure - COMMON SHARES (Details)", "menuCat": "Details", "order": "29", "role": "http://tegocyber.com/role/CommonSharesDetails", "shortName": "COMMON SHARES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "tgcb:ScheduleForTheCompanysExerciseWarrantDataTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "AsOf2022-09-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://tegocyber.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R30": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "tgcb:NumberOfWarrantsOutstandingBeginning1", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000030 - Disclosure - COMMON SHARES (Details 1)", "menuCat": "Details", "order": "30", "role": "http://tegocyber.com/role/CommonSharesDetails1", "shortName": "COMMON SHARES (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "AsOf2022-06-30", "decimals": "0", "first": true, "lang": null, "name": "tgcb:NumberOfWarrantsOutstandingBeginning1", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "tgcb:ScheduleForTheCompanysOutstandingNonQualifiedStockOptions", "ix:continuation", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "AsOf2022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "tgcb:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000031 - Disclosure - COMMON SHARES (Details 2)", "menuCat": "Details", "order": "31", "role": "http://tegocyber.com/role/CommonSharesDetails2", "shortName": "COMMON SHARES (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "tgcb:ScheduleForTheCompanysOutstandingNonQualifiedStockOptions", "ix:continuation", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "AsOf2022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "tgcb:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "tgcb:ScheduleOfStockOptionsOutstandingtabletextblock", "ix:continuation", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "tgcb:WeightedAverageLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000032 - Disclosure - COMMON SHARES (Details 3)", "menuCat": "Details", "order": "32", "role": "http://tegocyber.com/role/CommonSharesDetails3", "shortName": "COMMON SHARES (Details 3)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "tgcb:ScheduleOfStockOptionsOutstandingtabletextblock", "ix:continuation", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "tgcb:WeightedAverageLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "tgcb:ScheduleOfWeightedAverageAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": "INF", "first": true, "lang": null, "name": "tgcb:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000033 - Disclosure - COMMON SHARES (Details 4)", "menuCat": "Details", "order": "33", "role": "http://tegocyber.com/role/CommonSharesDetails4", "shortName": "COMMON SHARES (Details 4)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "tgcb:ScheduleOfWeightedAverageAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": "INF", "first": true, "lang": null, "name": "tgcb:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "tgcb:ScheduleForTheCompanySOutstandingPerformanceStockUnits", "ix:continuation", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": "0", "first": true, "lang": null, "name": "tgcb:NumberOfWarrantsGranted", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000034 - Disclosure - COMMON SHARES (Details 5)", "menuCat": "Details", "order": "34", "role": "http://tegocyber.com/role/CommonSharesDetails5", "shortName": "COMMON SHARES (Details 5)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "tgcb:ScheduleForTheCompanySOutstandingPerformanceStockUnits", "ix:continuation", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": "0", "first": true, "lang": null, "name": "tgcb:NumberOfWarrantsGranted", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "tgcb:ScheduleForTheCompanysPerformanceUnitsOutstandingTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "AsOf2022-09-30", "decimals": "0", "first": true, "lang": null, "name": "tgcb:NumberExercisable", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000035 - Disclosure - COMMON SHARES (Details 6)", "menuCat": "Details", "order": "35", "role": "http://tegocyber.com/role/CommonSharesDetails6", "shortName": "COMMON SHARES (Details 6)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "tgcb:ScheduleForTheCompanysPerformanceUnitsOutstandingTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "AsOf2022-09-30", "decimals": "0", "first": true, "lang": null, "name": "tgcb:NumberExercisable", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "tgcb:ScheduleOfFairValueOfThePerformanceUnitsGrantedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": "INF", "first": true, "lang": null, "name": "tgcb:ExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000036 - Disclosure - COMMON SHARES (Details 7)", "menuCat": "Details", "order": "36", "role": "http://tegocyber.com/role/CommonSharesDetails7", "shortName": "COMMON SHARES (Details 7)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "tgcb:ScheduleOfFairValueOfThePerformanceUnitsGrantedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": "INF", "first": true, "lang": null, "name": "tgcb:ExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "tgcb:WeightedAverageRemainingContractualLifeOfWarrantsOutstanding", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000037 - Disclosure - COMMON SHARES (Details Narrative)", "menuCat": "Details", "order": "37", "role": "http://tegocyber.com/role/CommonSharesDetailsNarrative", "shortName": "COMMON SHARES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "tgcb:WeightedAverageRemainingContractualLifeOfWarrantsOutstanding", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "AsOf2022-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000038 - Disclosure - INCOME TAXES (Details Narrative)", "menuCat": "Details", "order": "38", "role": "http://tegocyber.com/role/IncomeTaxesDetailsNarrative", "shortName": "INCOME TAXES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "AsOf2022-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2021-07-01to2021-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000039 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "menuCat": "Details", "order": "39", "role": "http://tegocyber.com/role/SubsequentEventsDetailsNarrative", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2023-02-01to2023-02-06", "decimals": "0", "lang": null, "name": "tgcb:CommonStockTotalValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)", "menuCat": "Statements", "order": "4", "role": "http://tegocyber.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "AsOf2021-06-30_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY (UNAUDITED)", "menuCat": "Statements", "order": "5", "role": "http://tegocyber.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "AsOf2021-06-30_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "menuCat": "Statements", "order": "6", "role": "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS", "menuCat": "Notes", "order": "7", "role": "http://tegocyber.com/role/OrganizationAndDescriptionOfBusiness", "shortName": "ORGANIZATION AND DESCRIPTION OF BUSINESS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "8", "role": "http://tegocyber.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "tgcb:PrepaidExpensesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000009 - Disclosure - PREPAID EXPENSES", "menuCat": "Notes", "order": "9", "role": "http://tegocyber.com/role/PrepaidExpenses", "shortName": "PREPAID EXPENSES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tgcb_10qa.htm", "contextRef": "From2022-07-01to2022-09-30", "decimals": null, "first": true, "lang": "en-US", "name": "tgcb:PrepaidExpensesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 35, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r284" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r285" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line 1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line 2" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r287" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tegocyber.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r154", "r155", "r156", "r157", "r196", "r250", "r253", "r261", "r262", "r277", "r278", "r282", "r304", "r338", "r339", "r340", "r341", "r342", "r343" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails", "http://tegocyber.com/role/CommonSharesDetails4" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r154", "r155", "r156", "r157", "r196", "r250", "r253", "r261", "r262", "r277", "r278", "r282", "r304", "r338", "r339", "r340", "r341", "r342", "r343" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails", "http://tegocyber.com/role/CommonSharesDetails4" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r154", "r155", "r156", "r157", "r195", "r196", "r198", "r199", "r200", "r249", "r250", "r253", "r261", "r262", "r277", "r278", "r282", "r300", "r304", "r339", "r340", "r341", "r342", "r343" ], "lang": { "en-us": { "role": { "label": "Range Axis" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails", "http://tegocyber.com/role/CommonSharesDetails4" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r154", "r155", "r156", "r157", "r195", "r196", "r198", "r199", "r200", "r249", "r250", "r253", "r261", "r262", "r277", "r278", "r282", "r300", "r304", "r339", "r340", "r341", "r342", "r343" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails", "http://tegocyber.com/role/CommonSharesDetails4" ], "xbrltype": "domainItemType" }, "tgcb_AccountsPayableAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ACCOUNTS PAYABLE ACCRUED LIABILITIES (Details)" } } }, "localname": "AccountsPayableAbstract", "nsuri": "http://tegocyber.com/20220930", "xbrltype": "stringItemType" }, "tgcb_AccretionExpenseOnConvertibleDebts": { "auth_ref": [], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Accretion expense]", "verboseLabel": "Accretion expense" } } }, "localname": "AccretionExpenseOnConvertibleDebts", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "tgcb_AdditionalAmountPaidInCashTransactionCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Additional amount paid in cash transaction costs" } } }, "localname": "AdditionalAmountPaidInCashTransactionCosts", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tgcb_AdditionalCashPaymentTransactionCost": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Additional cash proceeds" } } }, "localname": "AdditionalCashPaymentTransactionCost", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tgcb_AllowanceForDoubtfulAccounts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccounts", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tgcb_AmortizationOfDiscountOfDebtIssuance": { "auth_ref": [], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Amortization of discount of debt issuance" } } }, "localname": "AmortizationOfDiscountOfDebtIssuance", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "tgcb_BasicAndDilutedLossPerCommonShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BASIC AND DILUTED LOSS PER COMMON SHARE" } } }, "localname": "BasicAndDilutedLossPerCommonShare", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "perShareItemType" }, "tgcb_CapitalizedComputerSoftwareNetDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[SOFTWARE]", "verboseLabel": "SOFTWARE" } } }, "localname": "CapitalizedComputerSoftwareNetDisclosureTextBlock", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/SOFTWARE" ], "xbrltype": "textBlockItemType" }, "tgcb_CarryingValueOfNotePayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Carrying value of note payable" } } }, "localname": "CarryingValueOfNotePayable", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tgcb_CashCostsForPromissoryNotes": { "auth_ref": [], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "[Cash Costs for promissory notes]", "negatedLabel": "Cash Costs for promissory notes" } } }, "localname": "CashCostsForPromissoryNotes", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "tgcb_ChrisWhiteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Chris White" } } }, "localname": "ChrisWhiteMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_CommitmentFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Commitment fee" } } }, "localname": "CommitmentFee", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tgcb_CommonSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Shares [Member]" } } }, "localname": "CommonSharesMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_CommonStockFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock, fair value" } } }, "localname": "CommonStockFairValue", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tgcb_CommonStockRelativeFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Common stock relative fair value" } } }, "localname": "CommonStockRelativeFairValue", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tgcb_CommonStockSold": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock, sold" } } }, "localname": "CommonStockSold", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "tgcb_CommonStockTotalValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Common stock, total value" } } }, "localname": "CommonStockTotalValue", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tgcb_ConsultantsContractorsAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Consultants and contractors" } } }, "localname": "ConsultantsContractorsAmount", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/PrepaidExpensesDetails" ], "xbrltype": "monetaryItemType" }, "tgcb_DecemberEightTwoZeroTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "December 8, 2021" } } }, "localname": "DecemberEightTwoZeroTwentyOneMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_DecemberThirtyOneTwoZeroTwentyOneAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "December 31, 2021 A" } } }, "localname": "DecemberThirtyOneTwoZeroTwentyOneAMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_DecemberThirtyOneTwoZeroTwentyOneBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "December 31, 2021 B" } } }, "localname": "DecemberThirtyOneTwoZeroTwentyOneBMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_EarlJohnsonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earl Johnson" } } }, "localname": "EarlJohnsonMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_ExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise price" } } }, "localname": "ExercisePrice", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative" ], "xbrltype": "perShareItemType" }, "tgcb_ExercisePrice1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Exercise]", "verboseLabel": "Exercise" } } }, "localname": "ExercisePrice1", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails6" ], "xbrltype": "perShareItemType" }, "tgcb_ExercisePrices": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise" } } }, "localname": "ExercisePrices", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails3" ], "xbrltype": "perShareItemType" }, "tgcb_ExpectedVolatilityRate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Expected volatility]", "verboseLabel": "Expected volatility" } } }, "localname": "ExpectedVolatilityRate", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails7" ], "xbrltype": "percentItemType" }, "tgcb_ExpirationDate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expiry Date" } } }, "localname": "ExpirationDate", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails3" ], "xbrltype": "stringItemType" }, "tgcb_ExpiryDate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expiry date" } } }, "localname": "ExpiryDate", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails6" ], "xbrltype": "stringItemType" }, "tgcb_FairValueOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Fair value of warrants" } } }, "localname": "FairValueOfWarrants", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tgcb_GoingConcernPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Going Concern" } } }, "localname": "GoingConcernPolicyTextBlock", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "tgcb_InterestOnShortTermDebt": { "auth_ref": [], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Interest on short term debt" } } }, "localname": "InterestOnShortTermDebt", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "tgcb_JanuaryFourTwoZeroTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "January 4, 2022 [Member]" } } }, "localname": "JanuaryFourTwoZeroTwentyTwoMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails3" ], "xbrltype": "domainItemType" }, "tgcb_JanuaryOneTwoZeroTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "January 1, 2022" } } }, "localname": "JanuaryOneTwoZeroTwentyTwoMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_JanuaryThreeTwoZeroTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "January 3, 2022 [Member]" } } }, "localname": "JanuaryThreeTwoZeroTwentyTwoMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails3" ], "xbrltype": "domainItemType" }, "tgcb_JulyEighteenTwoThousandTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "July 18, 2022" } } }, "localname": "JulyEighteenTwoThousandTwentyTwoMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_JulyFifteenTwoThousandTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "July 15, 2022" } } }, "localname": "JulyFifteenTwoThousandTwentyTwoMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_JulyTwelveTwoThousandTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "July 12, 2022" } } }, "localname": "JulyTwelveTwoThousandTwentyTwoMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_JulyTwentySixTwoThousandTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "July 26, 2022" } } }, "localname": "JulyTwentySixTwoThousandTwentyTwoMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_MarchEightTwoZeroTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "March 8, 2022 [Member]" } } }, "localname": "MarchEightTwoZeroTwentyTwoMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails6" ], "xbrltype": "domainItemType" }, "tgcb_MarchTwentyFiveTwoZeroTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "March 25, 2022" } } }, "localname": "MarchTwentyFiveTwoZeroTwentyTwoMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_MayNineteenTwoZeroTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "May 19, 2022" } } }, "localname": "MayNineteenTwoZeroTwentyTwoMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_NegativeWorkingCapitalSurplus": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Negative working capital (Surplus)" } } }, "localname": "NegativeWorkingCapitalSurplus", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tgcb_NonCashTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NON-CASH TRANSACTIONS" } } }, "localname": "NonCashTransactionsAbstract", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "tgcb_NotesPayableInExchangeForCash": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Notes payable in exchange for cash" } } }, "localname": "NotesPayableInExchangeForCash", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tgcb_NotesPayableInExchangeForCashFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Notes payable in exchange for cash, fair value" } } }, "localname": "NotesPayableInExchangeForCashFairValue", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tgcb_NotesPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable [Member]" } } }, "localname": "NotesPayableMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_NotesPayableOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable One [Member]" } } }, "localname": "NotesPayableOneMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_NotesPayableTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable Two [Member]" } } }, "localname": "NotesPayableTwoMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_NumberExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number Exercisable" } } }, "localname": "NumberExercisable", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails6" ], "xbrltype": "sharesItemType" }, "tgcb_NumberOfOptionExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of option Exercisable" } } }, "localname": "NumberOfOptionExercisable", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails3" ], "xbrltype": "sharesItemType" }, "tgcb_NumberOfOptionOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Number of option outstanding]", "verboseLabel": "Number of option outstanding" } } }, "localname": "NumberOfOptionOutstanding", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails6" ], "xbrltype": "sharesItemType" }, "tgcb_NumberOfOptionOutstanding1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of option outstanding" } } }, "localname": "NumberOfOptionOutstanding1", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails3" ], "xbrltype": "sharesItemType" }, "tgcb_NumberOfWarrantsGranted": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "[Number Of Warrants Granted]", "verboseLabel": "Number Of Warrants Granted" } } }, "localname": "NumberOfWarrantsGranted", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails5" ], "xbrltype": "monetaryItemType" }, "tgcb_NumberOfWarrantsOutstandingBeginning": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Number Of Warrants Outstanding, beginning]", "periodStartLabel": "Number Of Warrants Outstanding, beginning" } } }, "localname": "NumberOfWarrantsOutstandingBeginning", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails5" ], "xbrltype": "sharesItemType" }, "tgcb_NumberOfWarrantsOutstandingBeginning1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Number Of Warrants Outstanding, Beginning]", "periodStartLabel": "Number Of Warrants Outstanding, Beginning" } } }, "localname": "NumberOfWarrantsOutstandingBeginning1", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails1" ], "xbrltype": "sharesItemType" }, "tgcb_NumberOfWarrantsOutstandingBeginning2": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Number Of Warrants Outstanding, Beginning 1]", "periodStartLabel": "Number Of Warrants Outstanding, Beginning" } } }, "localname": "NumberOfWarrantsOutstandingBeginning2", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails2" ], "xbrltype": "sharesItemType" }, "tgcb_NumberOfWarrantsOutstandingEnding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Number Of Warrants Outstanding,Ending]", "periodEndLabel": "Number Of Warrants Outstanding,Ending" } } }, "localname": "NumberOfWarrantsOutstandingEnding", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails5" ], "xbrltype": "sharesItemType" }, "tgcb_NumberOfWarrantsOutstandingEndingBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Number Of Warrants Outstanding,Ending Balance]", "periodEndLabel": "Number Of Warrants Outstanding,Ending Balance" } } }, "localname": "NumberOfWarrantsOutstandingEndingBalance", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails1" ], "xbrltype": "sharesItemType" }, "tgcb_NumberOfWarrantsOutstandingEndingBalance2": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Number Of Warrants Outstanding, Ending Balance]", "periodEndLabel": "Number Of Warrants Outstanding, Ending Balance" } } }, "localname": "NumberOfWarrantsOutstandingEndingBalance2", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails2" ], "xbrltype": "sharesItemType" }, "tgcb_NumberOfWarrantsReleased": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Number Of Warrants Released" } } }, "localname": "NumberOfWarrantsReleased", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails5" ], "xbrltype": "monetaryItemType" }, "tgcb_NumberofwarrantsforfeitedOrCancelled": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Number Of Warrants Forfeited or cancelled" } } }, "localname": "NumberofwarrantsforfeitedOrCancelled", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails5" ], "xbrltype": "monetaryItemType" }, "tgcb_OctoberFifteenTwoZeroTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "October 15, 2021" } } }, "localname": "OctoberFifteenTwoZeroTwentyOneMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_OctoberTwetyEightTwoZeroTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "October 28, 2021" } } }, "localname": "OctoberTwetyEightTwoZeroTwentyOneMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_PlatformCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Platform cost" } } }, "localname": "PlatformCost", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/AccountsPayableAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "tgcb_PlatformCostsAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Platform costs" } } }, "localname": "PlatformCostsAmount", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/PrepaidExpensesDetails" ], "xbrltype": "monetaryItemType" }, "tgcb_PrepaidExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "PREPAID EXPENSES" } } }, "localname": "PrepaidExpensesAbstract", "nsuri": "http://tegocyber.com/20220930", "xbrltype": "stringItemType" }, "tgcb_PrepaidExpensesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of prepaid expenses" } } }, "localname": "PrepaidExpensesTableTextBlock", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/PrepaidExpensesTables" ], "xbrltype": "textBlockItemType" }, "tgcb_PrepaidExpensesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[PREPAID EXPENSES]", "verboseLabel": "PREPAID EXPENSES" } } }, "localname": "PrepaidExpensesTextBlock", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/PrepaidExpenses" ], "xbrltype": "textBlockItemType" }, "tgcb_ReclassificationOfPriorYearPresentationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[RECLASSIFICATION OF PRIOR YEAR PRESENTATION]", "verboseLabel": "RECLASSIFICATION OF PRIOR YEAR PRESENTATION" } } }, "localname": "ReclassificationOfPriorYearPresentationTextBlock", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/ReclassificationOfPriorYearPresentation" ], "xbrltype": "textBlockItemType" }, "tgcb_ReclassificationOfPriorYearPresentationabstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RECLASSIFICATION OF PRIOR YEAR PRESENTATION" } } }, "localname": "ReclassificationOfPriorYearPresentationabstract", "nsuri": "http://tegocyber.com/20220930", "xbrltype": "stringItemType" }, "tgcb_RiskFreeInterestRates": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Risk-free interest rate]", "verboseLabel": "Risk-free interest rate" } } }, "localname": "RiskFreeInterestRates", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails7" ], "xbrltype": "percentItemType" }, "tgcb_ScheduleForTheCompanySOutstandingPerformanceStockUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "schedule for the Company's outstanding performance stock units:" } } }, "localname": "ScheduleForTheCompanySOutstandingPerformanceStockUnits", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesTables" ], "xbrltype": "textBlockItemType" }, "tgcb_ScheduleForTheCompanysExerciseWarrantDataTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "schedule for the Company's exercise warrant data" } } }, "localname": "ScheduleForTheCompanysExerciseWarrantDataTableTextBlock", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesTables" ], "xbrltype": "textBlockItemType" }, "tgcb_ScheduleForTheCompanysOutstandingNonQualifiedStockOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "schedule for the Company's outstanding non-qualified stock options:" } } }, "localname": "ScheduleForTheCompanysOutstandingNonQualifiedStockOptions", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesTables" ], "xbrltype": "textBlockItemType" }, "tgcb_ScheduleForTheCompanysPerformanceUnitsOutstandingTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "schedule for the Company's performance units outstanding" } } }, "localname": "ScheduleForTheCompanysPerformanceUnitsOutstandingTableTextBlock", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesTables" ], "xbrltype": "textBlockItemType" }, "tgcb_ScheduleOfCapitalizedComputerSoftwareNetTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of software" } } }, "localname": "ScheduleOfCapitalizedComputerSoftwareNetTableTextBlock", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/SoftwareTables" ], "xbrltype": "textBlockItemType" }, "tgcb_ScheduleOfFairValueOfThePerformanceUnitsGrantedTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "schedule of fair value of the performance units granted" } } }, "localname": "ScheduleOfFairValueOfThePerformanceUnitsGrantedTableTextBlock", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesTables" ], "xbrltype": "textBlockItemType" }, "tgcb_ScheduleOfStockOptionsOutstandingtabletextblock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of stock options outstanding:" } } }, "localname": "ScheduleOfStockOptionsOutstandingtabletextblock", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesTables" ], "xbrltype": "textBlockItemType" }, "tgcb_ScheduleOfWeightedAverageAssumptionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of weighted average assumptions" } } }, "localname": "ScheduleOfWeightedAverageAssumptionsTableTextBlock", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesTables" ], "xbrltype": "textBlockItemType" }, "tgcb_SecuritiesPurchaseAgreementWithNonRelatedPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Securities Purchase Agreement With Non-Related Party [Member]" } } }, "localname": "SecuritiesPurchaseAgreementWithNonRelatedPartyMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_SecuritiesPurchaseAgreementWithNonRelatedPartyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Securities Purchase Agreement With Non-Related Party One [Member]" } } }, "localname": "SecuritiesPurchaseAgreementWithNonRelatedPartyOneMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_SecuritiesPurchaseAgreementWithNonRelatedPartyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Securities Purchase Agreement With Non-Related Party Two [Member]" } } }, "localname": "SecuritiesPurchaseAgreementWithNonRelatedPartyTwoMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_ServicesValued": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Services valued" } } }, "localname": "ServicesValued", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tgcb_ServicesValuedAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Services valued]", "verboseLabel": "Services valued" } } }, "localname": "ServicesValuedAmount", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tgcb_ShannonWilkinsonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shannon Wilkinson" } } }, "localname": "ShannonWilkinsonMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelled": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number Of Warrants Cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelled", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails2" ], "xbrltype": "sharesItemType" }, "tgcb_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of warrants expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpired", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails1" ], "xbrltype": "sharesItemType" }, "tgcb_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Fair value of warrant granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValue", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tgcb_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Weighted Average Exercise Price Outstanding, Beginning Balance]", "periodStartLabel": "Weighted Average Exercise Price Outstanding, Beginning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails2" ], "xbrltype": "perShareItemType" }, "tgcb_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceEnding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Weighted Average Exercise Price Outstanding, Ending Balance]", "periodEndLabel": "Weighted Average Exercise Price Outstanding, Ending Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceEnding", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails2" ], "xbrltype": "perShareItemType" }, "tgcb_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Weighted Average Exercise Price Granted]", "verboseLabel": "Weighted Average Exercise Price Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceGranted1", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails2" ], "xbrltype": "perShareItemType" }, "tgcb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Exercised", "terseLabel": "Weighted Average Exercise Price Released", "verboseLabel": "Weighted Average Exercise Price Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails1", "http://tegocyber.com/role/CommonSharesDetails2", "http://tegocyber.com/role/CommonSharesDetails5" ], "xbrltype": "perShareItemType" }, "tgcb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Expired", "terseLabel": "Weighted Average Exercise Price Forfeited or Cancelled", "verboseLabel": "Weighted Average Exercise Price Cancelled" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails1", "http://tegocyber.com/role/CommonSharesDetails2", "http://tegocyber.com/role/CommonSharesDetails5" ], "xbrltype": "perShareItemType" }, "tgcb_ShareBasedCompensationNonQualifiedStockOptions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Share-based compensation non qualified stock options" } } }, "localname": "ShareBasedCompensationNonQualifiedStockOptions", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tgcb_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Expected life]", "verboseLabel": "Expected life" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails7" ], "xbrltype": "durationItemType" }, "tgcb_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expected life" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerms", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails4" ], "xbrltype": "durationItemType" }, "tgcb_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expected volatility" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails4" ], "xbrltype": "percentItemType" }, "tgcb_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risk-free interest rate" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails4" ], "xbrltype": "percentItemType" }, "tgcb_SharesIssuedAsTransactionCostsForNotesPayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Shares issued as transaction costs for notes payable" } } }, "localname": "SharesIssuedAsTransactionCostsForNotesPayable", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "tgcb_SharesIssuedAsTransactionCostsForNotesPayableAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Shares issued as transaction costs for notes payable, amount" } } }, "localname": "SharesIssuedAsTransactionCostsForNotesPayableAmount", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "tgcb_SharesIssuedAsTransactionCostsForNotesPayableShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares issued as transaction costs for notes payable, shares" } } }, "localname": "SharesIssuedAsTransactionCostsForNotesPayableShares", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited" ], "xbrltype": "sharesItemType" }, "tgcb_SharesIssuedForServices": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Shares issued for services]", "verboseLabel": "Shares issued for services" } } }, "localname": "SharesIssuedForServices", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "tgcb_SharesIssuedWithNotesPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Shares issued with notes payable" } } }, "localname": "SharesIssuedWithNotesPayable", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "tgcb_SharesissuedconversionPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Conversion price" } } }, "localname": "SharesissuedconversionPrice", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "tgcb_SharesissuedconversionPriceA0": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Conversion price]", "verboseLabel": "Conversion price" } } }, "localname": "SharesissuedconversionPriceA0", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "tgcb_SoftwareBeginningBalance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Software, Beginning Balance]", "periodStartLabel": "Software, Beginning Balance" } } }, "localname": "SoftwareBeginningBalance", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/SoftwareDetails" ], "xbrltype": "monetaryItemType" }, "tgcb_SoftwareEndingBalance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Software, Ending Balance]", "periodEndLabel": "Software, Ending Balance" } } }, "localname": "SoftwareEndingBalance", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/SoftwareDetails" ], "xbrltype": "monetaryItemType" }, "tgcb_SoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Software [Member]" } } }, "localname": "SoftwareMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_StockBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[Share-based compensation]", "verboseLabel": "Share-based compensation" } } }, "localname": "StockBasedCompensation", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tgcb_SubscriptionReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subscription Receivable [Member]" } } }, "localname": "SubscriptionReceivableMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "tgcb_TotalStockIssuedDuringPeriodSharesConversionOfUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total common shares issued" } } }, "localname": "TotalStockIssuedDuringPeriodSharesConversionOfUnits", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative" ], "xbrltype": "sharesItemType" }, "tgcb_TroyWilkinsonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Troy Wilkinson" } } }, "localname": "TroyWilkinsonMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_ValueOfShares": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Total value" } } }, "localname": "ValueOfShares", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tgcb_WarrantExercisablePriceperShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant exercisable" } } }, "localname": "WarrantExercisablePriceperShare", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative" ], "xbrltype": "perShareItemType" }, "tgcb_WarrantExercisePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant exercise price per share" } } }, "localname": "WarrantExercisePricePerShare", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "tgcb_WarrantsExercisableIssuedDuringPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants exercisable issued" } } }, "localname": "WarrantsExercisableIssuedDuringPeriod", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "tgcb_WarrantsIntrinsicValue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants intrinsic value" } } }, "localname": "WarrantsIntrinsicValue", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "tgcb_WarrantsIssuedWithNotesPayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Warrants issued with notes payable" } } }, "localname": "WarrantsIssuedWithNotesPayable", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "tgcb_WarrantsIssuedWithPromissoryNotes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Warrants issued with promissory notes" } } }, "localname": "WarrantsIssuedWithPromissoryNotes", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "tgcb_WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant [Member]" } } }, "localname": "WarrantsMember", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tgcb_WarrantsRelativeFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Warrants relative fair value" } } }, "localname": "WarrantsRelativeFairValue", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tgcb_WarrantsindexedissuedofcommonShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants indexed issued" } } }, "localname": "WarrantsindexedissuedofcommonShares", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative" ], "xbrltype": "sharesItemType" }, "tgcb_WeightedAverageExercisePriceBeginningBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Weighted Average Exercise Price Beginning balance]", "periodStartLabel": "Weighted Average Exercise Price Beginning balance" } } }, "localname": "WeightedAverageExercisePriceBeginningBalance", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails5" ], "xbrltype": "perShareItemType" }, "tgcb_WeightedAverageExercisePriceEndingBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Ending, Balance" } } }, "localname": "WeightedAverageExercisePriceEndingBalance", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails5" ], "xbrltype": "perShareItemType" }, "tgcb_WeightedAverageExercisePriceGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Granted" } } }, "localname": "WeightedAverageExercisePriceGranted", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails1" ], "xbrltype": "perShareItemType" }, "tgcb_WeightedAverageExercisePriceGranted2": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Weighted Average Exercise Price Granted 1]", "verboseLabel": "Weighted Average Exercise Price Granted" } } }, "localname": "WeightedAverageExercisePriceGranted2", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails5" ], "xbrltype": "perShareItemType" }, "tgcb_WeightedAverageExercisePriceGranted3": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average exercise price granted" } } }, "localname": "WeightedAverageExercisePriceGranted3", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "tgcb_WeightedAverageExercisePriceOutstandingBeginning": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Weighted Average Exercise Price Outstanding, Beginning]", "periodStartLabel": "Weighted Average Exercise Price Outstanding, Beginning" } } }, "localname": "WeightedAverageExercisePriceOutstandingBeginning", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails1" ], "xbrltype": "perShareItemType" }, "tgcb_WeightedAverageExercisePriceOutstandingEnding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Outstanding, ending" } } }, "localname": "WeightedAverageExercisePriceOutstandingEnding", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails1" ], "xbrltype": "perShareItemType" }, "tgcb_WeightedAverageLife": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Weighted Average life]", "verboseLabel": "Weighted Average life" } } }, "localname": "WeightedAverageLife", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails3" ], "xbrltype": "durationItemType" }, "tgcb_WeightedAverageNumberOfCommonSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING" } } }, "localname": "WeightedAverageNumberOfCommonSharesOutstanding", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "sharesItemType" }, "tgcb_WeightedAverageRemainingContractualLifeOfWarrantsOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual life of warrants outstanding" } } }, "localname": "WeightedAverageRemainingContractualLifeOfWarrantsOutstanding", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "durationItemType" }, "tgcb_WeightedAverageUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Life (Years)" } } }, "localname": "WeightedAverageUsefulLife", "nsuri": "http://tegocyber.com/20220930", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails6" ], "xbrltype": "durationItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "ACCOUNTS PAYABLE" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/AccountsPayableAndAccruedLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableAndOtherAccruedLiabilities": { "auth_ref": [], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other.", "label": "Accounts payable & accrued liabilities (Note 7)" } } }, "localname": "AccountsPayableAndOtherAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r1", "r10" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "[Accounts Payable, Trade, Current]", "verboseLabel": "Total" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/AccountsPayableAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r147", "r148" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccretionExpense": { "auth_ref": [ "r273", "r301" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 6.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.", "label": "[Accretion Expense]", "negatedLabel": "Accretion expense" } } }, "localname": "AccretionExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedAdvertisingCurrent": { "auth_ref": [ "r14" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for advertising of the entity's goods and services. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Exchange & listing fees" } } }, "localname": "AccruedAdvertisingCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/AccountsPayableAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r14" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Legal and accounting" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/AccountsPayableAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted Average life", "verboseLabel": "Weighted Average Life (Years)" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails3", "http://tegocyber.com/role/CommonSharesDetails6" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r5", "r281" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid in capital", "verboseLabel": "Additional paid in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative", "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r201", "r202", "r203", "r294", "r295", "r296", "r332" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-In Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r28", "r48" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Amortization" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_Assets": { "auth_ref": [ "r74", "r79", "r93", "r114", "r141", "r143", "r145", "r149", "r158", "r159", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r220", "r224", "r229", "r281", "r302", "r303", "r336" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "[Assets]", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r92", "r98", "r114", "r149", "r158", "r159", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r220", "r224", "r229", "r281", "r302", "r303", "r336" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "[Assets, Current]", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date Axis" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails3", "http://tegocyber.com/role/CommonSharesDetails6", "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [ "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331" ], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails3", "http://tegocyber.com/role/CommonSharesDetails6", "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Preparation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r0", "r37", "r43" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business Description and Basis of Presentation [Text Block]", "verboseLabel": "ORGANIZATION AND DESCRIPTION OF BUSINESS" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/OrganizationAndDescriptionOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalizedComputerSoftwareAdditions": { "auth_ref": [ "r46" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Additions made to capitalized computer software costs during the period.", "label": "Additions" } } }, "localname": "CapitalizedComputerSoftwareAdditions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SoftwareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedComputerSoftwareAmortization1": { "auth_ref": [ "r87", "r88" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for amortization of capitalized computer software costs.", "label": "Depreciation" } } }, "localname": "CapitalizedComputerSoftwareAmortization1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SoftwareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedComputerSoftwareNet": { "auth_ref": [ "r263" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.", "label": "Software (Note 6)" } } }, "localname": "CapitalizedComputerSoftwareNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedComputerSoftwareNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SOFTWARE" } } }, "localname": "CapitalizedComputerSoftwareNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CapitalizedContractCostAxis": { "auth_ref": [ "r153" ], "lang": { "en-us": { "role": { "documentation": "Information by cost capitalized in obtaining or fulfilling contract with customer.", "label": "Capitalized Contract Cost [Axis]" } } }, "localname": "CapitalizedContractCostAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CapitalizedContractCostDomain": { "auth_ref": [ "r153" ], "lang": { "en-us": { "role": { "documentation": "Cost capitalized in obtaining and fulfilling contract with customer." } } }, "localname": "CapitalizedContractCostDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Cash": { "auth_ref": [ "r259", "r260", "r281", "r289" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r31" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "verboseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r25", "r30", "r36" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "[Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents]", "periodEndLabel": "CASH AT END OF THE PERIOD", "periodStartLabel": "CASH AT BEGINNING OF THE PERIOD" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r25", "r68" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "[Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect]", "totalLabel": "NET INCREASE (DECREASE) IN CASH" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r94", "r95", "r96", "r114", "r128", "r129", "r131", "r132", "r134", "r135", "r149", "r158", "r160", "r161", "r162", "r165", "r166", "r180", "r181", "r183", "r187", "r193", "r229", "r264", "r288", "r292", "r297" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r294", "r295", "r332" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value", "verboseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative", "http://tegocyber.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, authorized", "verboseLabel": "Common stock, authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative", "http://tegocyber.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, issued", "terseLabel": "Common stock, issued", "verboseLabel": "Common stock, issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative", "http://tegocyber.com/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r4", "r53" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r4", "r281" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common shares 50,000,000 shares authorized $0.001 par value 26,483,044 shares issued and outstanding at September 30, 2022 and 25,508,044 shares at June 30, 2022" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r78", "r138" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentrations of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtConversionConvertedInstrumentRate": { "auth_ref": [ "r33", "r35" ], "lang": { "en-us": { "role": { "documentation": "Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments.", "label": "Notes payable interest rate" } } }, "localname": "DebtConversionConvertedInstrumentRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1": { "auth_ref": [ "r33", "r35" ], "lang": { "en-us": { "role": { "documentation": "The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Warrants issued" } } }, "localname": "DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtConversionOriginalDebtAmount1": { "auth_ref": [ "r33", "r35" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Original issue discount", "verboseLabel": "Original issue discount" } } }, "localname": "DebtConversionOriginalDebtAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative", "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NOTES PAYABLE (convertible only at default)" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r52", "r112", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r177", "r178", "r179" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "verboseLabel": "NOTES PAYABLE (convertible only at default)" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefault" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r70", "r71", "r167", "r237", "r275", "r276" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r15", "r70", "r176" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Debt related interest rate", "verboseLabel": "Debt instrument interest rate" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative", "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateIncreaseDecrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Incremental percentage increase (decrease) in the stated rate on a debt instrument.", "label": "Debt instrument interest rate increase" } } }, "localname": "DebtInstrumentInterestRateIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r99", "r274", "r333" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Maturity Date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r69", "r71", "r305" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Unamortized discounts" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r62", "r63", "r64", "r65", "r267" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument Risk Axis" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DevelopmentCostsCumulative": { "auth_ref": [ "r73" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The capitalized costs incurred (excluded from amortization), as of the date of the balance sheet, to obtain access to proved reserves and to provide facilities for extracting, treating, gathering and storing the oil and gas.", "label": "Software development" } } }, "localname": "DevelopmentCostsCumulative", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/AccountsPayableAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DevelopmentInProcess": { "auth_ref": [ "r83" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current amount of expenditures for a real estate project that has not yet been completed.", "label": "Software Development" } } }, "localname": "DevelopmentInProcess", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/PrepaidExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind dividends declared for award under share-based payment arrangement.", "label": "Share-based compensation" } } }, "localname": "DividendsShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r38", "r39" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings (Loss) per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r53", "r90", "r103", "r104", "r105", "r116", "r117", "r118", "r120", "r125", "r127", "r133", "r150", "r194", "r201", "r202", "r203", "r212", "r213", "r227", "r230", "r231", "r232", "r233", "r234", "r235", "r239", "r254", "r255", "r256" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r66", "r67" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r20" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General & administration" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r115", "r206", "r207", "r210", "r214", "r215", "r216", "r217", "r218" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "verboseLabel": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r102", "r204", "r205", "r207", "r208", "r209", "r211" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r32" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Cash paid for taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r27" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r27" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "[Increase (Decrease) in Accounts Receivable]", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r27" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "[Increase (Decrease) in Prepaid Expense]", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r106", "r109", "r110" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InternalUseSoftwarePolicy": { "auth_ref": [ "r49", "r50" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.", "label": "Software" } } }, "localname": "InternalUseSoftwarePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "auth_ref": [ "r28" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.", "label": "Shares issued for services" } } }, "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LegalFees": { "auth_ref": [ "r19" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.", "label": "Legal services valued" } } }, "localname": "LegalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r238" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r13", "r114", "r149", "r158", "r159", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r221", "r224", "r225", "r229", "r270", "r302", "r336", "r337" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "[Liabilities]", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r9", "r76", "r82", "r281", "r293", "r298", "r334" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "[Liabilities and Equity]", "totalLabel": "TOTAL LIABILITIES & SHAREHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES & SHAREHOLDERS' DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermNotesPayable": { "auth_ref": [ "r16" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Notes payable, net (Note 9)" } } }, "localname": "LongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentGross": { "auth_ref": [ "r51" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Computer equipment, net" } } }, "localname": "MachineryAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketingAndAdvertisingExpense": { "auth_ref": [ "r20" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising.", "label": "Marketing And Branding Services" } } }, "localname": "MarketingAndAdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketingExpense": { "auth_ref": [ "r20" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs.", "label": "Prepaid marketing services" } } }, "localname": "MarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r108" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 18.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "[Net Cash Provided by (Used in) Financing Activities]", "totalLabel": "NET CASH PROVIDED BY FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r108" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 17.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "[Net Cash Provided by (Used in) Investing Activities]", "totalLabel": "NET CASH USED IN INVESTING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r25", "r26", "r29" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 16.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "[Net Cash Provided by (Used in) Operating Activities]", "totalLabel": "NET CASH USED IN OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r18", "r29", "r77", "r84", "r91", "r100", "r101", "r105", "r114", "r119", "r121", "r122", "r123", "r124", "r126", "r127", "r130", "r141", "r142", "r144", "r146", "r149", "r158", "r159", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r228", "r229", "r271", "r302" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "[Net Income (Loss) Attributable to Parent]", "totalLabel": "NET LOSS", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited", "http://tegocyber.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recently Issued Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NotesPayable": { "auth_ref": [ "r2", "r75", "r80" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.", "label": "Notes payble" } } }, "localname": "NotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "[Operating Expenses]", "totalLabel": "TOTAL OPERATING EXPENSES" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OPERATING EXPENSES" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r141", "r142", "r144", "r146", "r271" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 7.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "[Operating Income (Loss)]", "totalLabel": "NET OPERATING LOSS" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r61" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Net Operating Loss Carry Forward" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ORGANIZATION AND DESCRIPTION OF BUSINESS" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r21" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 8.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "[Other Nonoperating Income (Expense)]", "totalLabel": "TOTAL OTHER EXPENSE" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "OTHER EXPENSE" } } }, "localname": "OtherNonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsToDevelopSoftware": { "auth_ref": [ "r22" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.", "label": "[Payments to Develop Software]", "negatedLabel": "Capitalized software development costs" } } }, "localname": "PaymentsToDevelopSoftware", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidAdvertising": { "auth_ref": [ "r266", "r272", "r299" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration paid in advance for advertising that provides economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Advertising and promotion" } } }, "localname": "PrepaidAdvertising", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/PrepaidExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r97", "r151", "r152", "r265" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses (Note 5)", "verboseLabel": "Total" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets", "http://tegocyber.com/role/PrepaidExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r23" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from shares issued" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r24" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Cash received from issuance of notes payable" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r85", "r86" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional fees" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r91", "r100", "r101", "r107", "r114", "r119", "r126", "r127", "r141", "r142", "r144", "r146", "r149", "r158", "r159", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r219", "r222", "r223", "r228", "r229", "r252", "r271", "r279", "r280", "r290", "r302" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "[Net Income (Loss), Including Portion Attributable to Noncontrolling Interest]", "negatedLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Estimated useful life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.", "label": "Receivables and Allowance for Doubtful Accounts" } } }, "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r89", "r242", "r243", "r335" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction Axis" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r89" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": { "auth_ref": [ "r72" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Management Fees" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r240", "r241", "r243", "r244", "r245" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "verboseLabel": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": { "auth_ref": [ "r59", "r60" ], "lang": { "en-us": { "role": { "documentation": "Information by form of arrangement related to research and development.", "label": "Research And Development Arrangement Contract To Perform For Others By Type Axis" } } }, "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": { "auth_ref": [ "r59", "r60" ], "lang": { "en-us": { "role": { "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others." } } }, "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r6", "r55", "r81", "r257", "r258", "r281" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r90", "r116", "r117", "r118", "r120", "r125", "r127", "r150", "r201", "r202", "r203", "r212", "r213", "r227", "r254", "r256" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated Deficit [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r268", "r269" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SalariesAndWages": { "auth_ref": [ "r291" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "Gross Wages" } } }, "localname": "SalariesAndWages", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]", "verboseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/AccountsPayableAndAccruedLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in common stock outstanding.", "label": "schedule for the Company's outstanding warrants:" } } }, "localname": "ScheduleOfCommonStockOutstandingRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Sales & marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r27" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "[Share-Based Payment Arrangement, Noncash Expense]", "verboseLabel": "Share-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r199" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Expected Dividend Rate", "terseLabel": "Expected dividend rate", "verboseLabel": "Expected dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails", "http://tegocyber.com/role/CommonSharesDetails4", "http://tegocyber.com/role/CommonSharesDetails7" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r198" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Expected Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r200" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Risk-free Interest Rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "auth_ref": [ "r58" ], "lang": { "en-us": { "role": { "documentation": "Number of non-option equity instruments exercised by participants.", "label": "Number of warrants Exercised", "verboseLabel": "Number Of Warrants Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails1", "http://tegocyber.com/role/CommonSharesDetails2" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "Number Of Warrants Granted", "terseLabel": "Number of warrants granted", "verboseLabel": "Number Of Warrants Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails1", "http://tegocyber.com/role/CommonSharesDetails2", "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Stock Price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r197" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Expected Life" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r53" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "[Shares, Issued]", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares", "verboseLabel": "Stock issued" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative", "http://tegocyber.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Share price", "verboseLabel": "Share price" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative", "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-Term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r37", "r111" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "verboseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r94", "r95", "r96", "r114", "r128", "r129", "r131", "r132", "r134", "r135", "r149", "r158", "r160", "r161", "r162", "r165", "r166", "r180", "r181", "r183", "r187", "r193", "r229", "r264", "r288", "r292", "r297" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Statement Class Of Stock Axis" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r17", "r53", "r90", "r103", "r104", "r105", "r116", "r117", "r118", "r120", "r125", "r127", "r133", "r150", "r194", "r201", "r202", "r203", "r212", "r213", "r227", "r230", "r231", "r232", "r233", "r234", "r235", "r239", "r254", "r255", "r256" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails", "http://tegocyber.com/role/CommonSharesDetails3", "http://tegocyber.com/role/CommonSharesDetails4", "http://tegocyber.com/role/CommonSharesDetails6", "http://tegocyber.com/role/CommonSharesDetailsNarrative", "http://tegocyber.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited", "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative", "http://tegocyber.com/role/RelatedPartyTransactionsDetailsNarrative", "http://tegocyber.com/role/SubsequentEventsDetailsNarrative", "http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED CONSOLIDATED BALANCE SHEETS" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY (UNAUDITED)" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r116", "r117", "r118", "r133", "r251" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetails", "http://tegocyber.com/role/CommonSharesDetails3", "http://tegocyber.com/role/CommonSharesDetails4", "http://tegocyber.com/role/CommonSharesDetails6", "http://tegocyber.com/role/CommonSharesDetailsNarrative", "http://tegocyber.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited", "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative", "http://tegocyber.com/role/RelatedPartyTransactionsDetailsNarrative", "http://tegocyber.com/role/SubsequentEventsDetailsNarrative", "http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r33", "r34", "r35" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Common shares issue value", "verboseLabel": "Proceeds from share issued" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonSharesDetailsNarrative", "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": { "auth_ref": [ "r3", "r4", "r53", "r54", "r55" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Common shares issue" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/NotesPayableConvertibleOnlyAtDefaultDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Shares issued for services, shares" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r3", "r4", "r53", "r55" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Shares issued for cash, shares", "verboseLabel": "Shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited", "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Shares issued for services, amount" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r3", "r4", "r53", "r55" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Shares issued for cash, amount", "verboseLabel": "Shares issued, value" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited", "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r4", "r7", "r8", "r45", "r281", "r293", "r298", "r334" ], "calculation": { "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "[Stockholders' Equity Attributable to Parent]", "periodEndLabel": "Balance, amount", "periodStartLabel": "Balance, amount", "totalLabel": "TOTAL SHAREHOLDERS' EQUITY" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets", "http://tegocyber.com/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SHAREHOLDERS' EQUITY" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r56", "r113", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r194", "r226" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "verboseLabel": "COMMON SHARES" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CommonShares" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r236", "r247" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r236", "r247" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type Axis" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r236", "r247" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r246", "r248" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "verboseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r40", "r41", "r42", "r136", "r137", "r139", "r140" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tegocyber.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131252-203054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(6)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394232&loc=d3e17558-110866", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r283": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r284": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r285": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r286": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r287": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r37": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r43": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "40", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=16397303&loc=d3e19379-109286", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-10.(c)(7)(ii))", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126954596&loc=d3e511914-122862", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.10)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 57 0001654954-23-002031-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001654954-23-002031-xbrl.zip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Ȁ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end

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